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Abstract
Charcot-Marie-Tooth disease (CMT) is a peripheral neuropathy presenting with distal weakness and 
sensory loss. This thesis examines the role that proximal activity plays in compensating for distal 
weakness to maintain functional walking.
Comparative 3D gait analysis showed reduced range of ankle motion kinetics in people with CMT. 
Additionally, swing phase hip flexion increased, moments and power around the knee altered during 
preswing and trunk motion increased. These changes were related to the degree of distal 
weakness. Proximal adaptations were also observed in healthy control subjects following isolated 
bilateral fatigue of the plantarflexors but did not resemble those of people with CMT.
The role the hip flexors play in compensating for plantarflexor weakness to maintain walking was 
examined in two studies. When walking on a treadmill people with CMT took an average of 48 
minutes to reach level 17 on the Borg perceived exertion scale whereas matched control subjects 
reached level 8 while walking at the same speed and cadence. After prolonged walking the 
maximum voluntary contraction of the hip flexors reduced by 20% in the CMT group. Additionally, 
hip flexor velocity reduced during swing phase and trunk motion increased. A separate study 
specifically fatigued the hip flexors by 20% resulting in similar kinematic changes to the first study, 
plus a reduction in walking time to reach Borg level 17 in people with CMT.
The effect of ankle foot orthoses (AFO) was investigated in people with CMT. A variation in the 
stiffness of the three splints was observed when worn with footwear. During walking all AFOs 
reduced footdrop during swing phase but did not reduce hip flexion. One of the more rigid devices 
also reduced the total ankle power generation during preswing.
These studies suggest that proximal compensations are present, they maintain functional walking 
and may be influenced by orthotics intervention.
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1 Introduction
People with peripheral neuropathy may present with muscle weakness, sensory loss and 
musculoskeletal deformities that in turn affects their balance and walking. The presence of such 
impairments can lead to the adoption of compensatory strategies to maintain function. 
Understanding exactly how these impairments affect walking, and the role of compensatory 
strategies in maintaining function, will in turn allow the development of more effective rehabilitation 
techniques. This investigation focuses on the most common hereditary peripheral neuropathy, 
Charcot-Marie-Tooth disease.
1.2 Pathology of Charcot-Marie-Tooth Disease
1.2.1 Classification and Genetics
Charcot-Marie-Tooth disease (CMT) is a relatively common hereditary condition that affects 36 in 
100 000 people 35. The hereditary nature and presentation of distal weakness was first described in 
1886. In the 1950s improvements in neurophysiological testing revealed differences in the speed of 
peripheral nerve conduction in individuals with an apparently similar clinical presentation suggesting 
that variations exist in the underlying pathology. In the 1960s, CMT was renamed hereditary motor 
and sensory neuropathy (HMSN) and divided into four types depending inheritance pattern, clinical 
findings and neurophysiology 21. Confusingly the terms HMSN and CMT have been used 
interchangeable since then with the patient groups preferring the term CMT. The most common 
classification now in use reverts back to the CMT label (table 1.1)
The first gene causing the CMT phenotype was mapped in 1989. Since then many more have been 
identified and an interesting observation has been made. The common CMT phenotype can be 
caused by as many as a 100 gene mutations that do not have a common theme linking them and 
the mechanism of cell damage can vary greatly depending on the mutation that occurs53
Type 1 CMT (CMT1) has a demyelinating presentation. The most common mutation is of the 
peripheral myelin protein 22 gene (PMP22) on the short arm of chromosome 17. Duplication of this 
gene causes CMT1a, that accounts for up to 80% of people with CMT. Rarer point mutations can 
occur resulting in a more severe form e.g. Dejerine-Sottas syndrome which can often start 
sporadically 21. Mutations of the myelin protein zero gene, on chromosome 1, give rise to CMT 1b 
and accounts for approximately 4% of cases. Mutations of both of these genes affect the stability of 
the myelin sheath causing demyelination. On neurophysiological examination, people with CMT1
9
have slowed peripheral nerve conduction velocities (<38 ms'1) due a reduction in saltatory 
conduction.
Type Inheritance Pathology
CMT1
(inc. Dejerine-Sottas syndrome)
autosomal
dominant
Demyelination
uniformly slowed conduction velocity <38 m/s
CMT2 autosomal
dominant
Axonal degeneration 
conduction velocities >38 m/s 68
CMTX X linked Predominantly axonal condition
CMT4 autosomal
recessive
Either demyelinating or axonal neuropathies
Table 1.1: Classification of Charcot-Marie-Tooth disease based on inheritance and pathology.
The axonal forms of CMT cause type 2 disease (CMT2) and are less common but mutation of the 
mitofusin 2 gene does account for about 10% of cases. Deficiency of the mitofusin protein affects 
the fast anterograde axonal transport system 6?. Disruption of axonal transport results in 
degeneration of the distal axon that is initially seen in longer nerves such as those supplying the 
foot and ankle muscles. The predilection for the disease process to affect longer nerves could 
reflect the increased energy required to sustain axonal transport to distant regions of the axon. 
People with CMT 2 have normal conduction velocities but show a reduction in the amplitude of 
compound motor action potentials (CMAP) and sensory nerve action potentials (SNAP) due to 
axonal degeneration.
In CMTX there is a mutation of the connexion 32 gene on the X chromosome. This accounts for 
approximately 10-15% of CMT cases with a mixed presentation of axonal loss and some 
demyelination. Connexin 32 forms gap junctions between the paranodal areas of the Schwann cells 
so myelin structure is not as compromised as in CMT 1. Nerve biopsy reveals a predominant axonal 
picture though the exact mechanism is not clear. It has been suggested that cell to cell interactions 
between Schwann cell membranes and the associated axons are affected 67
The differences between the two main phenotypes are not strictly distinct. CMT 1 may not only show 
slowed nerve conduction velocities due to demyelination but also secondary axonal loss as 
reflected by a reduction in the amplitude of the CMAP and SNAP. In CMT1 it is the reduction in 
CMAP amplitude that most strongly predicts muscle strength and physical disability 72. This 
suggests that it is axonal loss rather than primary demyelination that results in clinically identifiable 
symptoms. How demyelination leads to axonal loss in CMT1 is unclear. It may result in an alteration 
of axonal ion channels and/or increased energy requirements that lead to disturbances in axonal 
transport and subsequent axonal degeneration. There are also reports of down regulation of 
neurotrophic factors in Schwann cells where structural changes in myelin are observed 53. Further 
investigation of the cause of secondary axonal degeneration may result in future medical therapies.
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How the disease process affects the muscles supplied by peripheral nerves may also vary between 
the two phenotypes. In CMT 1 there is an increase in the motor unit size, that is, an increase in the 
number of muscle fibres supplied by one motor axon. This occurs during the chronic, slow 
denervation process when unaffected motor axons are able to produce collateral sprouts that 
reinnervate previously denervated muscle fibres. In CMT2 the motor unit size is not increased to the 
same extent as in CMT 1, however muscle biopsies show that the muscle fibres themselves are 
hypertrophied. Thus, in CMT1 there is collateral sprouting and reinnervation to compensate for 
gradual denervation whilst people with CMT2 may show a compensatory increase in contractile 
tissue as reflected by muscle fibre hypertrophy. The reasons for the differences are not clear but it 
is suggested that in CMT2 there may be a reduced ability to form collateral sprouts13.
1.2.2 Related conditions
Only the most common gene mutations have been presented in the previous section so far but 
there are associated genotypes that come under the CMT umbrella. Hereditary neuropathy with 
liability to pressure palsy (HNPP) is caused by a deletion of the PMP22 gene. The myelin structure 
is affected but not as profoundly as in CMT 1. An asymmetrical pattern of demyelination is observed 
with transient episodes of weakness and sensory loss often attributable to some type of external 
pressure or trauma 67.
Recently the gene for hereditary sensory and autonomic neuropathy type 1 (HSN1) has been 
identified as serine palmitoyltransferase, long chain base subunit 1 (SPTLC1) 27. It has been 
suggested that the name HSN1 is in fact a misnomer as it implies a predominant sensory and 
autonomic presentation. Sensory dysfunction is prominent in this condition with severe loss, 
painless injuries and neuropathic pain but weakness is also a major symptom similar to the CMT 
phenotype. Autonomic features are rare though loss of sweating does feature53. Recently there has 
been a call to bring HSN1 back into the CMT classification system 54.
1.3 Clinical presentation
The most common types of CMT show a decline in distal muscle strength and sensation that 
predominantly affects the longer peripheral nerves.
Muscle strength: The distal lower and upper limb muscles tend to weaken first showing a slow 
decline in strength over decades. On clinical testing the ankle dorsiflexors muscles may appear to 
weaken more quickly than the ankle plantarflexors despite being innervated by a shorter nerve. This 
apparent anomaly is actually because the plantarflexor muscles are much larger so the onset of
11
Chapter 1
weakness is initially not as apparent on clinical manual testing 62. The proximal limb muscles are 
less affected but are still weak compared to normative data 9
Magnetic resonance imaging (MRI) reveals that atrophy of the distal muscles can occur even when 
an individual appears unaffected on clinical examination 14. Pes cavus is a common deformity 
observed in people with CMT where the condition starts early in life and is described as a foot type 
with an excessively high longitudinal arch and foot supination (figure 1.1). Pes cavus is thought to 
develop through imbalance between the relatively spared peroneus longus and weakened tibialis 
anterior causing forefoot cavus. It is further exacerbated by imbalance between the stronger tibialis 
posterior and the weakened peroneus brevis causing forefoot adduction. Associated hind foot varus 
is thought to be caused by the unopposed tibialis posterior and long toe flexors 22,25'40-81.
I
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Figure 1.1: Distal wasting and pes cavus. Illustration outlines a high medial arch (A), mid foot 
supination (B) and dorsiflexed metatarsal phalangeal joints (C).
Toe clawing develops due to gradual wasting of the plantar lumbricals and interossei25,62 40 with 
wasting and fatty infiltration observed with MRI 14. This selective wasting of the intrinsic muscles 
results in unopposed activity of the toe extensors causing dorsiflexion of the metatarso-phalangeal 
joints. Over time flattening of the transverse arch develops, with tightening of the plantar 
aponeurosis and Achilles tendon 14. Where symptoms start later in life foot drop tends to develop 
rather than pes cavus. In such cases there is a more variable distribution of fatty infiltrate that tends 
to be higher within the lateral, anterior and superficial posterior leg compartments 14. Thus, although 
distal muscle wasting is cited as one of the cardinal symptoms of this condition it does not follow a 
stereotyped course and variations in the pattern of atrophy can occur that can be observed clinically
75
Sensory loss: In addition to weakness and wasting, a length dependant gradual loss of sensation 
occurs. People with CMT1 show a principal impairment of the thickly myelinated large diameter
12
sensory nerves that mediate the sensations of light touch and vibration 49 However, sensations that 
are felt to be conveyed by smaller diameter fibres, such as the ability to detect a painful stimulus 
like pin prick, may also be reduced 9 This implies that there is not a clearly delineated pattern of 
large fibre damage in CMT1. In CMT2 a more general mixed picture of distal sensory loss is seen 
with both large and smaller diameter sensory fibres affected.
In summary, this section describes various pathological signs observed in people with CMT that 
could potentially impair movement. Walking requires the co-ordinated execution of lower limb 
movements so one may expect gait to be altered in people with CMT. Before examining gait 
deviations in CMT, we should first define normal walking.
1.4 Normal Walking
1.4.1 Definitions of Walking and the Gait Cycle
Walking is defined as an activity where repeated limb movements propel the body forwards while 
stability is maintained 59,77 Bipedal walking is distinguished as having one foot always on the 
ground with the feet advancing alternately. Although the terms walking and gait are often used 
interchangeably, the term “gait” will be used in the current context to describe the style or pattern of 
walking 77.
1.4.1.1 Phases of the gait cycle
Walking is a repeated action (cyclic) so, to simplify the description and observation of gait, it is 
helpful to split it into individual cycles. One gait cycle starts at the initial contact of the heel (heel 
strike) and terminates when the heel of the same limb contacts the floor for a second time. Within 
the gait cycle, distinct phases are identified. Stance phase spans approximately the first 60% of the 
gait cycle and occurs from heel strike to when the toe of the same leg leaves the floor (toe off), 
corresponding to the entire period when the foot is on the ground. Swing phase is the period when 
the foot is off the ground for limb advancement and lasts from toe off to the next heel strike.
To describe the events that occur during stance and swing phase, there are further divisions into 
smaller sub-phases or segments. Different authors divide stance phase in different ways but for this 
thesis, the definitions by Whittle will be used 11. The first sub-phase is the loading response which 
occurs from heel strike to when the toe of the opposite leg leaves the ground (opposite toe off). It is 
essentially the period of double support where both feet are on the ground sharing the body’s 
weight and typically lasts for the first 10-12% of the whole cycle. The next segment is mid stance or 
the single support phase. This spans from opposite toe off to when the heel of the stance leg starts 
to rise (heel rise). This segment represents about 18% of the cycle and corresponds to when the 
opposite, swinging leg passes the stance leg. Terminal stance is the segment between heel rise
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and the heel strike of the opposite leg. It is the last portion of the single stance phase and leads into 
preswing. Preswing occurs from opposite heel strike to toe off of the stance leg and is a period 
when both legs are again in contact with the ground. Swing phase accounts for approximately 40% 
of the gait cycle and can be further divided into initial swing (toe off to when feet are adjacent), mid 
swing (from feet adjacent to where the tibia of the swinging leg is vertical) and terminal swing (tibia 
vertical to the next heel strike). The length of stance and swing phase determines the gait speed 
with an inverse relationship 59,77; the shorter the gait phases, the faster the walking speed.
1.4.1.2 The mechanics of walking
The linear forward progression of the body during walking is achieved through angular motion at 
joints that connect adjacent body segments. Angular motion of a joint is caused by force acting at a 
distance from the joint axis resulting in a torque or moment. The direction of joint motion is 
determined by the summation of all the moments acting on the interconnected limb segments.
During walking, turning moments are normally caused by a combination of external and internally 
generated forces and moments. External forces include gravity (that acts downward through the 
centre of mass of the segment); and ground reaction responses (that act through the point of 
contact of the body with the ground). Internally generated moments are mainly due to the actions of 
muscles. The torques generated by the ligaments and peri-articular soft tissues are small as their 
line of action pass close to the joint axis and the structures are normally lax when the joints are not
78at the end of their range of motion
1.4.1.3 Energetics of walking
For a body segment to move, work must be done on that segment. Much of this energy is derived 
from muscle activity. All types of muscle contraction will expend chemical energy associated with 
excitation-contraction coupling. However, the resulting mechanical work done varies depending on 
whether the muscle contraction is concentric (where the muscle shortens), isometric (where there is 
no movement) or eccentric (where the muscle lengthens). With a concentric contraction the muscle 
moment acts in the same direction as the angular velocity of the joint and positive work is done. 
Energy is transferred from the muscle to the segment and the power, the product of the muscle 
moment and the joint angular velocity, is positive and is said to be generated. With an eccentric 
contraction the muscle moment acts in the opposite direction to the angular velocity of the joint. 
Energy is transferred from the limbs to the muscle. Here the power is negative and is absorbed,
either stored as elastic potential energy within the muscle-tendon complexes and ligaments or
82dissipated in the muscle . In contrast with an isometric contraction no net mechanical work is 
being done although the muscle still spends chemical energy.
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Determining the flow of energy between segments is complicated by the multi-link structure of the 
body. Energy can be transferred directly between segments with the direction and type of energy 
flow depending on the relative motion of the two segments 61. However, energy can also be 
transmitted to distant segments that the muscle does not directly attach to. For example, the soleus 
muscle generates force that will control the lower leg (shank) and foot. However, it also influences 
the more proximal knee and hip joints that it does not span through a process called dynamic
coupling. The joints transmit forces from one segment to the other via joint inter-segmental forces
82(internal joint reaction forces)
The architecture of the muscle also needs to be considered. The example given above is of a uni­
articular muscle, but bi-articular muscles may work differently. A bi-articular muscle will 
simultaneously produce moments at the spanned joints but the muscle may rotate a joint opposite 
to its muscle moment because the moment of the second joint produces a stronger counter 
acceleration. As a result of this the energy flow between segments caused by the activity of a bi- 
articular muscle is the summed energy flow due to the two moments51,82.
1.4.1.4 Biomechanical analysis of human walking
Individual human muscle moments cannot be directly measured, instead net moments and forces 
are often calculated. The net moment is the sum of the individual moments about a joint derived 
from forces developed by muscles and other structures crossing that joint, such as ligaments. The 
net force or joint inter-segmental force arises from the acceleration of the body and external forces 
such as gravity and the ground reaction force. By measuring the body’s motion and the application 
of any external forces it is then possible to calculate these net forces and moments; a process 
called inverse dynamics. When the joint angular velocity is known it is possible to calculate the net 
power at different joints. There are some limitations to the inverse dynamics approach that must be 
considered. Individual joint moments do not reflect the activity of a given muscle group. In particular, 
the effect if bi-articular muscles are difficult to account for with this approach as is the influence of 
the proximal segments (pelvis, trunk, upper limbs, head) on the leg segments. It does not account 
for the energy expended during isometric contractions or to overcome antagonist muscle activity. 
Thus, although the sum of the individual joint powers should reflect the rate of energy production by 
the whole body it does not always equal measures of energy consumption estimated by other 
methods especially in people with pathological gait patterns79'82.
More recently forward dynamics models have been produced that simulate the musculo-skeletal 
system (including the head, arms and trunk as the HAT segment, individual muscle forces using 
Hill-type muscle actuators) and ground reaction forces. Such muscle-based simulations provide an 
estimation of the flow of mechanical power that may be generated by individual muscles. An 
example is the dynamic optimisation model 4. This model is optimised by varying the muscle
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excitation magnitudes and activation times and by kinematic alignment at the beginning and end of 
the gait cycle. The aim of the optimisation is to minimise the cost function (total metabolic energy 
consumed/displacement of the centre of gravity). The dynamic optimisation model has been 
compared with experimental data and was found to reproduce the salient features of normal gait4 
This method was utilised by Neptune et al 51 to explore which muscles contribute to forward 
progression of the body during walking 51. It also has a role in understanding pathological gait when 
impairments such as weakness or over-activity are simulated and has recently used been used to 
understand muscle functions related to impairments such as hip stiffness, and clinical gait 
dysfunction such as in crouch gait or walking with a below-knee amputation 5> 18,83,84
1.4.1.5 Muscle activity during walking
The pattern of muscle activity during walking is complex and concurrently helps to support the body 
weight, maintain balance and advance the limbs and trunk. The following section will review the 
muscles active during walking, emphasising the role of the ankle muscles that are often severely 
affected in CMT. To simplify the description, the task of walking will be summarised into four 
locomotor functions as described by Perry59.
Progression: The muscles that progress the body forwards during gait have been explored by a 
variety of methods. In early stance to mid-stance forward dynamics modelling studies, as described 
earlier, indicate that gluteus maximus and the quadriceps contribute to the forward progression of 
the trunk. The vasti muscles of the quadriceps are known to decelerate and slow the leg by acting 
eccentrically but by mid-stance they also act to accelerate the trunk due to a hip inter-segmental 
force that is directed upward and forward as they extend the knee 51 ’83. During this time the soleus 
is active to decelerate the tibia which allows the knee to accelerate into extension thus assisting the 
vasti5-18-29-50
The ankle plantarflexor muscles generate nearly all of the positive work in late stance and early 
swing. Their contribution is thought to be the body’s forward progression but this has been an area 
of speculation. Early studies contemplated whether the ankle plantarflexors actively pushed down to 
propel the body upwards against gravity. An investigation of ankle plantarflexors weakened through 
tibial nerve block found that there was a reduction in the second peak of the vertical component of 
the ground reaction force, normally associated with plantarflexor push-off, but there was no drop in 
the body’s forward velocity 69. The authors concluded that this demonstrated that the plantarflexors 
were involved in forward progression not propulsion vertically. An inverse dynamic study analysed 
joint powers and mechanical work done 43 It supported the findings of the first study with reports of 
plantarflexor contribution to forward velocity of the trunk and not to lifting the trunk up against 
gravity. They suggest that another mechanism to progress the trunk forwards is the “pull phase” at 
the end of swing phase i.e. energy transferred from the swing leg to the trunk as the leg is
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decelerated through eccentric activity of the hamstrings. In addition they found that at pre-swing 
there is primarily a transfer of energy to the leg accelerating it into swing phase.
Optimization modelling studies have investigated the role of the plantarflexors in accelerating the 
leg and trunk 50,51,83 They suggest that the individual plantarflexor muscles work differently.
Soleus, through a concentric action, decelerates the thigh and shank. This redistributes energy to 
the trunk resulting in trunk forward acceleration. The rectus femoris muscle works in synergy with 
soleus; when contracting eccentrically it decelerates the leg transferring energy to the trunk. In 
contrast the gastrocnemius delivers energy to the leg working synergistically with the uni-articular 
hip flexors to accelerate the thigh, shank and foot segments.
There is some controversy about whether or nor the plantarflexors, mainly gastrocnemius, actually 
initiate swing. This is based on the timing of activity of the plantarflexors which are active at 52% of 
the gait cycle whereas toe off occurs at about 60% 19 indicating that it is the hip flexors that are 
responsible for swing initiation. One study used an alternative method of investigating this approach
19measuring EMG when stepping and trunk progression was assisted . They found that when swing 
phase was assisted with a pull forwards on the feet, there was no change in medial gastrocnemius 
and soleus EMG but a reduction in iliopsoas activity was seen. A change in the plantarflexors was 
observed when trunk progression was assisted. A problem with this study was that the assistance 
given to the feet was linear which may have affected the action of the plantarflexors and could have 
caused them to brake the stance limb if the assistance was perceived as a perturbation. Another 
modelling study suggests a combined influence on swing initiation with swing phase initiated by a 
combination of gastrocnemius activity from late-stance to pre-swing and iliopsoas from pre-swing to 
swing51.
Upright support: To maintain upright support during walking a combination of anti-gravity muscle 
activity and balance is required. When the heel strikes the ground at the beginning of stance phase, 
muscle activity is required to prevent the body’s segments from collapsing under the influence of 
gravity.
The support role of the muscles is shared and varies through the support period. Early in stance 
phase, the vasti acts eccentrically on the leg to decelerate the thigh segment and prevent collapse 
at the knee as the centre of mass moves forward (loading response). The ankle plantar flexors and
3 18 28 29hip extensors also support the limb to control the range of ankle motion during loading ■
During the single stance phase, soleus and gastrocnemius generate inter-segmental forces that act 
through the knee and hip to accelerate the trunk upwards3’5’29'50183. At mid-stance, gluteus medius 
and minimus support the trunk in the coronal plane. The passive resistance of the joints and bones
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also play a significant role at this point. In late stance soleus and gastrocnemius provide the 
majority of segmental support and contribution to the ground reaction force3'50,50,83.
Winter (1980)80 introduced the concept of the support moment which is the sum of the hip, knee 
and ankle moments. He found that the variance of the support moment is less than that of the 
individual contributing moments. He further observed that if the ankle moment was low, the hip 
and/or knee moment would increase keeping the size of the support moment constant. This implies 
that variations in the moment produced by one joint can be compensated for by the remaining two 
joints. This model has recently been re-interpreted following a biomechanical analysis using a 
simple three segment model of the leg. To prevent collapse of the knee in stance phase does 
indeed require contributions from the hip, knee and ankle moments suggesting that the concept of 
the support moment is valid. However, in the new model the hip and ankle moments had half the 
weighting of the knee moment 24,77. The implication of these models is that muscle activity around 
the hip, knee and ankle joint can vary during stance phase providing their sum (support moment) 
remains the same.
As the muscles are working to maintain upright support and progression during walking the body 
must remain balanced during these movements and correct any perturbations. The challenge in this 
situation is that the centre of mass is in motion and the base of support changes its size through the 
gait phases. The traditional view of balance is that stability is achieved when the centre of mass is 
within the base of support but when walking this is only true for 20% of the gait cycle 58. Strategies 
to maintain or regain balance must be able to adapt to changing environmental and individual 
contexts and a combination of reactive, predictive and anticipatory strategies are utilised 45,58.
If the body is perturbed while walking, reactive strategies are employed to preserve stability. They 
rely on sensory input from the visual, vestibular and proprioceptive systems. Fast acting responses 
are required to prevent the body from falling but if a person does lose their balance when walking 
we do not observe local stereotyped responses one may associate with a reflex response. The 
muscles involved in the response to perturbation can involve the whole body, are context specific 
and can be biased. For example, if an individual is holding a hand rail, postural responses will be 
seen in upper limb muscles following perturbation. In contrast, if the arms are constrained any 
postural responses will predominantly occur in the leg muscles 45. Following an unexpected 
perturbation, voluntary responses would be too slow to prevent falling 58. What seems to happen is 
that there is an immediate short latency reactive response followed by a subsequent response the 
timing, magnitude and co-ordination of which are modulated according to the task conditions 58 
Misiaszeck 45 suggests that these fast acting responses are probably mediated by the spinal cord or 
brainstem. Sensory information is not only used reactively to trigger and modulate postural 
responses following perturbations. Multi sensory information is constantly monitored and provides
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ongoing information about body dynamics, relative limb positions and orientations. Such information 
is used to plan appropriate future motor responses. Balance control can also be anticipated based 
on visual information, for example permitting obstacle avoidance. Prior experience of balance 
perturbation will also influence the motor response58.
Shock absorption:
At heel strike, the trunk is accelerating forwards and downwards so the impact at foot contact could 
potentially be high, jarring the joints of the lower limb and trunk. Mechanisms at the foot, ankle, 
knee and hip help to reduce the magnitude of this impact. The fat pads under the heel serve to 
smooth the peak forces on impact and dampen vibration 64. Just after heel strike but before the foot 
falls flat to the ground, the dorsiflexors and ankle invertors act eccentrically to control plantarflexion 
and pronation29. By delaying the foot contact with the floor the dorsiflexors are acting to reduce the 
rate that the trunk falls forwards and down thus decreasing peak vertical force 59 At heel strike, the 
ground reaction force vector is anterior to the hip and posterior to the knee so creating a flexor 
torque at those joints. An internally generated extensor moment is required as the trunk moves 
forward and activity of the vasti and gluteus maximus is observed during this early stance period. 
The eccentric activity of the vasti muscles absorb the impact and dissipate energy into the muscle3’ 
59 so further reducing peak impact forces 17. As the fore-foot contacts the ground, shock absorption 
is provided by fat pads over the metatarsal heads but forces are also dissipated through energy 
storage in the muscles and ligaments of the foot. As weight is taken on the foot, it deforms as the 
soft tissues are strained. Much of the energy is stored in the plantarflexor muscles and plantar 
ligaments and can be used to deliver energy by elastic recoil later in the gait cycle 64
Energy conservation:
During walking the centre of mass (COM) moves vertically and medio-laterally. The total energy of a 
point mass is the sum of its gravitational potential energy plus its translational kinetic energy. It 
could be suggested, therefore, that the factors that reduce vertical excursion of the COM could 
reduce the energy cost of walking. In the 1950s a model of walking described six determinants of 
gait that were felt to conserve energy while walking 65 The original model was of two footless rigid 
limbs with rotation at the hip which described a gait pattern know as ‘compass gait’. This pattern of 
walking describes movement of the COM as an arc, with two depressions per gait cycle. The peak 
of the arc was mid-stance/mid-swing and the troughs were during the period of double support 
double support as weight switches from the trail to the lead leg. As each of the six determinants of 
gait were added on (pelvic rotation, pelvic obliquity, knee flexion in stance, foot rotation, heel rise, 
lateral displacement of trunk) then the centre of mass motion decreased its displacement11,17.
This model was accepted clinically and scientifically for decades but more recently research has 
taken place to investigate the role of the six determinants. Gard and Childress 16,17 demonstrated
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that the change in pelvic obliquity and knee flexion in stance did not alter the vertical trajectory of 
the trunk during walking. They suggest that both movements are actually strategies employed for 
shock absorption at heel strike. An investigation of the effect of heel rise on the centre of mass 
trajectory showed that the degree of rise contributes significantly to raising the centre of mass 
height when it is at its lowest point of the trajectory 31. This group found that the heel rise 
component accounted for 2/3 of the reduction in centre of mass displacement with pelvic rotation 
also contributing. Although some of these determinants have some influence of the path of the 
centre of mass, we must ask whether this indeed represents energy cost during walking. Kerrigan et 
a l32 found that vertical displacement of the centre of mass reliably predicts oxygen consumption 
when walking. Other authors point out that it would take a lot of effort to walk with the centre of 
mass trajectory completely flat and that the up and down motion allows mechanical energy to be 
stored and released during a cycle 11.
1.5 Altered Gait in CMT
This section will describe gait in people with CMT. Subsequent sections will explore the cause and 
effect of these changes. Up until the experimental work for this thesis commenced, there were only 
three small studies describing gait in adults with CMT and one larger study in children. Very 
recently, two new larger studies of gait in adults with CMT have been published that describe gait 
deviations using 3D kinetic and kinematic analysis 12,52. These studies did not contribute to the 
formulation of the original hypothesis for this thesis so will not be described here. They will, 
however, be discussed in the experimental chapters and final overview where they will be 
compared with the results of this work.
The first of the four studies is a descriptive observation of 12 subjects by Sabir and Lyttle 62. The 
second study by Hood and Whittle 28 used kinematic analysis and clinical measurement in nine 
subjects to investigate gait deviations, compared to normal laboratory values, and related the 
numbers of deviations observed to clinical measures. A third study by Kuruvilla et a l36 did a more 
detailed kinetic and kinematic analysis of five people comparing gait deviation in CMT to normative 
data using grand average graphs but no statistical comparisons were performed. A larger study of 
children with CMT by Ounpuu et a l57 compared kinetic and kinetic variables to normal laboratory 
data in 19 subjects. Comparing gait data of children and adults may be problematic in that certain 
gait deviations may be due to incomplete gait development, though in this study there were no very 
young children i.e. below five years. In a progressive condition such as CMT, though, one may 
expect impairments to be more severe in adults due to the extended duration of the disease 
process. There is also a methodological problem where gait data is compared to laboratory normal 
data in that there may be differences in gait variables due to faster gait speed of control subjects 37. 
None of the studies accounted for this methodologically or statistically.
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In all four studies foot drop during swing phase was observed with Kuruvilla et al 36 describing 
excessive plantarflexion prior to heel strike. Hood and Whittle26 reported its presence in five out of 
nine subjects and the study of children by Ounpuu et a l57 noted the variability of presentation with 
the absence of foot drop in some subjects with distal weakness. The observational study by Sabir 
and Lyttle additionally describes a small increase in flexion of the hip and knee and an elevation of 
the pelvis during swing phase 62. They attribute this finding to a proximal mechanism to keep the 
toes of the dropped foot from contacting the floor. Hood and Whittle reported that increased hip 
flexion was not observed in all subjects (four out of nine) and state that the so called ‘steppage gait’ 
is not necessarily a common characteristic 26 They also reported that the most common gait 
deviations were excessive motion of the pelvis in the horizontal plane (seven out of nine) and the 
coronal plane (six out of nine) 26. In contrast, Kuruvilla et al reported a near to normal range and 
pattern of motion of the hip36. The study of children did not report on pelvic and trunk motion.
In addition to foot drop, a lack of propulsive action of the plantarflexor muscles has been described. 
Ankle kinetics during the propulsive phase (preswing) were significantly less than normal values, in 
two studies, though these findings should be interpreted with caution due to the lack of account for 
differences in gait speed as discussed 57 36. Sabir and Lyttle reported that subjects compensated for 
the lack of propulsion at swing phase by lifting the trailing foot from floor by elevating the pelvis and 
flexing the hip and knee. This then necessitated a lateral shift of the trunk over the stance leg to 
maintain balance 62. Kurvilla et a l36 also noted this trunk shift but deduced that it was due to hip 
abductor weakness, despite having no measures of abductor strength to verify this 36 A further 
source of disagreement between the studies is over motion of the knee at heel strike. Sabir and 
Lyttle describe a hyperextension action at the knee 62 and Kuruvilla et al other describe excessive 
flexion 36. The study by Hood and Whittle found both deviations with increased stance knee flexion 
in six out of nine subjects and knee hyperextension in three out of nine. All three studies had small 
numbers so it is difficult to generalise the findings and but as with other deviations already 
discussed these differing observations also indicate that there is much variability in gait pattern in 
people with CMT.
1.5.2 Distal muscle weakness and compensatory strategies
Weakness and wasting in the muscles below the knee is a well recognised feature of CMT causing 
the classic ‘inverted wine bottle’ appearance of the lower leg. The ankle plantarflexor muscles are 
necessary to provide propulsive forces to continue gait progression through acceleration of the 
trunk and leg. In CMT the plantarflexors are weak and may be unable to provide sufficient force to 
do this as effectively (plantar flexor failure). Weakness of the anterior tibial muscles prevent 
sufficient dorsiflexion at mid-swing when the leg is at its longest. If there is inadequate dorsiflexion
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at mid-swing there is difficulty with foot clearance and a risk of tripping (foot drop)59 Despite these 
failings, people with CMT are still able to walk and progress forwards without tripping continually. 
This is because they have adapted their gait to compensate for these problems.
Studies of gait in CMT described in the previous section have suggested that the hip may 
compensate for distal weakness although they did not explore this in detail. Investigations in other 
neurological conditions were therefore considered to infer what may be occurring in people with 
CMT. One study of people with diabetic neuropathy showed a significant reduction in ankle joint 
moments and power compared to healthy controls. Further, the onset of hip flexion at the end of 
stance phase occurred earlier in the patient group than in the controls. It was suggested that the 
less affected hip compensates for the lack of propulsive activity of the plantarflexors at pre-swing by 
pulling the femur through to achieve limb progression 46
In people who had a stroke, the “percentage utilisation” for a muscle was measured at normal and 
maximal gait speeds 47. The joint moments estimated by inverse dynamics during walking were 
compared to the maximum torque that could be achieved at the same velocity as extrapolated from 
direct recordings of applied torque using a dynamometer. While walking, people with a stroke had a 
higher “percentage utilisation” compared to controls, that is, after stroke the peak ankle plantarflexor 
moments during walking was close to the maximal that could be achieved using the dynamometer. 
Although the joint moment during walking does not solely reflect muscle activity this finding was 
taken to suggest that the plantarflexor was working close to maximum during gait after stroke. The 
plantarflexor strength after stroke correlated inversely with the walking speed suggesting that 
weakness in this muscle may strongly influence walking speed as suggested in other studies. There 
was, however, variability in hip flexor strength in the stroke group that additionally seemed to 
influence gait speed. Subjects who had low hip flexor strength and were using their plantar flexors 
maximally tended to walk slower. In contrast, subjects who also used their plantarflexors maximally 
but had stronger hip flexors tended to walk faster. It was suggested that the stronger hip flexors 
were able to compensate for the inability of the plantarflexors to produce higher moments at faster 
walking speeds. Olney and Richards 56 further describe an increased hip flexor moment on the 
hemiparetic side of people following stroke that is highly correlated with gait speed.
Based on this evidence it is possible that in CMT a similar situation arises where the relatively intact 
hip flexors compensate for weak plantar flexors to accelerate the leg as swing is initiated. During 
normal walking, hip flexor muscle activity starts at about 55% of the gait cycle and hip flexor power 
is generated around this time. If the hip flexors are compensating for inadequate plantar flexor 
activity a difference in the timing or size of the hip flexor torque could be expected to help progress 
the limb forward. Further, with prolonged use it could be hypothesised that fatigue of the hip flexors 
could result in a breakdown in such a compensatory strategy that could limit walking distance.
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Indeed subjective reports from people with CMT attending the neuro-genetics clinic at the National 
Hospital for Neurology and Neurosurgery (NHNN) suggest that people often feel fatigue in proximal 
muscles around the hip with prolonged walking. Therefore as well as distal weakness, fatigue in 
proximal compensatory muscle may limit walking distance in CMT. However, there are other factors 
that may also limit walking endurance and speed that will be discussed in the next section.
1.5.3 Additional factors that may limit walking in CMT
1.5.3.1 Musculoskeletal changes: Biomechanical changes at the foot and ankle are common in 
CMT and have the potential to limit movement at the joints during the gait cycle either through 
biomechanical constraints or pain. The most frequent deformity observed is pes cavus 
characterised by mid and/or forefoot supination, plantar fascia tightness and Achilles tendon 
shortening. Each of these features can affect motion of the foot during stance phase.
Supination of the foot is often accompanied by calcaneal varus creating a rigid foot structure that 
has limited shock absorbent properties 7 The shape of the foot will also alter the initial point of 
contact at heel strike. It is normal to land on the lateral part of the heel on first contact but people 
with pes cavus will often land on the lateral border of the mid and forefoot 59, often resulting in 
excessive callous accumulation on the point of loading. Another consequence is an increased risk 
of ankle inversion injuries and ankle pain that commonly worsens with prolonged walking.
In addition to problems on initial loading, mid stance foot alignment can be affected due to tightness 
of the plantar fascia. The foot normally pronates during mid-stance to allow loading of the medial 
forefoot and first metatarsal but in pes cavus this is inhibited by planter fascial shortening. The 
changes in loading can lead to secondary problems such as pain. The causes of pain in the pes 
cavus foot has often been attributed to changes in plantar pressure distribution with the most 
common complaints being metatarsalgia and plantar fasciitis 7 A study of subjects with idiopathic 
pes cavus, neurogenic pes cavus (CMT) and healthy control subjects showed that both of the cavus 
groups were more likely to report foot pain. Increases in peak plantar pressures at the rear and 
forefoot were observed due to decreased mid foot loading in both cavus groups. In addition, CMT 
subjects demonstrated a prolonged foot contact time, due to distal weakness 7, that may also 
contribute to painful syndromes.
Achilles tendon tightness is very common in CMT and primarily restricts motion during some phases 
of gait, resulting in a premature heel lift and reduced ankle dorsiflexion during stance 59 Some 
authors argue that one benefit of Achilles tendon tightness is an increase in the passive moment at 
the ankle that could assist with push off. This has been investigated in peripheral neuropathy 63. 
Multiple regression analysis revealed that ankle stiffness accounts for a significant portion of the
23
peak plantarflexor moment at push off when there is weakness of the plantarflexor muscles. In 
addition, stiffness seemed to help control the forward motion of the tibia in early stance phase. The 
authors actually recommend stiffening the ankle further to increase to the passive moment at push 
off recommending caution against overstretching the Achilles in physiotherapy programmes. These 
recommendations need to be considered with caution, however, as the effect of restricting ankle 
motion on joint kinetics, in particular ankle power during preswing, was not discussed in the study.
1.5.3.2 Balance and sensation: Balance impairment is another potential influence on walking and 
gait, though this has mainly been investigated in standing. A study looking at postural sway 
observed a difference between people with CMT1 and CMT2 with an increase in sway area in 
CMT2 patients. The proposed explanation was that in CMT2 there is a mixed picture of sensory 
loss with large and small fibres being affected whereas in CMT 1 the larger fibres are preferentially 
degenerated. It was suggested that the smaller diameter fibres (e.g. type II spindle afferents) have 
a role in detecting the small, slow changes in muscle length that occur in standing. In contrast, the 
larger fibres (e.g. type 1a spindle afferents) are more velocity dependant and will not be activated 
by the small, slow oscillations that occur at the ankle during standing 48. However, during walking 1a 
afferents may be of importance. In people with CMT1 a delayed soleus stretch reflex is seen due to 
the preferential loss of type 1a afferents. This may account for some of the problems seen with 
dynamic balance. This evidence coupled with experiments pertubating the ankles of healthy 
subjects during walking suggests that the signals arising from the larger, group 1a nerve fibres are 
important in the modulation of soleus activity during locomotion 41,55
1.5.3.3 Deconditioning and fatigue: The discussion about gait in people with CMT has so far mainly 
looked at the effect of different impairments on gait kinematics and kinetics. For gait to be truly 
functional, it must be sustained over time. This can present two problems for people with CMT. 
Firstly, the compensations that have been developed to maintain locomotor function may require 
additional muscle activity so increasing the metabolic cost of walking. This has been observed in 
studies of people with peripheral neuropathy who showed increased aerobic or physiological cost 
when walking 6’ 20 Secondly, in chronic neurological diseases it is common for people to become 
de-conditioned due to reduced general activity levels. Indeed, people with CMT demonstrate 
reduced aerobic capacity during exercise. A bicycle ergometer test protocol demonstrated a 50% 
reduction in V02 max, compared to healthy subjects at 85% of maximum heart rate9 A reduction in 
maximum aerobic capacity in CMT will mean that patients would reach their maximum capacity 
earlier so making walking effortful and potentially limiting the duration of the activity.
A potential consequence of deconditioning is that 64% of CMT patients report severe fatigue 30. A 
study using the Sickness Impact Profile revealed high agreement with statements that come under 
the ‘sleep and rest’ and ‘alertness’ sections. The link between fatigue and deconditioning, however,
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has not been examined and fatigue is often caused by multiple factors. The nature of fatigue in 
CMT was investigated by a study comparing fatigue severity, measured by the Checklist Individual 
Strength (CIS-fatigue), with general health measured by the short form 36 (SF-36). There were no 
significant relationships between fatigue and sections of the SF-36 , such as physical functioning, 
social functioning and body pain 30 though other studies do show a reduction in all sections of the 
measure when compared with the healthy control subjects 70,76.
Studies of local muscle fatigue demonstrate that although CMT subjects are initially weaker than 
control subjects, they do not show an abnormal rate of fatigue when contracting repeatedly to the 
same percentage of their MVC 39166,73. It has been suggested that people with a lower maximum 
voluntary contraction (MVC) at the start of a task may reach a level of fatigue more quickly due to 
an inverse relationship between the percentage maximal force generated and the time to fatigue 
when performing repeated contractions to a set force/torque level 42. In addition, people with CMT 
will be working at a higher percentage of their maximum force generating capacity in order to 
perform functional tasks 66171. A recent study has examined fatigue more closely with a comparison 
of reported fatigue with peripheral fatigue, central activation and central fatigue in people with CMT 
(n=73) 66. This study used a twitch interpolation method to ascertain the peripheral and central 
influences on force degradation before and after a two minute sustained MVC of the biceps. They 
found that peripheral fatigue was less than control subjects (n=24) which they explained by 
differences in occasional blood flow. Interestingly, there was no correlation between peripheral and 
reported fatigue. In contrast they found that central activation failure and central fatigue was 
increased in people with CMT and central activation did relate to reported fatigue. This supported 
the suggestion that impairments of central drive are a key component of fatigability and the 
subjective experience of fatigue in neurological conditions 42 The reasons for reduced central 
activation are not clear but could related to adaptations of the central nervous system.
In people with CMT the sensory disturbance is another major presentation. A reduction in 
peripheral feedback from type la and type II sensory afferents may contribute to reduced central 
excitation of motor neurons during voluntary contractions 42 Also, disuse is a common problem in 
people with neuromuscular disorders that has been implicated in contributing to a reduced voluntary 
drive. In order to maintain the ability to maximally recruit motor neurons, voluntary use is necessary 
and this ability will be diminished in a disuse scenario 15,42,66. To overcome fatigue, people must 
increase the voluntary drive to the motor neurones and this can be perceived as increased effort 
which may further reduce motivation 71.
As can be seen from the investigations of fatigue in CMT to date, it is a commonly reported 
symptom that may have multiple causes though central activation appears to be influential. What
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remains to be seen, however, is how fatigue impacts the functional abilities of people with CMT and 
what potential interventions can help to alleviate or manage the symptom.
1.5.4 Current management of gait dysfunction in CMT
There are few good quality intervention trials of management strategies for gait problems in CMT. 
There are only three randomised control trials of interventions and of the other studies there are 
methodological problems and a variety of outcome measures making comparison and meta­
analysis difficult. This section describes and critiques some of these studies.
1.5.4.1 Orthotic management:
Foot orthoses have been recommended for people with foot deformity to either distribute pressure 
under the plantar surface or correct flexible pes cavus using lateral posting 2> 81. One good quality 
randomised control trial investigated the effects of foot orthoses in painful pes cavus 8. As such, the 
main outcome measures were foot pain and function using the Foot Health Status questionnaire. 
The sample size was powered and the group interventions included a prescribed, custom made foot 
orthoses and a flat sham insole. Groups were randomised and participants were blinded. The 
results demonstrated a significant improvement in foot pain and function. Analysis of plantar 
pressure distribution demonstrated that the customised orthoses reduced plantar pressure 
particularly at the fore and hind foot. It was concluded that this was the mechanism of the 
successful intervention. This study looked at a number of different conditions presenting with pes 
cavus though the majority of subjects had CMT. In addition there was no functional gait measure 
and it would have been interesting to investigate if the reduction in pain had a positive effect on 
parameters such as gait speed or maximal distance.
Very few studies have investigated the use of ankle foot orthoses (AFO) in people with CMT. The 
only study to look at the effect on gait is a single case study which examined perceived exertion, 
oxygen consumption and cardiac stress for an individual when wearing a basic posterior leaf AFO 
and a custom made device 6. The study found improvements in all three variables when the subject 
wore the custom made AFO. Although this was a good A-B-A single case study design, it was 
investigating a very specific situation and individualised intervention parameters making 
generalisation to other people difficult. The only other study of AFO intervention in people with CMT 
was a study of standing though the group investigated also included people with other lower motor 
neurone disorders 23. The intention of this study was to investigate people who were able to walk 
but not stand still on the spot. They found that people who showed this feature had severe bilateral 
weakness of the posterior tibial muscles. When ankle foot orthoses were worn, 14 out of 16 
subjects demonstrated a significant reduction in the path length of the centre of pressure over 30 
seconds. The study did not report a group effect so it is unclear if this was significant and there was 
no functional measure to see if this extra support assisted the subjects in activities of daily living.
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The only other study of external support was actually an investigation of the effect of night splinting 
to stretch the Achilles tendon 60. The effect of stretching programmes have been recommended in 
people with flexible deformity but it is not known if they are effective in assisting gait2. The night 
splinting study recruited 14 adults and children with CMT to a randomised, cross over trial. The 
intervention phase involved wearing a night splint set into maximum dorsiflexion on one leg for a 
period of six weeks. The cross over process involved the splint being worn on the other leg so the 
non-splinted side acted as the control. The main outcome measure was passive dorsiflexion and 
eversion range of motion and was powered to show a change of 5° dorsiflexion. The study found 
no significant effects on range of motion. The authors attributed the lack of effect to problems with 
positioning the foot within the splint that could have affected the efficacy of the stretch applied. They 
acknowledge that positive subjective reports from subjects were received. This could be because of 
a change in stiffness of the muscles, rather than passive range but this was not measured in this 
study. In addition there were no functional measures to see if these subjectively reported benefits 
carried over into activities of daily living.
1.5.4.2 Exercise and strengthening:
Early studies of strengthening of people with CMT were problematic to interpret in that they were 
mixed pathology studies and included people with different muscular dystrophies (M D)1>33 34 . CMT 
and muscular dystrophy, although both under the neuromuscular umbrella, affect different 
structures so looking at a group effect is difficult. Studies looking at strengthening and muscle 
fatigue in people with CMT and myotonic dystrophy have shown differences between the two 
groups 3d. In addition, these studies looked at strengthening the quadriceps muscles. The 
distribution of weakness in both conditions can be different and people with MD and proximal 
weakness may have reduced potential to strengthen compared to the CMT group 44. One 
randomised control study of strengthening in CMT and myotonic dystrophy actually separated the 
diagnostic groups 38. Subjects used weights to strengthen their knee flexors and extensors and hip 
extensors and abductors using a resistance of 60% of their one repetition maximum (1RM). This 
was progressed over a 24 week period to 80% of their 1RM with sessions being performed three 
times per week. The main outcome measure was isokinetic measurement of knee torque but this 
study also included functional tasks such as timed stair climbing and descent, standing from a chair, 
standing from supine and two times walk tests. People with CMT showed a significant improvement 
in knee torques that was comparable with strength training in healthy individuals. There were no 
significant improvements in the timed functional tests except for self selected gait speed.
A more recent article has investigated resistance training in an exclusively CMT sample 10. This was 
a trial of resistance training over a 12 week period with no control group. Twenty subjects trained 
their knee extensors and flexors and elbow extensors and flexors with a resistance of 40% percent
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of their maximum voluntary contraction for the knee and 20% for the elbow. This was progressed 
over the training period. Outcome measures included fixed myometry for strength measures, body 
composition and functional tests including timed rise from a chair and timed stair climbing. This 
study demonstrated improvements in strength and pooled scores for the functional tests. The main 
drawback to this study was the lack of control group and the improvements observed, particularly 
with the functional tests, could have been a learning effect. One important outcome of all of these 
strengthening studies, however, is that there were no reported adverse effects of moderate 
resistance training in people with CMT which should reassure clinicians prescribing exercise in the 
face of concerns about overwork weakness74.
1.5.4.3 Surgical management of foot deformities:
A number of surgical procedures are available to people with CMT. The aims of surgery are to 
balance forces and relieve symptoms, usually pain, and the procedures are dependent on the 
disease duration and presentation plus whether deformity is fixed and/or complicated by secondary 
degenerative changes2’22125,81.
One of the earliest surgical options is tendon transfer as a method of distributing forces and 
addressing muscle imbalance where there is no fixed deformity22. Common procedures include the 
transfer of the peroneus longus and tibialis posterior tendons. There is an argument that early 
intervention with these types of procedures can stall the progression to fixed deformity and 
secondary degeneration 81 however this is not supported by any data on longitudinal studies.
Other common procedures are contracture release, e.g. Achilles tendon and plantar fascia 22, and 
osteotomies. Osteotomies can be performed when problems remain after tendon transfer and there 
is mild to moderate fixed deformity 81. For example, where there is calcaneal varus, a lateral 
osteotomy can be performed to realign the hind foot2 Where there is mid foot cavus, osteotomies 
of the metatarsals can correct this. Joint fusion, often with a triple arthrodesis, is a procedure that is 
often employed when there are secondary degenerative changes 81 or failure to correct alignment 
with osteotomies. There is some disagreement as to how aggressively to pursue this approach with 
some recommending triple arthrodesis as a last resort procedure and others recommending early 
intervention to prevent secondary problems as the neuropathy progresses2.
All of the papers presented in this section make recommendations for when to use a particular 
procedure. However, only one paper attempted to present evidence of surgical outcome. Holmes 
and Hanson argue that measurement of surgical outcome is difficult due to the highly individualised 
approach to each patient. They present surgical outcomes from previous papers in terms of 
percentage success. There is no detail of how this is measured and whether it is the patient or the 
surgeon who decides a procedure is successful. With the current access to measurement
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techniques such as 3D gait analysis, plantar pressure scanning and even simple measures such as 
functional gait and pain scores, it is disappointing that there are no studies that even attempt to 
objectively measure the outcomes of these costly and considerable interventions.
1.6 Summary
In summary, CMT is an inherited condition that progresses slowly affecting the longest nerves first. 
People present with distal weakness and sensory loss as the primary impairments that can lead to 
secondary problems such as foot deformity, musculoskeletal pain, deconditioning and fatigue. 
People with CMT are usually able to maintain the ability to walk but with alterations in their gait 
pattern. Studies of other neurological conditions suggest that people with CMT may have to utilise 
proximal compensatory strategies to preserve functional walking by maintaining progression of the 
trunk, leg and foot clearance. To date there is limited evidence for therapeutic interventions to 
address gait abnormalities in people with CMT.
1.7 Hypothesis
The hypothesis for this thesis was developed from a combination of subjective reports from people 
with CMT and the research evidence presented. People with CMT often complain that they are 
unable to walk as far as their friends and unaffected family. There is a suggestion that these people 
utilise a compensatory strategy using their hip flexors 36146,47, 62 to progress the lower limb when 
plantar flexor failure is present and allow floor clearance if there is foot drop. If the hip flexor is more 
active or is working for longer periods of the gait cycle then it may fatigue quicker than normal 
during prolonged walking. Thus the hypothesis for this thesis is as follows:
People with CMT alter the action of the hip flexor muscles to compensate for reduced ankle 
muscle activity. Walking for a prolonged distance is limited by fatigue of the hip flexor 
muscles.
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2 Methods
2.1 Gait analysis
2.1.1 Three dimensional kinematics and kinetics
The CODAmotion CX1 system enabled calculations of 3-dimensional segmental gait analysis when 
a standardised marker set up is used.
2.1.1.1 Segmental Kinematics
Internal joint centres for the hip knee and ankle were calculated using joint width measurements 
using callipers and marker positions over the joints (table 2.1).
Joint Centre Distance Direction
Ankle
'A inter-malleolar distance
Perpendicular to shank lateral plane 
(defined by tibial wands)
Knee
1V2  knee width distance
Plane defined by virtual hip joint and 
thigh (defined by femoral wands)
Hip
'A inter ASIS distance - 0.19Wux - 0.36Wuz ± 0.3uy
Where W is the pelvic width, ASIS is the anterior superior iliac spine, ux,uy and uz 
are the unit vectors describing the pelvic plane 1,2
Table 2.1: Calculation of internal joint centres
Arrays of markers were used to determine a local coordinate system or embedded vector basis 
(EVB) for each segment. The EVB consisted of three orthogonal axes (table 2.2) from which unit 
vectors were defined and is used in the measurement of segmental rotations 2
2.1.1.2 Joint rotations and kinematics
Relative segment orientation was described in terms of Euler angles. The orientation of the distal 
segment relative to the proximal segment was described except for the pelvis and foot which was 
calculated relative to the global co-ordinate frame. Distal segment rotations occurred about the 
proximal segment axes in the following sequential order: Z (internal/external axial rotation) then X 
(medio-lateral bending) then Y (flexion/ extension). Once the angles were known, the time 
derivatives were calculated to give angular velocity and acceleration2’5
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EVB Principal axis 2nd axis 3 axis
Foot
Line connecting the heel 
and toe markers that is 
offset by !4 inter-malleolar 
distance (ux)
Line running from the heel 
marker to ankle marker and 
orthogonal to the principal 
axis (uz)
Orthogonal to 1st and 2nd 
axes (uy)
Shank
Ankle joint centre to knee 
joint centre (u2)
Tibial wand orientation 
orthogonal to principle axis 
(Ux)
Orthogonal to 1st and 2nd 
axes (uy)
Thigh
Knee joint centre to hip 
joint centre (uz)
Thigh wand orientation 
orthogonal to principle axis 
(ux)
Orthogonal to 1st and 2nd 
axes (uy)
Pelvis
Line between right and left 
ASIS markers (uy)
Line connecting mid PSIS 
to mid ASIS and orthogonal 
to the principal axis (uy)
Orthogonal (uz) to 1st and 
2nd axes
Table 2.2: Derivation of Embedded vector basis (EVBs) for each segment.
2.1.1.3 Joint forces and kinetics
A inverse dynamics approach was used to calculate the forces, moments and powers at each joint. 
The joint inter-segmental forces and net joint moments were calculated for the ankle as follows:
The linear (translational) equations of motion were:
£  F  = Fa + Fgrf + Wfoot-  mfootag (2.1) 
Solving for Fa:
F f -  m/oc,g <2-2)
Where:
IF  = sum of all the forces applied to the 
segment;
Fa = the unknown ankle inter- 
segmental force;
Fgrf = the ground reaction force;
Wfoot -  weight of the foot;
m foo t ~  mass the f°° t
a = linear acceleration of the foot
centre of mass (COM) 
g  = gravitational constant
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Taking moments about the centre of mass the rotational equations of motion were:
J j M g =  A/„ + (r{Fa) +  (r2FIJRI, ) +  f GR
^foot ^  foot (2.3)
Solving for M a
M a  ~  ( I f o o t * * f o o t) “  (/] ) + (f^ p G R F  ) ~ ^GR
(2.4)
Where:
Mg -  the sum of the moments of 
force acting about the centre of mass, 
M a = the vector of the unknown net 
ankle moment;
Fa = the vector of the joint inter- 
segmental force
rx = the vector of the distance from the 
ankle joint centre to the COM;
Fgrf = the vector of the joint reaction 
force;
r2 = the vector of the distance from the 
point of application of the centre of 
pressure to the centre of mass
Tgr =the vertical ground reaction torque
vector that normally acts to resist turning 
about the vertical axis
I  foot ~ the centroidal mass moment of 
inertia of the foot
& foot = an9u,ar acceleration of the body 
segment
Joint centre positions were calculated as described previously and the centre of mass was located 
along the principle axis (tables 2.1 and 2.2). The segment mass, centre of mass locations and the 
radius of gyration (expressed as a proportion of the segment length) were estimated from 
anthropometric data based on the subjects’ height, weight and gender. Each limb segment was 
assumed to be rigid and have a uniform distribution of mass around a longitudinal axis connecting 
the joint centres, to simplify its’ inertial properties 4.
The ground reaction force and ground reaction torque was measured using Kistler force plates that 
were embedded into a walkway (type 9286A Kistler Instruments Ltd, Alton, UK). The force plates
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measured the force in the x, y and z plane and the resultant ground reaction force vector at a 
sampling rate of 200 Hz and sensitivity set at 50 N/V for the X and Y plane and 0.5 kN/V for the Z 
plane force. Data collection was synchronised to the kinematic data and the position of the force 
plates within the global co-ordinate reference system defined.
The point of application of the COP was calculated as:
cop [k 7,i +7,2- 7,3- / . 4)]+(f ,4 )
F z
(2.5)
cop  [a(7,1 + 7,2 + 7 .3 - / ,4 ) ]  + ( ^ . )
F,
(2.6)
Calculation of joint kinetics proceeded in a distal to proximal direction with the net inter-segmental 
joint forces and net joint moments calculated for the more distal segment being used in the 
calculation of the next more proximal segment These moments and forces were expressed in the 
local co-ordinate system (EVB) of the proximal segment.
2.1.2.4 Joint Power
Joint power vectors were calculated from the vector product 
relative inter-segmental velocity 4.
?  =  J m(cop - a d)  (2.7)
of the joint moment vectors and the 
Where:
P  = the joint power vector;
J m =joint moment vector
=proximal segmental angular 
velocity
S)d =distal segment angular 
velocity
Where:
b= (inter-sensor distance in the x 
direction) 12
a -  (inter-sensor distance in the y 
direction) 12
f z 1 . .4 -  vertical force measured
by sensor 1..4
Fx = Antero-posterior force
Fy = Medio-lateral force
Fz = Vertical force
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2.2.2 Two dimensional kinematics
Kinematic or motion data was collected using CODAmotion motion analysis system (Charnwood 
Dynamics, Leicestershire, UK). This system consisted of two scanners containing three infrared 
cameras and active infrared emitting diode markers. The scanners were aligned to a global co­
ordinate frame where the X axis was defined as the travel (antero-posterior), the Y axis ran in the 
medio-lateral direction and the Z axis was vertical and orthogonal to the X and Y axes.
1st vector 2nd vector
Sagittal trunk angle Acromion to ASIS markers in 
XZ plane
Z axis
Sagittal hip angle Acromion to ASIS markers Upper to lower femoral 
markers
Sagittal thigh angle Upper to lower femoral markers 
in XZ plane
Z axis
Sagittal knee angle Upper to lowers femoral 
markers
Fibular head to malleolar 
markers
Sagittal ankle angle Fibular head to malleolar 
markers
Heel to toe markers
Coronal trunk angle Left to right acromial markers in 
the YZ plane
Y axis
Coronal pelvic angle Left to right ASIS marker 
motion in the YZ plane
Y axis
Horizontal trunk angle Left to right acromial markers in 
the XY plane
X axis
Horizontal pelvic angle Left to right ASIS markers in 
the XY plane
X axis
Table 2.3: Vectors forming the 2D joint angles identified from the marker set up.
Markers were placed on the lower limb and trunk to represent the segments of the subject i.e. foot, 
leg, thigh, and trunk. The markers were tracked by the motion analysis system, which measures 
their linear displacement. The data was AD converted at a sampling rate of 200 Hz (Winter 2005). 
Linear velocity and linear acceleration of the individual markers were calculated as first and second 
derivatives of displacement with respect to time 6. Infrared markers were applied bilaterally to the 
acromion, midway between the anterior superior iliac spines (ASIS) and posterior superior iliac 
spine (PSIS), upper femur, lower femur, fibular head, lateral malleolus, lateral heel and base of the 
5th metatarsal. Trunk and lower limb angles were identified (table 2.3). Angular displacement in the
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X-Z plane was calculated and angular velocity and angular acceleration were computed as time 
derivatives of the angular displacement measure6.
During off-line analysis of walking heel strike, heel rise and toe off were identified to allow the 
definition of periods of the gait cycle. Heel strike was defined from the displacement of the heel 
marker in the Z direction, heel rise from the linear acceleration of the heel marker in the X direction 
and toe off from the linear acceleration of the toe marker in the X direction.
One cycle was identified from the initial heel strike to the second heel strike of the same leg. The 
first three cycles of the trial were identified in this way and averaged, as recommended in previous 
studies 3' 7. Data from the first minute of the walking test was discarded to allow for the subject 
settling on the treadmill. The left cycle was used to normalise the data so each cycle duration was 
100%. The gait cycle was divided into phases and the maximum, minimum and peak to peak of the 
pertinent variables were found within each period (table 2.4).
Phase Stance Swing
Initial heel contact —► toe off Toe off -+ second 
heel contact
Period Loading Mid-stance Pre-swing
Initial heel contact 
-♦ opposite toe off
Opposite toe off —► 
opposite heel 
contact
Opposite heel 
contact - » toe off
Table 2.4: Definitions of the phases and periods of the gait cycle
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2.2 Measurement of ankle stiffness
Ankle stiffness into dorsiflexion and plantarflexion was measured using ramp and hold stretches 
delivered via a dynamometer (Biodex Medical Instruments Inc., New York, USA). Subjects lay 
supine, with their knee in extension, and placed their foot in a manipulandum set at plantigrade. The 
foot, ankle and proximal leg were secured using straps. The manipulandum was rotated through 5° 
with a peak velocity of 15° per second, as specified by a positional data file (Biodex System3 
Researchers Toolkit). Subjects remained relaxed during the test and six stretches in each direction 
were collected.
Muscular activity was recorded using a telemetry surface electromyography (EMG) unit (MIE 
Medical Research Ltd, Leeds, UK). Skin was prepared with alcohol rub and bipolar silver/silver 
chloride surface electrodes were placed longitudinally over the belly of the muscle of interest. 
Surface EMG was recorded from the tibialis anterior (TA) and medial gastrocnemius (GAS) to 
confirm muscle relaxation. A real time display of the raw signal allowed monitoring of relaxation 
during the test. Torque, velocity and position were collected via the Biodex remote access port. 
Signals were AD converted using a Power 1401. Data was sampled at 2000Hz and collected using 
Spike2 software (Spike2 version 5.06, Cambridge Electronic Design).
Stretch data was collected using Spike2 software and exported as spreadsheet text files for 
analysis using Matlab programmes written in house (MATLAB, Mathworks Inc). The last 5 stretches 
were averaged. The mean torque (Torque Totai) and position was measured over a 300ms period 
just prior to the stretch and 725ms post stretch onset when the ankle had stopped moving.
The torque due to the weight of the foot (Torque foot weight) was estimated as:
Torquefootweight =  mg sin Od (2.8)
Where 6  = ankle angle relative to vertical, g  = acceleration due to gravity, m -  mass of the foot 
estimated from anthropometric data based on the subject’s mass and gender, and d = the 
manipulandum length.
45
Chapter 2
Figure 2.1: Position of foot in manipulandum. 0  = angle relative to vertical.
4 6
The change in torque due to the manipulandum (Torque manipulandum) was measured directly. The 
torque due to stiffness in the ankle-foot complex (Torque anue-foot) was defined as:
= Torque M  -  T o r q u e -  Torquemlin:pulalxim (2.9)
Stiffness was calculated as the change in Torque ankle-foot divided by the change in position. This 
method has been used previously to measure stiffness of the ankle 6 and the glenohumeral joint9
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3 Investigation of Proximal Strategies in CMT
3.1 Introduction and Hypothesis
The primary hypothesis for this thesis states that in people with CMT, weak ankle muscles lead to 
increased muscle activity around the hip to compensate for reduced limb progression and foot drop 
during swing.
Distal muscle weakness is well described in CMT and will affect the motion, moments and power 
produced at the ankle during the gait cycle, particularly at the end of stance phase. Prior to this 
study, a detailed description of any proximal changes that may compensate for distal weakness had 
not been reported in CMT. However, from previous work in other conditions22'23 we would expect 
that weak plantarflexors would be compensated for by an earlier onset and/or increased magnitude 
of hip kinetics at the end of stance phase to maintain leg progression whilst dorsiflexor weakness 
and foot drop may be compensated for by an increase in hip flexion during swing phase to allow 
foot clearance.
In this study we will compare the gait pattern in people with CMT to healthy control subjects. Based 
on previous work in other types of neuropathy, predictions were constructed for this study from the 
primary hypothesis:
People with CMT will show
♦ Decreased ankle plantarflexor range, moment and power generation during preswing.
♦ The distal plantarflexor changes will be accompanied by a change in the magnitude and 
timing of the hip flexor moment and power generation normally seen during preswing,
♦ Decreased dorsiflexion during swing phase.
♦ The distal dorsiflexor changes will be accompanied by an increase in hip flexion during 
swing phase (a high stepping gait)
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3.2 Methods
People with CMT were recruited from the genetic peripheral neuropathy clinic at the National 
Hospital for Neurology and Neurosurgery. People with clinically definite CMT, regardless of type, 
and the ability to walk 100m in at least 10 minutes were included. People were excluded if they had 
a history of other neurological impairment, orthopaedic lower limb impairment unrelated to CMT and 
lower limb or back pain exceeding 7 out of 10 on a visual analogue scale. Healthy control subjects 
were matched for age, gender, weight and height and the same exclusion criteria were applied to 
this group.
Gait analysis: Three dimensional segmental analysis of gait was performed (CODAmotion, 
Leicestershire, UK) (figure 3.1). Infrared markers were applied in clusters that allowed the 
calculation of 3D lower limb kinematics via CODA motion software, (see methods, chapter 2). 
Subjects were asked to walk along a 10 metre walkway. An additional segment for the trunk was 
defined using markers on the anterior superior iliac spines (ASIS) and acromion processes of the 
shoulders. Two force plates were embedded in the walkway and used for the 3D kinetic analysis.
Infrared scanner
Infrared marker clusters
Force plates
Figure 3.1: Three dimensional gait analysis set up
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People with CMT were asked to walk along the walkway at a comfortable speed. Six seconds of 
synchronised motion and force data were collected per trial (sampling rate 200Hz). Trials were 
accepted if a single foot landed fully on a force plate. Three footfalls per leg were collected. 
Subjects walked in shoes but without the aid of any ankle-foot orthoses. Walking aids were used if 
necessary for safety. Control subjects were asked to walk at the same rate and step length as the 
CMT subject they were controlling for. Marks were drawn at the beginning of the walkway, to 
indicate the desired step length, and a metronome was used to cue the subject to the correct 
cadence. Practice sessions were given until the control subject was consistent in both parameters. 
Data was collected in the same way as with the CMT subjects.
Strength measures: Measures of isometric maximum voluntary contraction (MVC) of the ankle 
dorsiflexors, plantarflexors, hip flexors and extensors were recorded using a dynamometer (Biodex 
Medical Instruments Inc., New York, USA). For measures of ankle strength, subjects lay supine with 
their ankle in plantigrade. The foot was placed in a manipulandum and the axis of the dynamometer 
motor was aligned to the ankle joint axis. The foot, ankle and proximal leg were secured using 
straps and a manual restraint was applied at the shoulders. Hip strength was recorded with the hip 
at 40° flexion, with the subject supine and the femur secured to a manipulandum with straps. An 
extra strap was placed across the pelvis and this was reinforced by manual restraint during testing. 
The axis of the dynamometer motor was aligned with the hip joint axis. Strength was expressed in 
Nm per Kg of body weight. Contractions were held for three seconds and the peak of three values 
was taken.
Sensory testing: Two sensory modalities were tested in the CMT subjects. Light touch sensation 
was measured on the sole of the foot using 10g monofilaments (Neuropen, Owen Mumford, Oxford, 
UK). Ten standard areas of the plantar surface were tested (appendix 3). Subjects were asked to 
close their eyes and state “yes” when they felt the filament. The result was scored as the number of 
positive responses out of ten. Vibration threshold was tested using a biothesiometer (Bio-medical 
Instrument Co, Newbury, Ohio, USA, 120 Hz). The probe of the biosthesiometer was held still and 
at a constant pressure over the lateral malleolus and then the great toe. The subject was asked to 
close their eyes. The intensity of the vibration was gradually increased until the subject reported 
feeling it. This was identified as the appearance threshold. Then the intensity was gradually 
decreased until the subject reported that the vibration had disappeared. This was identified as the 
disappearance threshold. The appearance threshold was established over the malleolus and the 
great toe from the mean of three measures 6.
Passive ankle joint stiffness:
Ankle stiffness into dorsiflexion and plantarflexion was measured using a dynamometer (Biodex 
Medical Instruments Inc., New York, USA), (see chapter 2 for full description). Subjects lay supine, 
with their knee in extension, and placed their foot in a manipulandum set at plantigrade. The foot,
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ankle and proximal leg were secured using straps. The manipulandum was rotated through 5 with 
a peak velocity of 15° per second, as specified by a positional data file (Biodex System3 
Researchers Toolkit). Subjects remained relaxed during the test and six stretches in each direction 
were collected.
Surface EMG was recorded from the tibialis anterior (TA) and medial gastrocnemius (GAS) to 
confirm muscle relaxation. Torque, velocity and position were collected via the Biodex remote 
access port. Signals were AD converted using a Power 1401. Data was sampled at 2000Hz and 
collected using Spike2 software (Spike2 version 5.06, Cambridge Electronic Design).
Joint alignment: Subjects were screened for a scoliosis using Adam’s forward bend test7 (appendix 
3). The presence of pes cavus or planus, toe flexion deformities, plantar fascia tightness and 
calcaneal valgus or varus was noted. In the presence of calcaneal varus the block test was used to 
ascertain whether this was due to a fixed deformity (appendix 3).
3.2.1 Analysis
Three trials for the left and right legs were exported as text files for analysis using Matlab 
programmes written in house (Mathworks). A single gait cycle was identified from the heel marker 
acceleration traces and vertical forces. Cycle duration was normalised, and three cycles were 
averaged (appendix 2) 10,19. The data from the left and right legs were combined. Temporal and 
spatial gait parameters were recorded.
The primary analysis was based on the four predictions introduced at the beginning of this chapter.
♦ Peak ankle plantarflexion angular displacement, moment and power generation were measured 
during preswing (see methods, chapter 2).
♦ Peak hip flexion angular displacement, angular velocity, moment and power generation were 
measured during preswing (see methods, chapter 2).
♦ Foot drop was measured from the dorsiflexion angle in swing when a foot marker (toe or heel) 
was at its lowest vertical point i.e. at foot clearance.
♦ The maximal hip flexion angular displacement was measured during swing phase
♦ The relative timing of the onset of hip and ankle power generation during preswing
This gave a total of ten comparisons for the primary analysis. Consideration was given to correction 
for the multiple comparisons to decrease the chance of type 1 error. Bonferroni correction was 
considered too conservative as the correction does not account for dependency among the data 
which would be the case in this study 2' 29. In addition there is also the potential to increase type 2 
errors giving a false null result 21 ’ 34. A modified Bonferroni procedure was used as it is less 
conservative and has a type 1 error probability equal to a (see appendix 1 for calculation)38.
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Although attempts were made to match the walking speed between the two groups, significant 
group differences in walking speed were still found (see results, section 3.3.2). As many kinetic and 
kinematic gait parameters can vary with walking speed 18 the effect of this variable was taken into 
account by performing a univariate analysis of co-variance with gait speed as a covariate 
(ANCOVA).
A secondary analysis was performed that did not directly relate to the predictions of this study but 
aimed to see if:
♦ There were other changes in the motion and kinetics of proximal joints and segments to 
compensate for distal weakness e.g. the hip, knee, pelvis or trunk.
♦ There were changes in the ankle, knee and hip kinematics and kinetics during stance related to 
support.
♦ There were distal and proximal changes in ankle, knee and hip motion in the coronal and 
horizontal planes.
The variables analysed were:
♦ Maximum and minimum ankle kinematics and kinetics in the loading and stance phases
♦ Maximum and minimum sagittal knee kinematics and kinetics in preswing and hip velocity, 
moment, power generation in swing
♦ Peak to peak pelvis and trunk kinematics in all three planes
♦ Lower limb angular displacement in the coronal and horizontal planes in stance and swing 
phase
A modified Bonferroni adjustment was made to this data from the secondary analysis (appendix 1) 
but none of the group differences were significant due to the large number of comparisons. It was 
decided, however, to still look for patterns in the data using p<0.05 as a guide. Data were compared 
with findings of previous studies to evaluate whether or not a consistent and logical finding was real, 
and not a false positive result. It was acknowledged, however, that strictly the results of the 
secondary analysis gave an indication of group trends only.
Impairment measures, such as strength, sensation and stiffness, were compared using 2-tailed 
unpaired t-tests for interval data and the Mann-Whitney test for nominal data. Gait speed and other 
temporal and spatial measures were tested using a one way analysis of variance (ANOVA) 
comparing the CMT group, controls at a matched walking speed and controls at their normal 
walking speed. Significance was taken as p<0.05, with means reported ± the standard deviation 
unless indicated29.
Variability in presentation has been described in previous studies of gait in people with CMT14,31 so 
relationships were tested between:
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♦ Temporospatial gait parameters and distal impairments
♦ Distal gait parameters and impairment measures
♦ Proximal changes and measured gait variables
Pearson’s correlation for parametric data was used for this analysis. If there was more than one 
significant correlation then a stepwise multiple regression was performed using up to two predictors 
together to see whether either or both remain statistically significant. Variables were entered into 
the model if F < or = 0.05 and excluded if F > or = 0.1. Correlations for non-parametric data were 
tested with Spearman’s rank correlation test.
Finally, an intra-group comparison was made by separating the CMT group into people with type 1 
demyeiinating CMT and type 2 axonal CMT. Unpaired t-tests were used to compare the two CMT 
groups as there was no difference in gait speed with significance taken as P<0.05.
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3.3 Results
3.3.1 Subjects
Fourteen people with CMT and 12 matched control subjects participated in the study. Six of the 
subjects with CMT had type 1 disease and eight had type 2 CMT. There were no significant 
differences observed in their matching criteria (table 3,1), One person with CMT used a single 
walking stick. The two groups demonstrated differences in the maximum voluntary contraction of 
the distal limb muscles but not the proximal groups (table 3.2). It was not possible to get strength 
measures from one person with CMT due to their individual time constraints.
Age (years) Gender Height (m) Weight (kg)
CMT subjects 
N=14
38 ±14 9 male; 5 female 1.67 ±0.9 74 ±14
Control subjects 
N=12
40 ±10 6 male; 6 female 1.70 ±0.9 68 ±14
Table 3.1: Mean age, gender, height and weight data for both subject groups (± standard 
deviation).
MVC (Nm/kg) Hip flexion Hip extension Plantarflexion Dorsiflexion
CMT subjects 
N=13
1.19 ±0.49 1.21 ±0.68 0.55 ±0.57 * 0.07 ±0.06 *
Control subjects 
N=12
1.45 ±0.54 1.39 ±0.69 1.73 ±0.66 0.45 ±0.16
Table 3.2: Mean maximum voluntary contraction measures for the CMT and control groups (± 
standard deviation). * p<0.05
None of the subjects had a scoliosis but over half of the people with CMT had foot deformity 
associated with the condition (table 3.3). Only one person had a fixed ankle varus. Testing of 
sensory modalities over the foot and ankle demonstrated a decrease in vibration and light touch 
sensation in the CMT group (malleolus t =2.45, P=0.03; toe t =2.7, P=0.02; light touch z =-2.76, 
P=0.003). Although the control subjects appear to have stiffer ankles when they are stretched into 
dorsiflexion, the difference between the two groups was not significant. While walking none of the 
subjects with CMT reported lower limb pain.
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CMT subjects Control subjects
Percentage of subjects with 
scoliosis
0 0
Percentage of subjects with 
pes cavus
57% 0
Percentage of subjects with 
calcaneal valgus
50% 0
Stiffness of ankle into 
dorsiflexion (Nm/radians)
49.01 ±13.1 55.24 ±23.48
Sensation:
Light pressure 
(scores out of 10)
5.25 ±3.24* 10 ±0
Vibration Malleolus 
(microns) Great toe
8.0 ±9.2* 
7.4 ±8.9*
1.3 ±1.5 
0.4 ±0.28
Table 3.3: Comparison of distal sensation, ankle stiffness, spinal and foot alignment (mean ± 
standard deviation for stiffness and sensation data). * p<0.05
3.3.2 General Gait Comparison
The temporal and spatial comparison of walking is shown in table 3.4 including control data for the 
matched pace trials and normal pace trial.
Variable CMT subjects Control subjects 
(matched pace)
Control subjects 
(normal pace)
Gait Speed (m/s) 1.03 ±0.18*T 1.26 ±0.24 1.37 ±0.18
Cadence (steps/minute) 100.6 ±10.8* 108.5 ±12.6 112.8 ±9.8
Step length (m) 0.62 ±0.08** 0.71 ±0.069 0.74 ±0.07
Stride time (s) 1.21 ±0.13 1.12 ±0.14 1.07 ±0.1
Double support time (s) 0.19 ±0.03** 0.14 ±0.02 0.13 ±0.02
Table 3.4: Summary of temporal and spatial data for people with CMT, control subjects walking at a 
matched pace and control subjects walking at their normal pace (mean ± standard deviation). * 
p<0.05 people with CMT versus controls at a matched pace; T p<0.05 people with CMT versus 
controls at a normal pace.
Gait speed was slower in people with CMT compared to control subjects walking at both their 
normal speed and the matched speed (ANOVA: F= 10.04, P=0.0004; post hoc: CMT v controls 
matched: t =2.78, P=0.01; CMT v controls normal: t =-4.83, P<0.001). This implies that the methods 
used to constrain the control subjects did not successfully match the speed. Cadence, however, 
was better matched with no significant difference between people with CMT and controls at a
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matched pace. Controls walking at their normal pace had a higher cadence (ANOVA: F=4.08, 
P=0.03; CMT v controls matched: t =1.68, P=0.11; CMT v controls normal: t =-3.03, P=0.006).
Step length was longest in the control subjects walking at a normal pace and shortest in people with 
CMT (ANOVA: F=6.63, P=0.004; CMT v controls matched: t =1.72, P=0.005; CMT v controls 
normal: t =-4.82, P<0.001). There was no significant difference in stride time but the double support 
time was longer for people with CMT compared to controls walking at a matched pace and a normal 
pace (ANOVA: F=15.68, P<0.0001; CMT v controls matched: t =-4.51, P<0.001; CMT v controls 
normal: t =-5.43, P<0.001).
3.3.3 Kinematic and Kinetic Comparison
3.3.3.1 Primary comparison
Distal differences: There were significant differences in the plantarflexor moment and ankle power 
generation during preawing (table 3.5; figure 3.4 and 3.5). No significant differences were observed 
in the plantarflexor angle during preswing or the dorsiflexor angle at foot clearance (table 3.5; figure 
3.2).
Variable CMT subjects Control subjects F statistic P value
Peak PF angle preswing 
(deg)
6.44 ±9.52 17.26 ±7.58 2.78 0.11
Peak PF moment during 
preswing (Nm/Kg)
0.89 ±0.37 1.34 ±0.15 7.25 0.01 T
Peak ankle power 
generation preswing (W/Kg)
1.36 ±0.90 3.04 ±0.65 14.99 0.001 T
Peak DF angle at foot 
clearance in swing (deg)
-4.35 ±9.04 3.56 ±3.19 2.50 0.1
Table 3.5: Results of ANCOVA for distal gait variables for people with CMT and control subjects 
walking at a matched pace (mean values ± standard deviation). Deg: degrees; Nm: Newton metres; 
kg: Kilogram; W: Watts.f significant following modified Bonferroni procedure.
Proximal differences: No significant differences were seen in the motion, moment and power 
generation at the hip during preswing. During swing phase people with CMT demonstrated a 
significant increase in hip flexion angle (table 3.6; figure 3.2). There was a trend towards increased 
hip flexor velocity during preswing in people with CMT that was not significant post modified 
Bonferroni correction.
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Timing of kinetic data
As can be seen in figure 3.5, people with CMT showed a marked delay in the onset of ankle power 
generation relative to toe off (ANCOVA: F =10.26, p=0.004) with a decrease in total power 
produced during the push off period (ANCOVA: F =17.11, p<0.0001).
Although there was no significant difference in the onset of hip power generation, people with CMT 
tended to generate power at the hip before the ankle in contrast to the control subjects who all 
generated power at the ankle first (relative power onset between hip and ankle ANCOVA: F =5.9, 
p=0.02). This group difference was significant post modified Bonferroni correction.
Variable CMT subjects Control subjects F statistic P value
Peak hip flexor angle 
preswing (deg)
4.42 ±8.55 -1.76 ±7.31 2.11 0.16
Peak hip flexor angle swing 
(deg)
36.83 ±8.06 27.86 ±7.53 8.21 0.009 T
Peak hip flexor velocity 
preswing(deg/s)
103.75 ±31.94 98.23 ±42.38 4.92 0.037
Peak hip flexor moment 
preswing(Nm/kg)
0.15 ±0.23 -0.01 ±0.12 1.63 0.22
Peak hip power generation 
preswing(W/kg)
0.70 ±0.43 0.94 ±0.49 0.014 0.91
Table 3.6: Results of ANCOVA for proximal gait variables for people with CMT and control subjects 
walking at a matched pace (mean values ± standard deviation). r significant following modified 
Bonferroni procedure.
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Figure 3.2: Grand average angular displacement in the sagittal plane over one gait cycle for the 
ankle, knee, hip, pelvis and trunk (average of left and right sides). Comparison of people with CMT 
and controls walking at a matched pace. CTcon: contra-lateral toe off control subjects; CTcmt: 
contra-lateral toe off CMT subjects; CHcon: contra-lateral heel strike control subjects; CHcmt: 
contra-lateral heel strike CMT subjects; ITcon: ipsilateral toe off control subjects; ITcmt: ipsilateral 
toe off; DF: dorsiflexion; PF: plantarflexion.
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Figure 3.3: Grand average angular velocity in the sagittal plane over one gait cycle for the ankle, 
knee and hip (average of left and right sides). Comparison of people with CMT and controls walking 
at a matched pace. CTcon: contra-lateral toe off control subjects; CTcmt: contra-lateral toe off CMT 
subjects; CHcon: contra-lateral heel strike control subjects; CHcmt: contra-lateral heel strike CMT 
subjects; ITcon: ipsilateral toe off control subjects; ITcmt: ipsilateral toe off; DF: dorsiflexion; PF: 
plantarflexion.
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Figure 3.4: Grand average joint moments in the sagittal plane over one gait cycle for the ankle, 
knee and hip (average of left and right sides). Comparison of people with CMT and controls walking 
at a matched pace. CTcon: contra-lateral toe off control subjects; CTcmt: contra-lateral toe off CMT 
subjects; CHcon: contra-lateral heel strike control subjects; CHcmt: contra-lateral heel strike CMT 
subjects; ITcon: ipsilateral toe off control subjects; ITcmt: ipsilateral toe off; DF: dorsiflexion; PF: 
plantarflexion.
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Figure 3.5: Grand average joint powers in the sagittal plane over one gait cycle for the ankle, knee 
and hip (average of left and right sides). Comparison of people with CMT and controls walking at a 
matched pace. CTcon: contra-lateral toe off control subjects; CTcmt: contra-lateral toe off CMT 
subjects; CHcon: contra-lateral heel strike control subjects; CHcmt: contra-lateral heel strike CMT 
subjects; ITcon: ipsilateral toe off control subjects; ITcmt: ipsilateral toe off.
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3.3.3.2 Secondary comparison
Other proximal differences: Proximally, people with CMT had a reduction in knee extensor moment 
in pre-swing but showed an increase in knee power generation at the end of preswing compared to 
controls. Later in swing there was an increase in peak knee flexion in people with CMT. They also 
showed significant increases in horizontal rotation at the pelvis and trunk. This was accompanied by 
increased trunk rotation in the coronal plane (table 3.7; figures 3.2, 3.4 to 3.7).
Variable CMT subjects Control subjects F statistic P value
Peak knee extensor 
moment preswing (Nm/Kg)
0.12 ±0.07 0.22 ±0.12 6.35 0.019*
Peak knee power 
generation preswing 
(W/Kg)
0.60 ±0.31 0.32 ±0.19 7.58 0.011*
Peak knee flexion swing 
(deg)
68.56 ±5.13 64.56 ±6.68 5.42 0.029 *
Peak hip flexor velocity 
swing (deg/s)
206.84 ±41.25 194.23 ±44.12 4.87 0.038*
Peak to peak pelvis 
horizontal motion (deg)
41.97 ±5.62 34.69 ±6.70 15.70 0.001*
Peak to peak trunk coronal 
(deg)
7.10 ±3.11 4.09 ±1.25 5.09 0.03*
Peak to peak trunk 
horizontal
(deg) .........
11.88 ±3.55 8.84 ±3.51 5.09 0.04*
Table 3.7: Proximal kinetic and kinematic differences between people with CMT and control 
subjects walking at a matched pace (mean values ± standard deviation). * p<0.05 people with CMT 
versus controls at a matched pace
Other kinematic and kinetic changes during stance: During the initial loading phase, an increase in 
plantarflexion angle was seen in people with CMT accompanied by a decrease in the dorsiflexion 
moment. Later in loading, they showed an increase in dorsiflexion velocity. In addition, increased 
peak dorsiflexion angle was seen at the end of stance phase/preswing in people with CMT (table 
3.8; figures 3.2 to 3.4).
Variable CMT subjects Control subjects F statistic P value
Peak PF angle during 
loading (deg)
12.47 ±3.53 7.98 ±2.92 10.07 0.004 *
Peak DF velocity during 
loading (deg Is)
189.74 ±37.85 134.25 ±37.14 15.74 0.001 *
Peak DF moment during 
loading (Nm/Kg)
0.09 ±0.05 0.21 ±0.07 13.77 0.001 *
Peak DF angle at preswing 
(deg)
19.87 ±4.87 11.35 ±5.90 8.98 0.006 *
Table 3.8: Results of ANCOVA for distal gait variables for people with CMT and control subjects 
walking at a matched pace (mean values ± standard deviation). * p<0.05 people with CMT versus 
controls at a matched pace.
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Differences in the coronal and horizontal planes: The ankle was also more supinated in people with 
CMT during loading phase and through the rest of stance. They also showed changes at the knee 
in the other planes of motion with increased valgus and decreased external rotation in swing (table 
3.9; figures 3.6 and 3.7).
Variable CMT subjects Control subjects F statistic P value
Peak supination during 
loading (deg)
6.82 ±8.5 -1.04 ±5.17 4.90 0.04*
Peak supination during 
stance (deg)
8.79 ±8.42 1.22 ±6.61 4.47 0.05
Peak knee valgus preswing 
(deg)
9.20 ±5.70 2.62 ±4.06 7.59 0.011 *
Peak knee external rotation 
swing (deg)
0.91 ±18.81 18.72 ±4.99 6.53 0.018*
Table 3.9: Results of ANCOVA for coronal and horizontal angular displacement for people with 
CMT and control subjects walking at a matched pace (mean values ± standard deviation). * p<0.05 
people with CMT versus controls at a matched pace.
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Figure 3.6: Grand average angular motion in the coronal plane over one gait cycle for the ankle, 
knee, hip, pelvis and trunk (average of left and right sides). Comparison of people with CMT and 
controls walking at a matched pace. CTcon: contra-lateral toe off control subjects; CTcmt: contra­
lateral toe off CMT subjects; CHcon: contra-lateral heel strike control subjects; CHcmt: contra­
lateral heel strike CMT subjects; ITcon: ipsilateral toe off control subjects; ITcmt: ipsilateral toe off.
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Figure 3.7: Grand average angular motion in the horizontal plane over one gait cycle for the ankle, 
knee, hip, pelvis and trunk (average of left and right sides). Comparison of people with CMT and 
controls walking at a matched pace.CTcon: contra-lateral toe off control subjects; CTcmt: contra­
lateral toe off CMT subjects; CHcon: contra-lateral heel strike control subjects; CHcmt: contra­
lateral heel strike CMT subjects; ITcon: ipsilateral toe off control subjects; ITcmt: ipsilateral toe off.
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3.3.4 Correlations and regressions
Relationships between distal gait parameters versus impairment measures and the relationship 
between proximal changes versus other gait variables during gait in people with CMT were tested 
using Pearson’s correlation for parametric data and Spearman’s rank correlation for non-parametric 
data. Where there was more than one significant correlation then a stepwise multiple regression 
was performed using up to two predictors together to see whether either/both remain statistically 
significant
3.3.4.1 Temporal and spatial findings
Variable DF MVC PF MVC
Gait speed r=0.7 r=0.66
p=0.008 p=0.01
Step length r=0.53
NS NS
Double support r=-0.56
NT p=0.045
Cadence r=0.63 r=0.56
p=0.02 p=0.05
Table 3.10: Significant correlations and results of multiple regression for temporal and spatial data. 
NS: no significant correlation; NT: not tested if the variable was not expected to give a meaningful 
relationship, r = Pearson’s correlation coefficient; p = level of significance.
Gait speed and cadence were related to dorsiflexor and plantarflexor MVC with lower values for 
slower walkers (table 3.10, figure 3.8). Double support time was inversely related to the degree of 
plantarflexion strength (table 3.10).
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Figure 3.8: Correlation between gait speed and plantarflexor MVC (♦) and dorsiflexor MVC (■).
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3.3.4 2 Relationship between distal gait changes and impairments
Distal findings: Variables that were significantly different between the two groups, described in the 
previous section, were related to primary impairments of weakness and sensory loss (table 3.11).
The ankle plantarflexion moment and power generation during preswing were correlated with the 
degree of plantarflexor weakness and distal sensory loss (table 3.11). Stepwise multiple regression 
revealed that plantarflexor MVC and malleolar vibration threshold together accounted for 81% of the 
variance in ankle power and 82% of the variance in peak PF moment (ankle power: PF MVC plus 
malleolar vibration threshold F=18.53, P=0.001; PF moment: PF MVC plus malleolar vibration 
threshold F=20.05, P<0.0001) (figure 3.9). Dorsiflexion angle at preswing was greatest in subjects 
with distal weakness (table 3.12). No significant correlations were seen between distal coronal 
changes and impairments
Related Impairments Peak ankle power 
generation preswing
Peak PF moment at 
preswing
DF angle preswing
DF MVC r = 0.83 r = 0.83 r = -0.84
p = 0.0005 p = 0.0004 p = 0.0003
PF MVC r = 0.83 r = 0.84 r = -0.79
p=0.0004 p = 0.0004 p = 0.001
Vibration threshold toe r = -0.62 r = -0.65
p = 0.03 p = 0.02 NS
Vibration threshold r = -0.65 r = -0.66
malleolus p = 0.02 p = 0.02 NS
Table 3.11: Correlations for distal sagittal kinetic and kinematic data. NS: no significant correlation; 
r = Pearson’s correlation coefficient; p = level of significance.
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Figure 3.9: Correlation between (A) ankle power generation in preswing and plantarflexor MVC (♦) 
and dorsiflexor MVC (■); (B) ankle power generation and malleolar vibration threshold (•).
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3.3.4.3 Relationship between proximal gait changes and other gait variables
The increase in hip flexion during swing was significantly related to decreased peak dorsiflexion 
during swing phase (table 3.12). Increased hip flexor velocity in preswing and swing was related to 
knee power absorption in preswing. Additional changes were found with the knee kinetics during 
preswing. The knee extensor moment was reduced in people with CMT and was related to the 
ankle power generation and hip flexor moment in preswing (figure 3.10). Higher knee power 
generation observed in people with CMT at the end of pre-swing correlated with higher hip power 
generation in swing.
Related Gait 
Variables
Hip flexor 
angle swing
Hip flexor 
velocity 
preswing
Peak knee 
extensor 
moment
Peak knee 
power 
generation
Ankle power 
generation 
preswing
NS NS
r = 0.64
p = 0.01 NS
Peak DF angle 
swing
r = - 0.56 
p = 0.04 NS NS NS
Knee power 
absorption 
preswing
NS
r = 0.70 
p = 0.005
r = 0.76 
p = 0.002 NT
Hip flexor
moment
preswing
NS NS
r = 0.59 
p = 0.03 NS
Hip power 
generation 
swing
NS NS NS
r = 0.73 
p =0.003
Table 3.12: Correlations for knee and hip sagittal kinetic and kinematic data. NS: no significant 
correlation; r: Pearson’s correlation coefficient; p: level of significance.
Related Gait 
Variables
Horizontal 
pelvis rotation
Horizontal 
trunk rotation
Coronal trunk 
rotation
PF MVC NS r = 0.62
p = 0.02
NS
Hip flexion 
swing
r = 0.72 
p = 0.007
NS NS
Ankle
supination
stance
r = -0.63
p = 0.02
NS NS
Ankle
supination
swing
r = -0.69 
p = 0.007
NS NS
Ankle stiffness 
into DF
NS NS r = 0.62
p = 0.02
Table 3.13: Correlations for pelvis and trunk sagittal kinematic data. NS: no significant correlation; r: 
Pearson’s correlation coefficient; p: level of significance.
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Increased trunk horizontal rotation related to plantarflexor MVC and coronal motion related to ankle 
stiffness into dorsiflexion (table 3.13). Higher sagittal hip flexion during swing was associated with a 
larger range of horizontal pelvic motion. Additionally, supination of the ankle was inversely related 
to increased horizontal pelvic motion On stepwise multiple regression only swing phase sagittal hip 
flexion remained a significant predictor (table 3.13).
3.3.5 Intra-group comparison
3.3.5.1 General comparison
Age (years) Gender Height (m) Weight (kg)
CMT type 1 
N=6
41 ±10 2 male; 4 female 1.61 ±0.1 69 ±11
CMT type 2 
N=8
36 ±17 6 male; 2 female 1.71 ±0.07 77 ±16
Control subjects 
N=12
40 ±10 6 male; 6 female 1.70 ±0.09 68 ±14
Table 3.14: Mean age, gender, height and weight data for the three groups (± standard deviation).
The CMT group was split into two sub groups. Six subjects with the demyelinating CMT 1a condition 
were placed in the group type-1. Eight subjects with the axonal condition were put into the type-2 
group. The type-2 group consisted of 3 people with CMT2 of unknown gene, 4 people with CMTX 
and 1 person with HSN1 (see chapter 1). The type-1 group were older, shorter and lighter than 
group type-2 probably because two thirds of the type-1 group were female and thee quarters of 
type-2 were male (table 3.14). The differences, however, were not significant on testing.
MVC (Nm/kg) Hip flexion Hip extension Plantarflexion Dorsiflexion
CMT type 1 
N=6
1.00 ±0.12 1.38 ±0.81 0.86 ±0.79 0.12 ±0.06 *T
CMT type 2 
N=8
1.31 ±0.60 1.11 ±0.63 0.36 ±0.30T 0.04 ±0.03 *T
Control subjects 
N=12
1.45 ±0.54 1.39 ±0.69 1.73 ±0.66 0.45 ±0.16
Table 3.15: Mean maximum voluntary contraction measures for the two CMT and control groups (± 
standard deviation). * p<0.05 CMT type 1 versus CMT type 2; 1 p<0.05 CMT type 1 or 2 versus 
controls
71
Type-1 Type-2 Control subjects
Percentage of subjects 
with scoliosis
0 0 0
Percentage of subjects 
with pes cavus
66% 38% 0
Percentage of subjects 
with calcaneal valgus
50% 50% 0
Stiffness of ankle into
dorsiflexion
(Nm/radians)
47.62 ±18.9 60.96 ±26.1 55.24 ±23.48
Sensation:
Light pressure 
(scores out of 10)
5.5 ±2.5* 5.1 ±3.9* 10 ±0
Vibration
Malleolus 
(microns) Great toe
4.4 ±3.6 
4.2 ±3.4
10.6 ±11.3 
9.8 ±11.1
1.3 ±1.5 
0.4 ±0.28
Table 3.16: Comparison of distal sensation, ankle stiffness, spinal and foot alignment (mean ± 
standard deviation for stiffness and sensation data). * p<0.05 CMT type 1 or 2 versus controls
The type-2 group were significantly weaker than the type-1 group in the DF muscles (type-2 v type- 
1: t =2.67, P=0.04) and tended to be weaker in the PF muscles (type-2 v type-1: t =1.38, P=0.2) 
(table 3.15).
Pes cavus was present in a higher percentage of the type-1 group but calcaneal varus featured 
equally in both groups. Non-significant trends towards greater ankle stiffness and higher vibratory 
thresholds in the type-2 group can be seen from the mean values (table 3.16).
Variable Type 1 Type 2 Control subjects 
(matched pace)
Gait Speed (m/s) 1.12 ±0.16 0.96 ±0.18* 1.26 ±0.24
Cadence (steps/minute) 104.9 ±9.04 97.42 ±11.4 108.5 ±12.6
Step length (m) 0.64 ±.0.05 0.60 ±0.08 0.71 ±0.07
Stride time (s) 1.15 ±0.11 1.25 ±0.14 1.12 ±0.14
Double support time (s) 0.18 ±0.03t 0.19 ±0.03* 0.14 ±0.02
Table 3.17: Summary of temporal and spatial data for people with CMT type-1, type-2 and control 
subjects walking at a matched pace (mean ± standard deviation).* p<0.05 CMT type 1 or 2 versus 
controls
72
No significant differences were seen between the type-1 and type-2 groups in temporal and spatial 
gait parameters though there was a tendency for the type-2 group to walk slower with a reduced 
cadence (table 3.17).
3.3.5.2 Kinematic and kinetic comparison
Variable Type-1
group
Type-2
group
Control subjects
PF angle at toe off 
(deg)
12.82 ±7.2* 1.66 ±8.4 *T 17.26 ±7.6
Timing of ankle power 
onset (% gait cycle)
50.8 ±4.8* 58.9 ±4.9 *f 46.0 ±3.3
Peak DF velocity 
preswing (deg/s)
44.73 ±34.7 *T 120.6 ±32.1 -19.19 ±60.9
Peak DF angle in 
swing (deg)
3.31 ±1.8* -1.81 ±4.5 *+ 3.19 ±3.1
Peak DF angle at foot 
clearance in swing
(deg)
2.24 ±3.2* -9.29 ±8.9 *f 3.56 ±3.2
Table 3.18: Distal kinematic and kinetic differences between the type-1 CMT group, type-2 CMT 
group and control subjects (mean values ± standard deviation). Deg. degrees. * p<0.05 CMT type 1 
versus CMT type 2 ;t p<0.05 CMT type 1 or 2 versus controls
Distal Differences: In keeping with the greater peripheral involvement in the type-2 group distal 
changes were observed during walking between the groups (table 3.18, figure 3.10). In the type-2 
group there was a significant reduction in PF angle at toe off (type-2 v type-1: t = -2.68, P=0.02) 
with a greater delay in ankle power onset (type-2 v type-1: t = -3.09, P=0.01). Dorsiflexion velocity 
was higher in the type-2 group during the initial part of preswing (type-2 v type-1: t = -4.17, 
P=0.002) and in swing phase there was a reduction in the peak dorsiflexion angle (type-2 v type-1: t 
= 2.96, P=0.02) (figure 3.11) and dorsiflexion angle at foot clearance (type-2 v type-1: t = 3.38, 
P=0.008).
Proximal differences: Subjects in the type-2 group showed significantly greater trunk rotation in the 
horizontal plane compared to type-1 (type-2 v type-1: t = -2.26, P=0.04). Non-significant trends were 
seen for the type-2 group to increase hip flexion in swing, greater peak to peak coronal trunk motion 
and higher range of horizontal pelvic rotation (table 3.19).
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Variable Type-1
group
Type-2
group
Control subjects
Peak to peak trunk 
horizontal (deg)
11.48 ±4.37* 12.19 ±3.07 *T 8.84 ±3.51
Peak hip flexor angle 
swing 
(deg)
34.63 ±9.6 38.5 ±6.8t 27.86 ±6.9
Peak to peak trunk 
coronal (deg)
6.08 ±2.33 7.87 ±3.54t 4.09 ±1.25
Peak to peak pelvis 
horizontal (deg)
39.91 ±6.12 43.53 ±5.06t 34.58 ±6.74
Table 3.19: Proximal kinematic and kinetic differences between the type-1 CMT group, type-2 CMT 
group and control subjects (mean values ± standard deviation). Deg: degrees
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Figure 3.10: Grand average angular displacement in the sagittal plane over one gait cycle for the 
ankle, knee, hip, pelvis and trunk (average of left and right sides). Comparison of people with CMT, 
types 1 and 2, and controls walking at a matched pace. CT: contra-lateral toe off; CH: contra-lateral 
heel strike; CH: contra-lateral heel strike; IT: ipsilateral toe off; DF: dorsiflexion; PF: plantarflexion.
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Figure 3.11: Grand average angular velocity in the sagittal plane over one gait cycle for the ankle, 
knee and hip (average of left and right sides). Comparison of people with CMT, types 1 and 2, and 
controls walking at a matched pace. CT: contra-lateral toe off; CH: contra-lateral heel strike; CH: 
contra-lateral heel strike; IT: ipsilateral toe off; DF: dorsiflexion; PF: plantarflexion.
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Figure 3.12: Grand average joint moments in the sagittal plane over one gait cycle for the ankle, 
knee and hip (average of left and right sides). Comparison of people with CMT, types 1 and 2, and 
controls walking at a matched pace. CT: contra-lateral toe off; CH: contra-lateral heel strike; CH: 
contra-lateral heel strike; IT: ipsilateral toe off; DF: dorsiflexion; PF: plantarflexion.
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Figure 3.13: Grand average joint powers in the sagittal plane over one gait cycle for the ankle, 
knee and hip (average of left and right sides). Comparison of people with CMT, types 1 and 2, and 
controls walking at a matched pace. CT: contra-lateral toe off; CH: contra-lateral heel strike; CH: 
contra-lateral heel strike; IT: ipsilateral toe off;
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3.4 Discussion
3.4.1 Clinical presentation
The preference of the longer nerves in the pathology of CMT implicates distal symptoms as the 
major presentation. Measures of strength and sensation demonstrated that this was indeed the 
case in the people with CMT studied in this experiment. When the CMT group was split into types, it 
appeared that people with axonal neuropathy (type-2 group) presented with increased distal 
weakness compared to the controls and people with demyelinating neuropathy (type-1 group). 
These results are in contrast to a study comparing the phenotypes of 51 people with CMT1a and 61 
people with CMT2 3. The study found increased dorsiflexor weakness in the CMT1a group, 
however, the MRC scale was used to measure strength. The MRC scale has been criticised for 
giving contradictory findings in studies of CMT and more sensitive dynamometry methods, such as 
the ones used in the present study, are recommended 4 5. Some caution must be given to the 
comparison between different types in the present study due to the very small numbers but also 
because the type-2 group included people with CMTX which is a mixed neuropathy with both 
axonal and demyelinating features. There is no current consensus on which feature is most 
prevalent in CMTX 13.
3.4.2 Temporal and spatial gait characteristics
3.4.2.2 Gait speed
The people with CMT had a mean gait speed of 1.03m/s. This is lower than the study by Newman 
et a l27 where the mean gait speed was 1.12 m/s. The CMT group in Newman’s study also was a 
mixture of demyelinating and axonal CMT but only 31% of them were CMT type 2. In this study 66% 
were in the type-2 group and as can be seen in the intra group comparison the type-2 group tended 
to be slower walkers. This may account for the discrepancy between the two studies.
Gait speed was significantly slower in the CMT group compared to controls at both matched and 
normal paces. As gait parameters, and kinetic variables in particular, increase with increasing gait 
speed 18 this is an important covariate to account for. For this reason the comparison between the 
control and CMT groups were performed using an analysis of covariance with speed as a covariate. 
The correlation analysis showed that gait speed was related to distal weakness. A study of post 
polio syndrome (PPS) also found a non-linear relationship between combined lower limb muscle 
strength and maximal walking speed 40. An earlier study of PPS demonstrated that plantarflexor 
strength was the best predictor of walking speed 3S. Studies of people with stroke have also 
demonstrated the important role of the plantarflexors in determining gait speed 23,32.
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3.4.2.3 Gait parameters
This study showed a reduction in step length, cadence and double support in people with CMT. 
Although this has not been reported before in CMT, studies of people with diabetic peripheral 
neuropathy and older people reported a similar finding when compared with matched healthy 
subjects 20 15,22. The reduction in step length may be a strategy to increase stability and has been 
described by some authors as part of a “conservative gait pattern”. Alternatively the step length may 
be reduced in this group of people with CMT because lower ankle power generation did not propel 
the body and swing limb sufficiently. The prolonged double support phase in stance may also reflect 
the adoption of a conservative gait strategy8. In people with diabetic neuropathy the double support 
time was associated with reduced lower limb sensation. This was not seen in the present study 
where it was associated with distal weakness.
3.4.3 Kinematic and kinetic characteristics
3.4.3.1 Progression
Primary analysis: The plantarflexor moment at preswing and peak ankle power generation were 
reduced in the people with CMT. This finding was in agreement with other studies of gait in CMT27 
16 and both variables correlate strongly with plantarflexor strength. In addition a stepwise multiple 
regression showed that both ankle plantarflexor strength and malleolar vibration threshold are 
independent predictors of ankle power and plantarflexor moment, together accounting for over 80% 
of the variance for both variables. Newman et a l27 also felt that the reduced ankle power generation 
was associated with reduced muscle strength but they did not consider the role of sensory input. 
Vibratory thresholds measure the perception of the larger diameter sensory fibres involved in 
awareness of joint position. It is possible that reduced perception of the ankle motion during 
preswing could influence the velocity or forces produced.
No significant differences were seen in the magnitude of the hip kinetic variables in preswing. 
Recent investigations of gait in people with CMT have had contrasting results. Newman et a l27 also 
showed no significant increase in hip flexor moment or power generation during preswing when 
comparing a heterogeneous group of 16 subjects with control data. A study by Don et a l11 used a 
different kinetic variable to describe proximal compensations. They measured the angular impulse 
which was calculated from the area under the moment graph for a defined period i.e. preswing. A 
significant increase in the angular impulse of the hip was described between 21 people with CMT 
and 21 age and gender matched controls. They did not report a comparison of the peak moment or 
any joint powers so the results cannot be directly compared to the Newman et a l27 study or the 
data presented in chapter 3 due to the differing variables. Angular impulse was not formally 
measured in the present study but the grand average graphs do not indicate that there would be a 
difference (figure 3.4). In addition, there were no differences in the timing in magnitude of the
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moment in preswing, so angular impulse is was unlikely to be dissimilar with this data set. Neither 
study statistically or methodologically took account of the influence of gait speed on gait variables. 
Don et al 11 justified the use of the angular impulse variable as it accounted for changes in gait 
speed more accurately than peak values. They do not explain why this is and the paper they quote 
as evidence for this does not mention gait speed but discusses adaptations such as changes in the 
duration or magnitude of force9.
In people with stroke, Olney and Richards30 demonstrated an increase in hip flexor moment in late 
stance/early swing phase. Nadeau et al 23 observed a positive relationship between hip flexor 
strength and gait speed in people with plantarflexor weakness post stroke. The observation is less 
clear in people with CMT despite both conditions presenting with distal weakness. This could be 
due to differences in other presenting symptoms, for example, one is a unilateral disorder, the other 
is bilateral. People with stroke are more likely to present with proximal weakness of both the lower 
and upper limb which will affect the gait pattern. Another pertinent factor is disease progression. In 
stroke, compensatory strategies develop quickly in response to the acute onset of impairments. 
CMT is an insidious, slowly progressing condition where compensatory strategies develop over 
time. Diabetic peripheral neuropathy is a more comparable, slow progressing condition and gait 
analysis also does not show an increase in the magnitude of hip kinetics22.
In the present study, there were some changes in the timing of activity. Although people with CMT 
did not generate hip power earlier than control subjects, they did generate power at the hip before 
the ankle due to a delay in ankle power generation. This suggests that they rely wholly on the hip 
flexors to initiate swing rather than the synergistic action of the ankle plantarflexors and hip flexors 
as with healthy subjects. The question remains, however, as to why there was no increase in hip 
kinetics at preswing 25.
When looking at hip kinetic variables consideration must be given to the increased error in the 
calculation of hip variables using inverse dynamics 19. CODAmotion still uses the traditional method 
of locating hip joint centres described by Bell et a l1. This is based on external bony landmarks and 
has been criticised for its inaccuracy as a method that introduces error to the inverse dynamics 
calculation. Apparent discrepancies between studies could also be a product of this methodological 
problem.
Secondary analysis: Hip flexion velocity will be related to acceleration of the leg during swing. It was 
increased during swing compared to the control group, when walking speed was accounted for, and 
the primary analysis suggested a trend towards an increase in hip velocity during preswing. Hip 
flexion velocity is a variable one would expect to decrease with reduced speeds as the limb 
segments slow. This was not the case in the CMT group and could be a strategy to maintain
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sufficient limb progression where there is reduced synergistic activity distally. There was, however, 
no corresponding increase in hip kinetics that could cause this or correlations with distal variables.
Changes were also seen in the knee kinematics and kinetics. Figures 3.4 and 3.5 show that CMT 
subjects had a lower knee extensor moment in preswing and the knee extensor muscle most likely 
to be active at this time is the rectus femoris24. This has also been observed in the hemiparetic limb 
of people with stroke 32. An electromyographic (EMG) study demonstrated that in healthy subjects 
there is an increase in rectus femoris activity at late stance/early swing whereas the other vasti 
muscles became active later in swing 24. Previously it was thought that the main role of rectus 
femoris was to control excessive knee flexion in early swing24. More recently it has been suggested 
that rectus femoris decelerates the whole leg and re-distributes energy to assist with trunk 
acceleration through its eccentric action 26 Therefore the reduced knee extensor moment at 
preswing in people with CMT may reflect reduced activity of rectus femoris. If the acceleration of the 
leg is reduced through lower ankle power generation, rectus femoris may not need to decelerate the 
leg so much during preswing. A positive correlation between the knee extensor moment and ankle 
power generation at preswing support this hypothesis. If there is a reduction and delay in leg 
acceleration from the diminished action of gastrocnemius the iliopsoas may have to work alone to 
initiate swing. A reduction in rectus femoris activity could in turn reduce the opposition to the action 
of the iliopsoas. This may explain why an increase in the hip flexor moment is not observed in 
people with CMT but changes in the hip velocity are observed.
The difference in pelvic horizontal rotation was not reported in a previous gait analysis study27 The 
difference between the groups seems to mainly relate to hip flexion in swing. It is possible that the 
two strategies are used together to maximize stride length and therefore assist with limb and/or 
trunk progression, though there are no significant correlations to support this. More difficult to 
explain, though, is the relationship with ankle supination because it is a negative correlation i.e. 
subjects with CMT who supinated least rotate the pelvis more but this relationship is not seen in 
control subjects. It is possible that pronation assists horizontal rotation of the pelvis and subjects 
with pes cavus, who have a stiffer foot and ankle, may not be able to facilitate the range of pelvic 
motion in this way.
An interesting and previously unreported finding was the difference in range of trunk motion 
between the groups. Increased horizontal rotation was seen in people with CMT that related to 
distal impairments. Horizontal trunk motion correlated with plantarflexor strength suggesting that it 
may be a strategy used to compensate for a reduction of plantarflexor /activity at preswing. It has 
been suggested that horizontal motion of the lumbo-pelvic area is related to step length 37. If step 
length is limited by reduced propulsion from the plantarflexors, this may be why trunk rotation is 
employed as a strategy.
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The main focus of this study was compensation to maintain limb progression but plantarflexor 
weakness is also implicated in progression of the body. Previous modelling studies suggest that hip 
and knee extensor activity in early stance also contributes to progression of the trunk’s forward 
acceleration. An increase in such activity could be anticipated in this study but this was not 
observed. This could be because people with CMT used another strategy such as increased trunk 
and pelvis rotation. It is also possible that the variability of this group masked differences in weaker 
individuals. A recent study of gait in people with CMT separated the group according their ability to 
raise their heels of the ground more than 2 cm when standing i.e. defining plantarflexor failure 11. 
Increased knee extensor kinetics were observed in stance in the weaker subjects.
3.4.3.2 Foot clearance
Primary analysis: In the main comparison, people with CMT showed only a trend towards reduced 
dorsiflexion at foot clearance. This result was surprising as foot drop is well described in people with 
CMT39 and there was a significant difference in dorsiflexion MVC. This finding also disagreed with 
the study by Newman et a l27 who found a difference of 5.6° between people with CMT and controls 
though this could be because differences in gait speed was not accounted for statistically. The 
intra-group comparison could provide another explanation. The type-2 group show decreased 
dorsiflexion variables compared to the type-1 group. The type-1 group were not significantly 
different to the control subjects and must have influenced the combined group result. Although it is 
not clear whether this observation is typical for either the type-1 or type-2 group it does indicate 
variability within the group of people with CMT investigated in this study.
Although performing the ANCOVA was important to account for differences due to gait speed, the 
functional predicament of people with CMT must not be ignored. People with CMT frequently report 
tripping and demonstrate reduced dorsiflexion at foot clearance when walking at the speed they are 
limited to by their impairments. Correlation analysis showed a relationship between dorsiflexor MVC 
and gait speed so it is possible that foot drop limits speed in this group, though the converse could 
also be true. Because of this, interventions to address foot drop are still valid.
Increased hip flexion in swing was seen in people with CMT that relates positively to dorsiflexion 
angle in swing. High stepping gait is has been described in this group 14 and in healthy subjects with 
weak dorsiflexors following tibial nerve block 17 An increase in hip flexion could be a strategy to 
avoid tripping in the presence of foot drop. This suggested strategy could be supported by the 
increase in hip flexion velocity during swing discovered in the secondary analysis (section 3.4.3.1). 
The lack of change in hip kinetics in both preswing and swing, however, imply that another 
mechanism may be responsible for the increase in motion.
Secondary comparison: In preswing, a significant increase in knee power generation in people with 
CMT was noted prior to toe off. This feature was not present in the control subjects but a similar
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event has been described in studies of healthy subjects stepping over obstacles. A study of walking 
over varying heights of obstacle showed an increased knee power generation that increased with 
higher obstacles 28 The authors deduced that the increase in knee power generation was a knee 
flexor strategy to elevate the limb. Another study of walking over obstacles attributed the knee 
power generation to a flexor control of the knee joint that increased limb elevation by modulating the 
passive inter-segmental forces. Hip and knee flexion to clear higher obstacles was achieved
33through this strategy, not active control of the hip flexors . It is possible that this is the strategy 
adopted by the people with CMT in the present study. In keeping with this, the hip flexor and knee 
flexor angles were increased in swing phase and knee power generation does correlate with the 
peak hip power generation in swing phase (table 3.12). It is, however, unclear whether the change 
in knee power generation is adopted to compensate for the lack of preswing propulsion or to clear a 
plantarflexed foot in swing. A dropped foot may be considered a trip hazard by an individual in the 
same way an obstacle would.
Increased coronal trunk motion in people with CMT was related to stiffness of the ankle into 
dorsiflexion, i.e. stiffness of the plantarflexor muscles. Although there was not a clear relationship 
with dorsiflexion angle it is possible that stiffness of the plantarflexors would either reduce or slow 
the motion of the ankle into dorsiflexion during swing phase. Coronal trunk motion could be an 
additional way of assisting foot clearance through pulling the swing foot off the floor as the trunk 
leans away from it.
3.4.3.3 Support
Deficits in eccentric plantarflexor control were evident in people with CMT. Control subjects reached 
peak ankle dorsiflexion angle and velocity just prior to heel strike of the opposite leg which was 
when the plantarflexor moment reached its peak. In people with CMT the ankle continued to 
dorsiflex even after contra-lateral heel strike and the peak plantarflexor moment was delayed (figure 
3.4). This period of the gait cycle is sometimes described as the ankle rocker 36 where the leg 
advances over the fixed foot. In healthy subjects the plantarflexors are thought to prevent forward 
motion of the shank during the ankle rocker 41 25. Peak dorsiflexion angle seemed to relate to 
plantarflexor MVC and this would fit the possibility that excessive dorsiflexion occurs due to lack of 
eccentric control of the plantarflexors. The intra-group comparison supports this with the weaker 
type-2 group demonstrating greater dorsiflexion and velocity.
The loading phase was not part of the main analysis for this study but showed some interesting 
differences between the groups. People with CMT showed increased plantarflexion angle in this 
phase compared to controls. This finding has been described as a failure of the heel rocker where 
either the initial contact is with the forefoot or there is reduced dorsiflexion on heel strike 36. 
Intuitively one would expect this finding to be due to either reduced ankle dorsiflexion range of 
motion or weak anterior tibial muscles. A decrease in the dorsiflexor moment of the ankle was also
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seen in loading which in turn is correlated with the dorsiflexor MVC. This would fit with the theory of 
excessive plantarflexion due to reduced eccentric dorsiflexor activity. The difference in dorsiflexor 
moment was also observed in another study of gait in CMT where the authors relate this finding 
with excessive plantar flexion on loading27
3.4.3.4 Coronal and horizontal lower limb motion
Differences in motion in the coronal plane were observed. People with CMT showed increased 
ankle supination compared with controls throughout the gait cycle. No correlations were found with 
the variables measured in this study. The cause of foot supination and pes cavus, however, is still 
undecided. The development of pes cavus has been related to weakness of the intrinsic foot 
muscles but other authors implicate the long muscles of the leg and foot, particularly the imbalance 
between the peroneus brevis and tibialis posterior4 None of these muscles were tested in the 
present study. In this study the type-1 group were more supinated than the other groups on loading 
which can be explained by a higher incidence of pes cavus in CMT1a 3. Some caution must be 
given to these findings and their interpretation because subjects walked in footwear. Motion within 
the shoe and inaccurate placing of markers on the shoe over bony landmarks may reduce the 
accuracy of these findings. The decision to wear footwear was made partly to protect feet if tripping 
occurred on the rubber surface of the walkway and partly because this study was run concurrently 
with a comparison of three ankle foot orthoses (chapter 5) which are worn within footwear. The gait 
analysis and impairment measures took a long time so extra barefoot trials were not added to 
reduce the impact of fatigue. Because comparisons were done with subjects in footwear, distal 
findings should be treated with caution. The differences seen in the sagittal plane are probably large 
enough not to be too affected by this but comparisons in the coronal plane may be prone to more 
error.
An increase in knee varus was observed that was significantly different during preswing but 
appeared to be present throughout the gait cycle (figure 3.6). This could be a secondary problem of 
alignment related to loading feet with pes cavus and calcaneal varus, present in 50% of the 
subjects with CMT. People with CMT also presented with internal rotation of the knee during the 
gait cycle which was significantly different from controls during swing. Newman et a l 27 observed 
this feature and suggested that rotation of the knee was adaptive allowing weight to be transferred 
medially on loading in the absence of pronation.
3.4.5 Future work
A larger CMT group would allow a more meaningful comparison of the two main types of CMT 
perhaps including a CMTX group because it is a more mixed neuropathy. It has been 
acknowledged that there are differences in impairments between the two main types of CMT 3 but
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understanding the gait deviations particular to each group would be helpful in directing problem 
orientated interventions perhaps using care pathways.
One area of gait analysis that is missing in this study is electromyography. A comparative study of 
the timing of muscle activity would be interesting. Relating to the hypothesis for this study, it may be 
possible that proximal changes in the timing or duration of activity are apparent in the absence of 
changes in kinetics. One of the difficulties with an EMG study relating to proximal compensation 
would be the difficulty in recording from the hip flexors. Recording from rectus femoris would not be 
sufficient because as discussed this bi-articular muscle works differently to the hip flexors. The 
optimisation methods used in modelling studies investigating the role of individual muscles may be 
valuable tools to investigate pathological gait patterns. By excluding the action of muscles known to 
be impaired in a condition, proximal changes may be revealed by the model. This method is being 
used in other groups e.g. amputee walking 42 and elderly people 12.
3.5 Summary
♦ People with CMT present with distal impairments of weakness of the ankle muscles, foot 
deformity and reduced sensory perception when compared with control subjects.
♦ They walk with a slower gait speed, reduced cadence and step length but increased double 
support time.
♦ Distal kinetic and kinematic variables are altered in people with CMT with increased dorsiflexion 
angle in late stance and reduced plantarflexor moment and ankle power generation at preswing
♦ Proximal differences were observed between the two groups with increased hip flexion angle 
and velocity during swing. In addition there was a decrease in knee extensor moment and 
increased knee power generation during preswing.
♦ People with the axonal type of CMT were weaker distally. When compared to people with 
demyelinating CMT, they demonstrated reduced plantarflexor angle at toe off, a greater delay in 
the onset of ankle power and reduced peak dorsiflexion angle in swing and at foot clearance.
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4 The effect of plantarflexor weakness on gait in healthy
subjects
4.1 Introduction and Hypothesis
The primary hypothesis for this thesis states that in people with CMT, weak ankle muscles lead to 
increased muscle activity around the hip to compensate for reduced limb progression.
Distal muscle weakness is well described in CMT and will affect the motion, moments and power 
produced at the ankle during the gait cycle particularly at the end of stance phase. Prior to this 
study, a detailed description of any proximal changes that may compensate for distal weakness has 
not been reported in CMT literature. However, from previous work in other conditions we would 
expect that weak plantarflexors would be compensated for by an earlier onset and/or increased 
magnitude of hip kinetics at the end of stance phase. Further clarification is also required as to 
which proximal compensations are solely due to plantarflexor weakness and not other distal 
impairments such as those seen in people with CMT.
In this study the plantarflexor muscles were weakened in healthy subjects through a fatiguing 
exercise task. Gait was compared before and after plantarflexor fatigue. A prediction was 
constructed for this study from the primary hypothesis:
Following fatigue of the plantarflexor muscles, healthy subjects will demonstrate
♦ Reduced ankle plantarflexor moment and power generation during pre-swing
♦ Increased hip flexor moment and hip power generation during preswing
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4.2 Methods
Healthy subjects were recruited from the staff and students of University College London and the 
National Hospital for Neurology and Neurosurgery. Subjects were excluded if they had any 
neurological disease, musculoskeletal condition, any recent lower limb injury or participation in 
competitive sports around the time of the experiment.
The sequence of events in this study was:
♦ Initial 3D gait analysis
♦ Measurement of plantarflexor maximum voluntary contraction (MVC)
♦ Plantarflexor fatigue task
♦ Second measurement of plantarflexor MVC
♦ Second 3D gait analysis
♦ Third measurement of plantarflexor MVC
4.2.1 Gait analysis
Three dimensional segmental analysis of gait was performed (CODAmotion, Leicestershire, UK). 
Infrared markers were applied in clusters that allowed the calculation of 3D lower limb kinematics 
via CODA motion software, (see methods, chapter 2). An additional segment for the trunk was 
defined using markers on the anterior superior iliac spines (ASIS) and acromion processes of the 
shoulders. Two force plates were embedded in the walkway and used for the 3D kinetic analysis. 
Subjects were asked to walk along the 10m walkway at a comfortable speed. Six seconds of 
synchronised motion and force data were collected per trial (sampling rate 200Hz). Trials were 
accepted if a single foot landed fully on a force plate. Three footfalls per leg were collected.
Marker sites on the shoulders, pelvis and legs were marked to ensure correct replacement post 
fatigue test. Markers mounted on the skin and footwear were not removed. The step length and 
cadence of the subject was recorded from the initial gait trials. The step length was marked out at 
either end of the walkway. At the second gait measurement subjects were asked to maintain the 
same step length and cadence using a metronome as an auditory cue. This attempted to replicate 
the same gait speed for comparison.
4.2.2 Measurement of plantarflexor strength
Plantarflexor MVC was measured in standing. Two strain gauges were attached to an adjustable 
gantry on a rigid metal frame. A part wood and foam pad was attached to the other end of the strain 
gauge.
95
Chapter 4
The pad was lowered onto the shoulders of the subject until they were firmly held. This was 
adjusted and the pads fixed in a position where heel raise was limited but pressure from the pads 
did not cause excessive discomfort (figure 4.1).
Strain gauge
Figure 4.1: Set up for measuring bilateral plantarflexor MVC in standing. Strain gauges were fixed 
as shown on both shoulders.
Subjects were asked to push against the pads as hard as possible using their plantarflexor 
muscles. Subjects were monitored to ensure there was no excessive shoulder elevation and verbal 
encouragement was given throughout the contraction. The output voltage of the strain gauges was 
summed and the mean of two MVCs calculated. The positions of the strain gauges were marked on 
the gantry and foot position was marked on the floor. This allowed a consistent set up before and 
after the fatigue test.
4.2.3 Plantarflexor fatigue task
The plantarflexor muscles were fatigued using a heel raise exercise with the forefoot on a step. To 
minimise fatigue of the hip, knee and trunk muscles, subjects were asked to rest on a flat support in 
front of them set at 5° from vertical (figure 4.2). A weighted harness of approximately 10% of the 
subject’s body weight was placed on the trunk. Subjects stood with their forefeet on a non-slip step 
and were asked to perform through range concentric and eccentric plantarflexion contractions by 
raising and lowering their heels.
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A light was placed on the subject’s chest which was projected onto the wall in front. Targets were 
placed on the wall which corresponded to the position of the light beam when the heels were raised 
to their highest point and lowered to their lowest point. Another target was placed halfway between 
the two main targets.
Chest lamp
Targets
   Weight harness
Trunk rest
-  Non slip step
Figure 4.2: Set up for fatiguing the plantarflexors in standing. Repeat full range plantarflexion 
contractions were performed at a frequency of one per second. A metronome was used to aid 
timing.
Subjects performed repeated through-range exercises at a frequency of one per second until they 
were unable to reach the halfway target. A metronome was used to maintain the frequency and the 
subject was observed to ensure the targets were not reached through excessive knee or trunk 
extension. It was anticipated that the exercise would be painful so 15 second rests were given as 
required, the time between rests was at least 2 minutes in all subjects.
As soon as the subject was consistently unable to reach the midway target for 10 repetitions they 
were removed from the apparatus and the strain gauges immediately placed on their shoulders. As 
soon as the MVC measures were taken, the gait analysis markers were replaced and walking was 
measured. The entire process from cessation of the plantarflexor fatigue task to gait analysis took 
under five minutes.
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4.2.4 Analysis
Three trials for the left and right legs were exported as text files for analysis using Matlab 
programmes written in house (Mathworks). A single gait cycle was identified from the heel marker 
acceleration traces and vertical forces. Cycle duration was normalised, and three cycles were 
averaged 3 9 The data from the left and right legs were combined. Temporal and spatial gait 
parameters were recorded.
The primary analysis was based on the two predictions introduced at the beginning of this chapter.
♦ Reduced peak ankle plantarflexor moment and peak ankle power generation during 
pre-swing
♦ Increased peak hip flexor moment and peak hip power generation during preswing
This gave a total of four comparisons for the primary analysis and a modified Bonferroni test was 
applied to account for multiple comparisons (appendix 1) 23.
A secondary analysis compared:
♦ Maximum and minimum hip, knee and ankle kinetics and kinematics in loading, mid-stance and 
swing
♦ Peak to peak pelvis and trunk kinematics in all three planes
A modified Bonferroni adjustment was made to this data from the secondary analysis but none of 
the group differences were significant due to the large number of comparisons. It was decided, 
however, to still look for patterns in the data using p<0.05 as a guide. Data were compared with 
findings of previous studies to evaluate whether or not a consistent and logical finding was real, and 
not a false positive result. It was acknowledged, however, that strictly the results of the secondary 
analysis gave an indication of group trends only.
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4.3 Results
This section outlines changes in gait before and after fatigue of the plantarflexor muscles. Grand 
average graphs are presented at the end of this section. Some discrepancy exists in peak values 
and those presented on the grand average graphs due to variations in the timing of peak variables 
influencing the average trace.
Ten healthy subjects were recruited, four men and six women. The mean age of the group was 31 
(± 5 years). Average height of the subjects was 1.7 m and weight was 65.5 kg.
4.3.1 Changes in MVC
MVC measures were used to indicate how much the plantarflexor muscles fatigued and were 
expressed as a percentage of the initial pre test reading. Subjects continued with the heel raise 
exercise for an average of 7.1 ±2.1 minutes. The average drop in plantarflexor MVC after the 
fatigue test was 25.6%. After the second gait analysis the MVC returned to a level 3.39% less than 
the initial MVC. A significant correlation was seen between the duration of the exercise and the 
percentage drop in MVC (r =0.70, P=0.025) (figure 4.3).
MVC drop 
(% pre MVC)
T statistic P value
MVC post PF fatigue test -25.63 ±13.26 5.49 0.0004
MVC post walking test -3.39 ±19.87 3.69 0.003
MVC of CMT subjects 
% of controls
31.79% - -
Table 4.1: Changes in MVC before and after the plantarflexor fatigue test. Expressed as a 
percentage of the initial MVC measure. Percentage of PF MVC for CMT subjects compared to 
controls (data from chapter 3)
4.3.2 Temporal and spatial gait parameters
Subjects were requested to maintain the same gait speed following the plantarflexor fatigue test 
with the aid of visual and auditory cues. No significant differences in gait speed, cadence, step 
length or double support time were observed.
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FP = 0.4876
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Figure 4.3: Relationship between duration of the heel raise task (minutes) and percentage drop of 
MVC
4.3.3 Kinetic and kinematic changes
4.3.3.1 Primary comparison: ankle and hip kinetics in preswing
Little change was observed in the variables analysed in the primary comparison. No significant 
differences were seen in the distal kinetic variables with no change in ankle plantarflexor moment 
and power generation. Proximally, no significant changes were observed but there was a borderline 
trend towards increased hip power generation during pre-swing.
Gait variable Pre PF fatigue Post PF fatigue T statistic P value
PF moment preswing 
(Nm/kg)
1.51 ±0.18 1.58 ±0.23 -1.14 0.3
Ankle power generation 
preswing (W/kg)
3.79 ±0.93 3.97 ±1.01 -0.70 0.5
Hip flexor moment 
preswing (Nm/kg)
0.67 ±0.18 0.83 ±0.31 1.84 0.1
Hip power generation 
preswing (W/kg)
0.64 ±0.20 0.91 ±0.41 -2.65 0.03
Table 4.2: Changes in primary gait variables after plantarflexor fatigue test.
4.3.3.2 Secondary comparison: kinematics and kinetics in stance
The secondary comparison revealed significant changes in gait variables during loading and stance 
phase. On loading an increase in the flexion angle and flexion velocity of the knee is observed 
following fatigue of the plantarflexors (table 4.3, figures 4.4 and 4.5). Proximally there was an 
increase in hip extensor moment (table 4.4, figure 4.6).
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Gait variable Pre PF fatigue Post PF fatigue T statistic P value
Knee flexion angle 
loading (deg)
17.57 ±5.28 22.40 ±9.25 -2.95 0.02
Knee flexion velocity 
loading (deg/s)
234.18 ±53.69 266.66 ±63.34 -3.08 0.01
Peak trunk flexion stance 
(deg)
18.17 ±3.20 20.50 ±3.07 -2.44 0.04
Table 4.3: Changes in kinematic gait variables in loading and stance after plantarflexor fatigue test.
Following loading, in early stance, an increase in knee extensor moment and power generation was 
observed (table 4.4, figures 4.6 and 4.7). There was also a corresponding increase in hip power 
generation in early stance (table 4.4, figure 4.7). Later in stance, just prior to pre-swing, there was a 
significant increase in hip power absorption (table 4.4, figure 4.7). Trunk flexion was increased 
throughout the gait cycle with a significant difference during stance phase (figure 4.8). A trend was 
seen for increased hip flexion velocity during swing phase following fatigue of the plantarflexors 
(pre: 202 ±36 deg/s; post: 228 ±46 deg/s; t =-1.93, P=0.09).
Gait variable Pre PF fatigue Post PF fatigue T statistic P value
Knee extensor moment 
stance (Nm/kg)
0.88 ±0.30 1.05 ±0.37 -2.51 0.03
Knee power generation 
stance (W/kg)
1.19 ±0.56 1.57 ±0.76 -2.65 0.03
Hip extensor moment 
loading (Nm/kg)
1.21 ±0.35 1.49 ±0.47 -3.23 0.01
Hip power generation 
stance (W/kg)
0.98 ±0.24 1.45 ±0.38 -4.53 0.001
Hip power absorption 
stance (W/kg)
0.98 ±0.56 1.32 ±0.50 2.39 0.04
Table 4.4: Changes in kinetic gait variables in loading and stance after plantarflexor fatigue test.
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Figure 4.4: Grand average of angular displacement in the sagittal plane over one gait cycle for the 
ankle, knee, hip and pelvis (average of left and right sides). CT: contra-lateral toe off; CH: contra­
lateral heel strike; CH: contra-lateral heel strike; IT: ipsilateral toe off; DF: dorsiflexion; PF: 
plantarflexion.
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Figure 4.5: Grand average of angular velocity in the sagittal plane over one gait cycle for the ankle,
knee, hip and pelvis (average of left and right sides). CT: contra-lateral toe off; CH: contra-lateral
heel strike; CH: contra-lateral heel strike; IT: ipsilateral toe off; DF: dorsiflexion; PF: plantarflexion.
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Figure 4.6: Grand average of joint moments in the sagittal plane over one gait cycle for the ankle,
knee, hip and pelvis (average of left and right sides). CT: contra-lateral toe off; CH: contra-lateral
heel strike; CH: contra-lateral heel strike; IT: ipsilateral toe off; DF: dorsiflexion; PF: plantarflexion.
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Figure 4.7: Grand average of joint powers in the sagittal plane over one gait cycle for the ankle,
knee, hip and pelvis (average of left and right sides). CT: contra-lateral toe off; CH: contra-lateral
heel strike; CH: contra-lateral heel strike; IT: ipsilateral toe off; DF: dorsiflexion; PF: plantarflexion
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gait cycle for the ankle, knee, hip and pelvis (average of left and right sides). CT: contra-lateral toe 
off; CH: contra-lateral heel strike; CH: contra-lateral heel strike; IT: ipsilateral toe off; DF: 
dorsiflexion; PF: plantarflexion.
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4.4 Discussion
Subjects were successfully constrained for gait speed and cadence before and after the fatigue test 
as no changes were seen in temporal and spatial gait parameters. This allowed a comparison of 
gait kinetic and kinematic variables without the confounding influence of gait speed8.
4.4.1 Distal changes
It was anticipated that a change would be observed in plantarflexor moment and power generation 
post fatigue test. This was not the case in the present study. There could be a number of 
explanations for this finding that are discussed below:
Insufficient plantarflexor muscle fatigue: Although the heel raise exercise has been used in other 
behavioural studies to fatigue the plantarflexors25, it may not have fatigued them sufficiently to 
reduce ankle kinetics at preswing in the present study. Studies investigating the percentage 
utilisation of the plantarflexor muscles during walking found that the plantarflexors produce 
moments 60% of the maximum potential moment during walking at a self selected speed 13,19. As 
the subjects only fatigued by 25%, there was probably sufficient reserve in the plantarflexor muscles 
to produce the same force and power generation. An estimate of the strength in Nm/Kg for the 
healthy subjects pre and post fatigue (multiply force by -0.3 = lever arm) was compared to the 
strength in the CMT group (from chapter 3) and showed that the healthy subjects in this study did 
not weaken as much as the patient group.
During the heel raise task subjects complained of severe muscle pain induced by the exercise. 
Muscle pain during exercise is thought to be due to a number of mechanical and biomechanical 
factors for example intramuscular mechanical pressure 2 and noxious metabolic by-products such 
as H \ phosphocreatine, histamine, prostoglandins, substance P 2> 12. In the present study there was 
variability in how long subjects performed the fatigue task and high individual variability has been 
reported in the threshold of muscle induce pain in bicycle ergometry tasks 2 It is possible that 
subjects with a lower threshold to exercise induced pain limited their performance of the fatigue-task 
and how long they continued. Self efficacy for tolerating pain was found to correlate with peak pain 
ratings during bicycle ergometry task 14 indicating central influences on task performance that could 
account for variability in the present study. Variability in performance has the potential to influence 
the mean percentage drop of MVC and possibly the mean effects of plantarflexor fatigue on gait.
Increased effort to match gait speed: There is a suggestion that an increase in activation is the 
primary compensatory strategy when there is weakness of a muscle group 4. The walking task 
required the subjects to maintain their cadence and step length post fatigue test to allow
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comparison of the gait variables that may vary with differing gait speeds 8. Constraining the speed 
may have forced subjects to walk quicker and with a longer stride length than if they were allowed 
to walk at a self selected pace immediately after the fatigue test. This may have resulted in 
increased recruitment of the plantarflexors in an effort to achieve the set step length and cadence 
goals as opposed to just the goal of maintaining walking.
A change in temporal and spatial gait parameters may have been an interesting finding post 
plantarflexion fatigue as they may have been similar to people with CMT. Unfortunately, this was 
not investigated with the present protocol. An alternative approach for future studies would be to 
allow subjects to walk at a self selected speed after plantarflexor fatigue and then use analysis of 
covariance to statistically adjust for gait speed as in chapter 3. Another approach would have been 
to look at maximal walking speed to maximise the contribution of the plantarflexors. With reduced 
strength, effects on ankle kinetics may have been more apparent.
Recovery prior to and during walking test: The goal of the plantarflexor fatigue protocol was to 
weaken the plantarflexors and to investigate the effect of these changes on a behavioural task i.e. 
walking. The exercise selected to achieve this had been used in other studies to investigate the 
effect on behavioural tasks 4. The heel raise task involves a combination of eccentric and concentric 
contractions. Concentric and eccentric contraction have been shown to fatigue muscles at different 
rates and have different recovery times 18,24 In the present study, the heel raise task was an 
intense exercise with a work : rest ratio biased towards work duration. It is possible that some of the 
fatigue observed was due to depletion of energy stores 21 or local metabolic changes in the muscle 
leading to activation failure 5’ 18. Fatigue relating to muscle damage brought about by the eccentric 
contractions would have occurred later and been longer lasting 18,24. The subjects in the present 
study showed a period of recovery from the cessation of the heel raise task to the completion of the 
gait trials as measured by the plantarflexor MVC. They also reported a subjective sensation of 
recovery from fatigue as the walking trial progressed which may have affected the consistency of 
the gait trials. It is probable, therefore, that fatigue measured after the heel raise exercise was due 
to metabolic changes as the recovery was rapid. A study of the time course of fatigue and recovery 
from concentric and eccentric muscle contractions of the elbow flexors found that the lowest MVC 
after concentric exercise was 23 minutes whereas after eccentric exercise it was two hours, taking 
four hours to achieve recovery to half of the baseline level 24. Waiting longer to take the gait 
measurement may have allowed a more stable, sustained level of fatigue induced weakness 
resulting in more consistent gait trials. There are no studies looking at timing and recovery of fatigue 
after volitional exercise of the plantarflexor muscles so at present the percentage fatigue cannot be 
estimated. It would have been useful to trial the heel raise exercise at differing frequencies and 
numbers of repetitions measuring fatigue during the exercise and post exercise. This would help to 
ascertain the optimum time to perform the walking trials so it corresponded with the maximum drop 
in MVC due to long lasting fatigue.
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4.4.2 Proximal compensations
Despite the lack of change distally, proximal changes were observed post fatigue test. The changes 
in the healthy subjects were different to those seen in people with CMT (chapter 3) in that there 
were no changes in knee kinetics during preswing or in peak-to-peak trunk motion.
4.4.2.1 Limb progression
The primary comparison did not show any significant changes in hip kinetics at preswing. A trend 
towards increased peak hip power generation was observed, however, that was non-significant post 
modified Bonferroni correction. Correction for multiplicity for four comparisons was a conservative 
measure in this study and the chance of a type 1 error was less than 20% 17. In addition, hip flexor 
substitution has been suggested as a compensation for weak plantarflexors to assist with limb 
advancement4' 10,27. Based on this, it is possible that this trend is a real finding.
The secondary analysis showed an increase in flexion at the trunk though the cause of this is 
difficult to explain as few modelling studies have either included the trunk as a whole segment6 or 
considered the effects of the trunk musculature 4. It is possible that changes at the trunk are a 
consequence of altered hip muscle activation. It could also be an indication that the trunk and hip 
muscles, e.g. gluteus maximus, were also affected by the fatiguing task despite efforts to limit this. 
There were, however, increases observed in hip extensor moments and hip power generation in 
stance so this may not be the case. A study by Saunders et a l 22 found that sagittal lumbo-pelvic 
flexion was strongly correlated with stride length. It is possible that in the presence of plantarflexor 
weakness the increase in trunk flexion post fatigue was a compensation to achieve the target step 
length. The question remains, is this a strategy to accelerate the limb or trunk? It has been 
suggested that a ‘trunk leading’ strategy is a way of using the heavy trunk segment to direct 
movement of the lower body by pulling the leg into swing phase when distal muscle weakness is 
present11.
4.4.2.2 Trunk progression
The secondary comparison showed changes at the knee and hip during stance phase. In early 
stance, as the limb moves into single support, increases in hip and knee extensor moments and 
power generation are seen. Soleus has been shown to accelerate the trunk to aid progression 
during its action in preswing 15,26. The knee extensors and hip extensors also progress the trunk 
through their action in early stance 16, 26 so the increased hip extensor moment and power 
generation following fatigue observed could be a compensation for the reduction in trunk 
progression at preswing due to soleus weakness. This supposition is supported by findings in 
optimisation studies that found increased gluteus maximus 4 and knee extensor activity 7 in early 
stance in the presence of plantarflexor weakness. The increases in hip extensor moment and power 
generation may also be a strategy to control the increase in knee flexion angle that occurred due to
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plantarflexor weakness. Gluteus maximus has a role in accelerating the knee towards extension in 
single limb support1,7
4.4.2.3 Support
Knee kinematics changed after the plantarflexor fatigue test with an increase in peak flexion and 
flexor velocity on loading. The ankle plantarflexors have been implicated in control of knee 
extension during the support phase in stance 1’ 6. The increase in flexion, therefore, seems to 
represent a failure of the plantarflexors to control the advancement of the shank and exert an 
extensor moment at the knee. This change may be a consequence of plantarflexor weakness rather 
than a compensation for it. An optimisation modelling study 4 found that when soleus and 
gastrocnemius were weakened together, other muscle groups were not able to compensate 
sufficiently to give normal kinematics. This was also evident in the present study of healthy, 
neurologically intact adults. Fatigue of the quadriceps during the heel raise exercise cannot be ruled 
out and could also influence knee flexion. Subjective reports from participants, however, reported 
localised sensation of fatigue and pain during the exercise in the plantarflexors only.
Later in stance, post fatigue, an increase in hip power absorption and hip flexor moment was seen 
prior to preswing. This could represent eccentric activity of the hip flexors to control hip extension as 
there was a trend towards increased peak hip extension (t=1.87, p=0.09) (figure 4.4). When the 
knee is almost fully extended just prior to preswing, the limb could be assumed to be a strut. If 
soleus is not able to control forward rotation of the shank, and hence the thigh, this could lead to an 
increase in hip extension assuming the trunk remains relatively stable in space due to inertia. The 
iliopsoas muscle group has been described as working synergistically with the plantar flexors the 
control the ankle rocker7. In this situation, therefore, the hip flexor muscles could be recruited as a 
compensatory strategy to control hip extension if soleus is weak.
4.4.2.4 Overview
The present study demonstrates proximal changes that are consistent with proposed compensatory 
strategies investigated in other studies. The obvious question to ask is why do we see these 
changes when there were apparently no changes in the ankle kinetics? The myometry measure 
demonstrated that there was a 25% reduction in plantarflexor strength post heel raise exercise 
showing a significant drop in strength. An optimization study by Goldberg and Neptune 4 looked at 
combined weakness of the soleus and gastrocnemius by 30%. Their primary investigation was to 
measure the work done by other compensating muscles to maintain normal kinematics. Although 
they did not report on ankle kinetics, they found that reduction of the plantarflexion angle at push off 
was seen and proximally the main compensation was increased net gluteus maximus work in early 
stance and positive iliopsoas work in preswing/early swing. The proximal findings are very similar to 
the present study which also showed a trend towards reduced ankle plantarflexor angle after toe off 
(t =-1.82, P=0.1) (figure 4.4). Although there was not an overall change in kinetics, the possible
110
kinematic trend indicates distal changes. The majority of the proximal compensations seen in this 
study were in stance phase. Although the preswing ankle kinetics were unchanged it appears that 
impaired activation during loading and stance may have been more influential as maintaining 
support was considered the primary role of the plantarflexors in other studies20.
4.5 Summary
♦ Healthy subjects demonstrated a significant reduction in plantarflexor MVC by 25% with a 
repeated heel raise exercise, which was terminated when 50% of the full range could not be 
consistently achieved.
♦ No significant changes were seen in distal kinetic measures. A trend to a reduction in 
plantarflexor angle in early swing phase was observed
♦ There was a trend towards increased hip power generation during preswing that is consistent 
with significant changes reported in associated literature. This may be a compensatory strategy 
to assist limb progression in the presence of gastrocnemius weakness.
♦ Trunk flexion increased significantly during stance phase.
♦ Increases in knee and hip extensor moments and power generation were observed in early 
stance, after loading, that may be a compensatory strategy to assist trunk progression in the 
presence of soleus weakness
♦ Significant increases were seen in knee flexion angle and velocity on loading that may be due 
to reduced eccentric control by the plantarflexors.
♦ There was increase in hip extensor moment observed in loading that may be compensatory 
activity of the gluteus maximum to control knee flexion.
♦ Increased hip power absorption was seen in late stance. This may be a strategy to control hip 
extension in the absence of eccentric control of the plantarflexors over the shank and tibia.
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5 The effect of three foot drop splints on gait characteristics in 
Charcot-Marie-Tooth disease
5.1 1ntroduction and Hypothesis
The primary hypothesis for this thesis states that in people with CMT, weak ankle muscles leads to 
increased muscle activity around the hip to compensate for reduced limb progression and foot drop 
during swing. Chapter 3 demonstrated some of these differences with increased hip motion and 
altered timing of power generation relative to the ankle.
People with CMT show a reduced peak ankle dorsiflexion in swing phase compared to control 
subjects using 3D gait analysis 10. Traditionally ankle foot orthoses (AFOs) are given to assist the 
ankle into plantigrade to facilitate foot clearance during swing. As well as this positive benefit, AFOs 
may also influence other periods of the gait cycle. A study by Salsich and Mueller13 looked at ankle 
stiffness in diabetic peripheral neuropathy and the relationship with peak ankle moments. They 
found that in addition to plantarflexor strength, plantarflexor stiffness contributed significantly to the 
peak plantarflexor moment during walking. In their conclusions they suggested that stiffening the 
ankle with an external device, such as an AFO, could increase the passive ankle moment during 
preswing and in turn improve limb advancement. Improved limb advancement implies improved 
propulsion at preswing and this may reduce the need to compensate at the hip. This theory was 
explored in the present study using different commercially available splints with varying designs, 
materials and rigidity. Based on this theory and the primary hypothesis for the thesis a prediction for 
this study was proposed:
When wearing AFOs that stiffen the ankle, people with CMT will show:
♦ increased in peak dorsiflexion angle throughout swing and at foot clearance
♦ increased peak plantarflexor moment and ankle power generation during preswing
♦ reduced compensatory hip kinematics and kinetics
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Chapter 5
5.2 Methods
People with CMT were recruited from the genetic peripheral neuropathy clinic at the National 
Hospital for Neurology and Neurosurgery. Volunteers were included if they had clinically definite 
CMT and were able to walk 100m in at least 10 minutes. People were excluded if they had a 
history of other neurological impairment, orthopaedic lower limb impairment unrelated to CMT and 
lower limb or back pain exceeding 7 out of 10 on a visual analogue scale.
5.2.1 Ankle foot orthoses
Three commercially available off the shelf devices were compared. The first was called a ‘Footup 
splint’ (Somas, Saint Anthonis, Netherlands) which was a cuff worn around the ankle with a 
detachable elastic strap and a plastic flange at the one end to tie into the laces of a shoe (Figure 
5.1a). The material of the cuff did not extend over the ankle joint but the principle of the device was 
that the elastic strap provided a resistance to plantarflexion which was sufficient to maintain 
adequate dorsiflexion to allow ground clearance on swing phase.
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Figure 5.1: A- Footup splint; B- Push brace; C- Multifit Achilles
The second AFO was called a ‘Push brace’ (Nea International, Maastricht, Netherlands) and was 
designed as a support for ankle instability following ligament injury (Figure 5.1b). Anecdotal success 
of the brace in foot drop has lead to its prescription in a number of UK neurological centres. The 
main brace was made of preformed foam which covers the medial, posterior and lateral aspects of 
the ankle and extends under the calcaneum. The medial and inferior aspects were reinforced. 
Three elastic straps further reinforced the brace.
The Multifit Achilles drop foot orthosis (V-M Orthotics International, Halesworth, UK) was the third 
device investigated (Figure 5.1c). It is a variant of the posterior leaf AFO made of plastic polymer 
with a half foot plate, a cut out heel section and an adjustable back stem that extended to the calf. 
As the name suggests it was designed to reduce foot drop during swing phase so improving ground 
clearance.
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Four conditions were tested in ail: a shoe only condition (shoe); the shoe and Footup splint 
(Footup); the shoe and Push brace (Push); the shoe and Multifit Achilles AFO (Multifit).
5.2.2 Measurement of ankle stiffness
Ankle stiffness into dorsiflexion and plantarflexion was measured using ramp and hold stretches 
delivered via a dynamometer (Biodex Medical Instruments Inc., New York, USA). Subjects lay 
supine, with their knee in extension, and placed their foot in a manipulandum set at plantigrade. The 
foot, ankle and proximal leg were secured using straps. The manipulandum was rotated through 5° 
with a peak velocity of 15° per second, as specified by a positional data file (Biodex System3 
Researchers Toolkit). Subjects remained relaxed during the test and six stretches in each direction 
were collected.
Surface EMG was recorded from the tibialis anterior (TA) and medial gastrocnemius (GAS) to 
confirm muscle relaxation. Torque, velocity and position were collected via the Biodex remote 
access port. Signals were AD converted using a Power 1401. Data was sampled at 2000Hz and 
collected using Spike2 software (Spike2 version 5.06, Cambridge Electronic Design).
5.2.3 Gait Analysis
Gait analysis was performed as in chapter three with synchronised 3D motion analysis and force 
plate recordings. Subjects were asked to walk along the walkway at a comfortable speed. Six 
seconds of motion and force data were collected per trial at a 200Hz sampling rate. Trials were 
accepted if a clean foot fall on the force plate was achieved. A total of three clear trials for each leg 
were collected.
5.2.4 Analysis
Stretch data was collected using Spike2 software and exported as spreadsheet text files for 
analysis using Matlab programmes written in house (MATLAB, Mathworks Inc). The last 5 stretches 
were averaged and stiffness calculated (chapter 2).
A repeated measures general linear model was used to compare stiffness measures for the four 
conditions and 2-tailed paired T-tests were used for the post hoc analysis. Significance was taken 
as p<0.05.
For the gait analysis, three trials for the left and right legs were exported as text files for analysis 
using Matlab programmes written in house (Mathworks). A single gait cycle was identified from the 
heel marker acceleration traces and vertical forces. Cycle duration was normalised, and three 
cycles were averaged 5l 9. The data from the left and right legs were combined. Temporal and
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spatial gait parameters were recorded. The primary comparison was based on the predictions 
introduced at the beginning of this chapter and consisted of:
♦ Peak plantarflexion and dorsiflexion angle in swing and dorsiflexion angle at foot clearance 
(defined in chapter 3)
♦ Peak plantarflexor moment and ankle power (max and min) at preswing
♦ Peak hip flexion during swing phase
♦ Peak hip moment and power generation during preswing
This gave a total of nine comparisons for the primary analysis which was tested using a general 
linear model (factor: splints, four levels) and a modified Bonferroni test was applied to account for 
multiple comparisons (appendix 1) 14. A priori contrasts were set up comparing the shoe only 
condition with the three AFO conditions. Significance was taken as p<0.05.
A secondary analysis compared:
♦ Remaining maximum and minimum sagittal hip, knee and ankle kinematics and kinetics in 
loading, mid-stance and swing
♦ Peak-to-peak pelvis and trunk kinematics in all three planes
This secondary analysis and temporal spatial data was tested using a repeated measures general 
linear model (factor: splints, four levels). A modified Bonferroni adjustment was made to the data 
from the secondary analysis but none of the group differences were significant due to the large 
number of comparisons. It was decided, however, to still look for patterns in the data using p<0.05 
as a guide. Data were compared with findings of previous studies to evaluate whether or not a
consistent and logical finding was real, and not a false positive result. It was acknowledged,
however, that strictly the results of the secondary analysis gave an indication of group trends only.
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5.3 Results
This section outlines the comparisons of the four orthotic conditions: shoe only, Footup brace, Push 
ankle brace and Multifit AFO. Grand average graphs are presented at the end of this section. There 
are discrepancies between peak values and apparent peaks on the grand average graphs. This is 
due to alterations in the grand average trace resulting from variations in the timing of the peaks 
between individual participants.
Fourteen people were recruited to participate in this study. Their details and impairment measures 
are outlined in chapter 3. Five of the subjects used AFOs prior to this study. Two used the Footup 
brace, two used the Push brace and one used a supra-malleolar silicon AFO.
5.3.1 Stiffness comparison
The stiffness of the four conditions varied with stretches into both dorsiflexion and plantarflexion 
(ANOVA dorsiflexion: F =6.61, P=0.001; plantarflexion: F =18.11, P<0.0001). Stiffness into 
dorsiflexion was greatest when the Push brace and the Multifit AFO were worn, though the Footup 
brace also increased stiffness compared to the shoe condition (post hoc: shoe v Footup t =-2.41, 
P=0.03; shoe v Push t =-3.51, P=0.004; shoe v Multi t =-2.97, P=0.01) (figure 5.3). Stiffness into 
dorsiflexion maybe more relevant to the later part of stance or early part of preswing at the ankle 
rocker when the ankle moves into maximum dorsiflexion.
Figure 5.3: Stiffness of the four conditions when worn by the subjects during a 15 °/sec stretch into 
5° dorsiflexion. Shoe only, Footup brace, Push ankle brace, Multifit AFO. Error bars: standard error 
of the mean. Post hoc: * p<0.05
When stretched into plantarflexion, the ankle was stiffest when the Push brace and the Multifit AFO 
were worn (post hoc: shoe v Push t =-4.66, P=0.0006; shoe v Multifit t =-5.81, P<0.0001). Again, 
the Footup brace also increased ankle stiffness compared to just the shoe (post hoc: shoe v Footup
*
Shoe Footup Push Multifit
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t =-5.50, P=0.0001) (figure 5.4). Stiffness into plantarflexion maybe more relevant to the later part of 
preswing and swing when the AFO resists plantarflexion during heel raise and after toe off.
Figure 5.4: Stiffness of the four conditions when worn by the subjects during a 15 °/sec stretch into 
5° plantarflexion. Shoe only, Footup brace, Push ankle brace, Multifit AFO. Error bars: standard 
error of the mean. Post hoc: * p<0.05
5.3.2 Gait analysis
5.3.2.1 Temporal and spatial measures
No significant difference was observed in gait speed, step length and cadence when the AFOs were 
worn. The AFOs did not make a significant difference to the percentage of the gait cycle spent in 
double support but there was a trend towards an increase when the Multifit AFO was worn 
(ANOVA: F =2.21, P=0.1; post hoc: shoe v Multifit t =-3.99, P=0.002) (figure 5.5).
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Figure 5.5: Percentage of the gait cycle spent in double support. Shoe only, Footup brace, Push 
ankle brace, Multifit AFO. Error bars: standard error of the mean. Post hoc: * p<0.05
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5.3.2 2 Primary kinematic and kinetic comparison
The foot drop measure defined for this study, the dorsiflexion angle when the foot markers are 
closest to the floor during swing phase, showed a significant difference between AFO conditions 
(ANOVA: f =6.35, P=0.001) (figure 5.10). Post hoc testing revealed that all three AFOs improved 
the dorsiflexion angle at foot clearance compared to just a shoe. The Multifit AFO gave the biggest 
improvement (post hoc: shoe v Footup t =-2.64, P=0.02; shoe v Push t =-3.12, P=0.008; shoe v 
Multifit t =-4.37, P=0.008) (figure 5.6). The only other kinematic event worth noting was a trend 
towards reduced plantarflexion angle at preswing when the Multifit AFO was worn (ANOVA: f =2.76, 
P=0.06; post hoc: Footup v Multifit t =-3.18, P=0.007) (figure 5.10).
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Figure 5.6: Ankle dorsiflexion angle at foot clearance (degrees). Shoe only, Footup brace, Push 
ankle brace, Multifit AFO. Dorsiflexion: positive values, plantarflexion: negative values. Error bars: 
standard error of the mean. Post hoc: * p<0.05
In early swing phase the ankle was in less plantarflexion when the AFOs were worn compared to 
just shoes (ANOVA: F =12.85, P<0.0001) (figure 5.10). The Multifit AFO was most effective at 
reducing the plantarflexion angle (post hoc: shoe v Footup t =-3.10, P=0.01; shoe v Push t =-3.55, 
P=0.004; shoe v Multifit t =-4.17, P=0.001) (figure 5.7).
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Figure 5.7: Peak plantarflexor angle in swing phase (degrees). Shoe only, Footup brace, Push 
ankle brace, Multifit AFO. Error bars: standard error of the mean. Post hoc: * p<0.05
When the AFOs were worn, no significant differences were seen in ankle moment produced in 
preswing (figure 5.12). The only significant difference in the power profile was at the ankle (ANOVA: 
f =5.39, P=0.003) (figure 5.13). The Multifit AFO reduced the peak ankle power generation at 
preswing compared to the Push brace and shoe only conditions (post hoc: shoe v Multifit t =3.6, 
P=0.003; Push brace v Multifit t =2.80, P=0.02) (figures 5.8 and 5.13). There was also a trend 
towards an increase in ankle power absorption when the Multifit AFO was worn (ANOVA: f =2.18, 
P=0.1; post hoc: Multifit v Footup t =2.56, P=0.03).
Proximally there were no significant differences in peak values. Although not a planned comparison, 
a trend was noted toward an increase in total hip power generation in swing phase when the Multifit 
AFO was worn (ANOVA: f =2.62, P=0.09; post hoc: Push v Multifit t =-3.09, P=0.009) (figure 5.13).
Figure 5.8: Peak ankle power generation at preswing (Watts/Kg). Shoe only, Footup brace, Push 
ankle brace, Multifit AFO. Error bars: standard error of the mean. Post hoc: * p<0.05
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5.3.2.3 Secondary kinematic and kinetic comparison
The secondary analysis revealed no further differences in stance phase or trunk motion. In swing 
phase there was a difference in the peak dorsiflexion angle achieved (ANOVA: f =3.11, P=0.04) 
(figure 5.10). The Push ankle brace and the Multifit AFO were the most effective at improving the 
peak dorsiflexion angle and reducing how far the ankle dropped into plantarflexion (post hoc: shoe v 
Push brace t =-2.32, P=0.04, shoe v Multifit t =-2.45, P=0.03) (figure 5.9).
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Figure 5.9: Peak dorsiflexor angle in swing phase (degrees). Shoe only, Footup brace, Push ankle 
brace, Multifit AFO. Error bars: standard error of the mean. Post hoc: * p<0.05
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Figure 5.10: Grand average of angular displacement in the sagittal plane over one gait cycle for the
ankle, knee, hip and pelvis (average of left and right sides). CT: contra-lateral toe off; CH: contra­
lateral heel strike; CH: contra-lateral heel strike; IT: ipsilateral toe off
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Figure 5.11: Grand average of angular velocity in the sagittal plane over one gait cycle for the
ankle, knee and hip (average of left and right sides). CT: contra-lateral toe off; CH: contra-lateral
heel strike; CH: contra-lateral heel strike; IT: ipsilateral toe off
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Figure 5.12: Grand average of joint moments in the sagittal plane over one gait cycle for the ankle,
knee and hip (average of left and right sides). CT: contra-lateral toe off; CH: contra-lateral heel
strike; CH: contra-lateral heel strike; IT: ipsilateral toe off
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Figure 5.13 Grand average of joint powers in the sagittal plane over one gait cycle for the ankle,
knee and hip (average of left and right sides). CT: contra-lateral toe off; CH: contra-lateral heel
strike; CH: contra-lateral heel strike; IT: ipsilateral toe off.
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Figure 5.14: Grand average of angular displacement of the trunk in the sagittal, coronal and
horizontal planes over one gait cycle (average of left and right sides). CT: contra-lateral toe off; CH:
contra-lateral heel strike; CH: contra-lateral heel strike; IT: ipsilateral toe off
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5.4 Discussion
5.4.1 Effect of AFOs on foot drop
5.4.1.1 Distal comparison
The three prefabricated AFOs compared in this study are commonly prescribed to improve foot 
clearance and reduce foot drop in people with neuromuscular conditions. It is reassuring that all of 
the devices controlled the ankle in swing phase, as they were designed. Three of the variables 
measured in this study demonstrate this.
Plantarflexion angle in swing showed how the drop of the foot into plantarflexion was reduced when 
the foot was lifted from the ground. Greater dorsiflexion was achieved by the time the swinging foot 
was closest to the ground so preventing foot drag and potentially reducing the frequency of tripping. 
The maximum dorsiflexion angle was achieved prior to heel strike with significant improvement in 
two out of the three braces. An improvement in peak dorsiflexion occurred in late swing with the 
AFOs leading to better heel contact so improving the heel rocker for the next cycle. The foot up 
brace increased the peak dorsiflexion angle but not significantly more than just wearing a shoe. 
This may be because it was less stiff than the other two AFOs so exerting a lower dorsiflexion 
moment at the ankle. The moment the brace did exert, however, was sufficient to successfully 
assist foot clearance when the person was at most risk of tripping. The Footup splint may be best 
prescribed to an individual who has occasional tripping but still has sufficient dorsiflexor activity to 
achieve heel contact. There have been no other kinematic studies of Footup or Push braces in 
neurological conditions but studies of posterior leaf AFOs in adults with stroke 7 and children with 
cerebral palsy 4' 11 have also shown improved dorsiflexion in swing phase.
5.4.1.2 Proximal compensations
We saw in chapter three that compared to healthy subjects, people with CMT flexed their hips more 
during swing phase and this correlated with the peak dorsiflexion angle in swing. Although the 
AFOs were effective in improving dorsiflexion in swing, there was no corresponding reduction in hip 
flexion. Increased hip flexion in swing is an established compensatory strategy in people with CMT. 
This study only looked at the immediate effect of orthotic intervention. It is possible that it would 
take longer to alter an established motor pattern and that hip flexion angle could change over a 
period of time wearing AFOs. A longitudinal study would be required to see if this is the case. 
Alternatively, sensory impairment could have reduced the perception of ankle angle so the strategy 
was not altered. A similar observation was seen in a study of healthy subjects who had undergone 
peroneal nerve block. Increased hip flexion was seen post block but this was only partly improved 
by wearing an AFO 8. The authors deduced that this could be due decreased sensation or a 
conscious overcompensation to prevent foot drag.
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5.4.2 Effect of AFOs on progression
5.4.2.1 Distal comparison
In this study stiffening the ankle did not increase the plantarflexor moment at preswing, as 
suggested by Salsich et al 13. Two previous studies have investigated the effect of a posterior leaf 
AFO in children with cerebral palsy 11 and a solid AFO (i.e. without the cut away around the 
malleoli) in children with myelomeningolcele 15. The posterior leaf AFO did not increase the ankle 
moment at preswing but the more rigid, solid AFO did. These studies were performed by the same 
research group and were flawed in that the AFO comparison was with barefoot walking and not with 
a shoe only condition. Footwear can affect lower limb kinetics so this must be considered 4. Despite 
this, these papers do offer an explanation as why the AFOs in the present study did not increase 
the plantarflexor moment as they were not sufficiently stiff.
The present study demonstrated some interesting differences in the three AFOs and how they 
influenced power generation in pre-swing. Results from chapter three and previous gait comparison 
studies 10 show that people with CMT generate less power at the ankle than healthy subjects and 
that this could lead to compensatory changes proximally. The Footup and Push braces did not 
significantly alter the power profile of the ankle. They did not assist or interfere with power 
generation despite stiffening the ankle. The Multifit AFO appeared to diminish the generation of 
power at the ankle despite stiffening the ankle to a similar degree as the Push brace. The prior 
experience of AFO use must be considered when reasoning why this occurs. Two subjects had 
used the Footup and two had used the Push brace so the Multifit AFO was new to all subjects. This 
may have skewed the responses to the Footup and Push brace. Another potential explanation 
could be other mechanical properties of the AFOs. This study only measured how an AFO stiffens 
the ankle and not its visco-elastic properties that could account for the difference.
Studies of plastic posterior leaf and solid AFOs also show a reduction in ankle power11,12 Other 
orthotic devices have been produced and tested to assist with ankle propulsion. Carbon fibre spring 
splints have proven more successful at increasing ankle power generation in preswing 1' 2. An 
increase in ankle velocity during the forefoot rocker was also observed. As ankle power is the 
product of the moment and angular velocity, it is probably this increase in velocity that contributes to 
better power generation rather than an increased plantarflexor moment. None of the studies 
investigated how carbon fibre splints stiffen the ankle or their visco-elastic properties so it is unclear 
what properties allowed them to work most effectively. More novel devices are also being produced 
to provide a more active ankle power generation at preswing, for example AFOs with pneumatic 
“muscles” 6 and variable impedance splints 3 These devices, however, are still in development and 
not yet commercially available.
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In figure 5.13, the pattern of power absorption in stance was varied with a trend to increased peak 
power absorption when the Multifit AFO was worn. This could reflect a storage of energy by the 
Multifit as it was deformed by the ankle rocker. Heel rise was not facilitated at the forefoot rocker so 
it would appear that the energy stored was either dissipated as heat or, when delivered back to the 
ankle, was insufficient to exert a sufficient force to assist propulsion of the leg and trunk. During 
concentric plantarflexion, subjects with CMT may still have had sufficient active plantarflexor 
strength to push down against the foot piece of the AFO. Both the Footup and Push braces would 
exert a dorsiflexion moment at this point but it is possible that the Multifit AFO in doing this also 
significantly absorbed energy as the foot piece deformed so reducing the power generation. After 
toe off the Multifit AFO lifted the foot into dorsiflexion more than the shoe alone implying an elastic 
assistance bringing the ankle into dorsiflexion.
5.4.2.2 Proximal compensations
There were no significant differences in proximal motion or kinetics that could be a consequence of 
the reduction in ankle power generation when the Multifit AFO was worn. There was, however, a 
trend towards increased total hip power generation in early swing phase when the Multifit AFO was 
worn, with a significant post hoc result when compared to the Push brace. This result must be 
regarded with caution but it is possible that the increased total power generation reflects increased 
overall activation of the hip during swing phase to compensate for the reduction in power generated 
at the ankle. Although this would fit with the predictions for this chapter, this is not a definite and 
clear result which may be influenced by the increased error in the calculation of hip kinetics using 
inverse dynamics9.
5.4.3 Effect of AFOs on support
The present study demonstrated that the AFOs did not control peak dorsiflexion in preswing. The 
study of solid AFOs did show a reduction in peak dorsiflexion in stance 15 but posterior leaf AFOs 
did not11. It is possible that the increased plantarflexor moment exerted by a solid AFO contributed 
to preventing excessive dorsiflexion at the end of stance.
5.4.4 Future work
As this study only looked at the immediate effect of different orthoses, a longitudinal study would be 
useful to look at any effects over time. As seen in chapter three, people with different types of CMT 
have a varied presentation so it would be helpful to stratify the groups according to key impairments 
such as the degree of distal weakness. This would allow us to see if some AFOs are more effective 
with certain patient characteristics. In addition to 3D motion analysis it would be very useful to look
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at functional measures in such a comparative study, for example walking endurance, ambulation 
over a variety of surfaces, perceived exertion and functional balance scores. Problems with the 
acceptance of AFOs is a well known issue so comfort scores and subjective opinions on 
acceptability would also be of interest.
As discussed the only property of the splint materials investigated in this study was stiffness. The 
net work done during cyclic stretching of the AFOs could be examined by measuring the area inside 
the torque x angle hysteresis loop. As with the present study it would be useful to look at the 
hysteresis loop for the AFO/ankle/shoe combination to reflect all of the components influencing 
ankle motion.
Another approach could be to calculate the visco-elastic properties of the AFO. The leg, splint 
footwear combination could be stretched using ramp and hold stretches by the dynamometer and 
stiffness calculated as in the present study. The torque produced during the stretch could be 
calculated for the AFO combination and a shoe only condition. The viscosity of the AFO could be 
estimated from the following equations:
Torque AF0 = TorquecomiMd -  Torque shoe (5.1)
Torque AFO = Iq  +  Bq +  Kq (5.2)
Where I  is the inertia of the foot (from anthropometric data), B is the viscosity coefficient, K  is the 
calculated stiffness, q is the displacement, q is the velocity and q is the acceleration of the 
manipulandum during the stretch.
5.5 Summary
♦ Ankle foot orthoses vary in the degree they stiffen the ankle depending on their material and 
design.
♦ All three of the AFOs tested improved dorsiflexion in swing
♦ The Multifit AFO decreased the peak ankle power generation during preswing
♦ There were no significant proximal changes to compensate for these distal changes but there 
was a trend towards increased total hip power generation in swing.
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Chapter 6
6 Effect of Hip Flexor Fatigue on Walking Endurance in
People with CMT
6.11ntroduction and Hypothesis
The primary hypothesis for this thesis states that in people with CMT, weak ankle muscles lead to 
increased muscle activity around the hip to compensate for reduced limb progression and foot drop 
during swing. Chapter 3 demonstrated some of these differences with increased hip motion and 
altered timing of power generation relative to the ankle. Over a short distance these strategies may 
help to achieve the goal of limb progression. However, when walking for long distances these 
compensations may cause the muscles to tire prematurely. Subjective reports from people with 
CMT attending a peripheral nerve clinic support this supposition with complaints of proximal leg 
weakness when walking for a prolonged distance or time.
Based on the original hypothesis a prediction was made for this study:
People with CMT will be limited in how far they can walk by fatigue of the hip flexors as 
demonstrated by a reduction in hip flexor strength and alteration in hip motion.
For this study two experiments were performed. The first (session 1) measured the change in hip 
flexor strength after subjects walked to fatigue. The second experiment (session 2) involved 
specifically fatiguing the hip flexor muscles and investigating the effect on walking endurance.
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6.2 Methods
People with CMT were recruited from the genetic peripheral neuropathy clinic at the National 
Hospital for Neurology and Neurosurgery. Inclusion requirements were clinically definite CMT and 
the ability to walk 100m in at least 10 minutes. Subjects were excluded if they had a history of 
cardiac dysfunction, orthopnoea, other neurological impairment, orthopaedic lower limb impairment 
unrelated to CMT, and lower limb or back pain exceeding 7 out of 10 on a visual analogue scale. 
Healthy control subjects were recruited for comparison in session 1 and were matched for age, 
gender, weight and height. The same exclusion criteria were applied to this group
6.2.1 Session 1: Treadmill Walking Endurance Test
6.2.1.1 Clinical Measures
People with CMT were examined for impairments associated with their condition.
Strength: Isometric strength of the lower limb muscles was measured using strain gauges attached 
at one end to a custom made rigid frame and to the subjects’ limb at the other via canvass straps 
for most muscle groups and a metal stirrup for the plantarflexors. The proximal segment was 
secured with extra straps and restraints as necessary. The muscles tested and the subject positions 
are indicated in table 4.1. Subjects were tested in supported sitting with the knees at 90° except for 
the dorsiflexors which were tested in supine. The dorsiflexors were not measured at plantigrade as 
many people with CMT have tight Achilles tendons and restricted dorsiflexion. This would mean that 
the muscle would be contracting in inner range with possible resistance from the plantarflexor 
shortening. Therefore a standardised position of 10° of plantarflexion was used. After one practice 
attempt the maximum voluntary contraction (MVC) was measured. The moment arm from the joint 
axis to the centre of the strap was measured for each muscle group
Muscle group Subject position Joint position
Hip extensors Supported sitting: chest and pelvis restraint 50° hip flexion
Hip flexors Supported sitting: chest and pelvis restraint 50° hip flexion
Quadriceps Supported sitting: chest and pelvis restraint 90° knee flexion
Plantarflexors Supported sitting: thigh, tibial and ankle inversion restraint plantigrade
Dorsiflexors Supine: tibial restraint 10° of plantarflexion
Table 6.1: Standardised joint position for fixed myometry measures.
Range of motion: Subjects were screened for a scoliosis using Adam’s forward bend test 4 
(appendix 3). The presence of pes cavus or planus, toe flexion deformities, plantar fascia tightness 
and calcaneal valgus or varus was noted. In the presence of calcaneal varus the block test was
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used to ascertain whether this was due to a fixed deformity (appendix 3). Hand held goniometers 
measured the sagittal ranges of the hip, knee and ankle in standardised positions. The presence 
and site of ulcers or excessive callous on the plantar surface was recorded
Sensation: Two sensory modalities were tested. Light touch sensation was measured on the sole of 
the foot using 10g monofilaments (Neuropen, Owen Mumford, Oxford, UK). Ten standard areas of 
the plantar surface were tested (appendix 3). Subjects were asked to close their eyes and state 
“yes” when they felt the filament. The result was scored as the number of positive responses out of 
ten. Vibration threshold was tested using a biothesiometer (Bio-medical Instrument Co, Newbury, 
Ohio, USA, 120 Hz). The probe of the biosthesiometer was held still and at a constant pressure 
over the lateral malleolus and then the great toe. The subject was asked to close their eyes. The 
intensity of the vibration was gradually increased until the subject reported feeling it. This was 
identified as the appearance threshold. Then the intensity was gradually decreased until the subject 
reported that the vibration had disappeared. This was identified as the disappearance threshold. 
The appearance and disappearance thresholds were established over the malleolus and great toe 
from the mean of three measures3.
Cardiorespiratory Function: Resting heart rate and blood pressure were taken prior to the walking 
task (MX3 plus model, Omron-Healthcare, Milton-Keynes, UK). The predicted maximal heart rate 
was calculated using the formula: max heart rate = 220 -  age. Lung function was measured using 
spirometry (One Flow FVC spirometer, Medisave, Weymouth, UK). Forced expiratory volume 
(FEV1), forced vital capacity (FVC) and peak expiratory flow rate (PEF) were recorded from the 
best of three attempts.
Fatigue and health status: Subjects completed the fatigue severity scale (FSS) and the short form 
36 (SF-36) questionnaire (appendix 5 and 6). The fatigue severity scale is a nine item scale 
assessing the functional outcomes of fatigue. It has been used in a variety of conditions including 
multiple sclerosis, systemic lupus erythematosus 8. The SF-36 is a questionnaire assessing health 
status. It consists of eight heath concepts: physical functioning, bodily pain, role limitation due to 
physical or emotional problems, emotional well being, social functioning, energy and fatigue, and 
general health perceptions19.
6.2.1.2 Treadmill test
Prior to the walking endurance test CMT subjects performed a 10m timed walk to ascertain their 
normal gait speed and cadence. They then walked on a motorised treadmill at the same speed. An 
auditory metronome was set at the same cadence to cue the subject to maintain a consistent 
stepping rate. A practice trial on the treadmill followed by 5 minutes rest was performed prior to the 
test. During the test the subjects wore a safety harness attached to an overhead gantry that was 
capable of supporting their weight. The tension in the support system was set so that it did not
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interfere with treadmill walking (figure 6.1). Two dimensional kinematics were measured during the 
treadmill test rather than three dimensional because the harness would not allow the subject to 
wear the pelvic marker frame needed to create the local embedded vectors required for 3D 
analysis.
Figure 6.1: Harness, marker and EMG set up for the treadmill 
walking test
Fifteen seconds of motion data was collected every minute the subject remained walking on the 
treadmill. Prior to the walking test a standing trial was collected to measure the ‘neutral’ alignment. 
Angles during walking were expressed relative to this standing trial. Heart rate was measured 
during the treadmill walking test using a Polar heart rate monitor (Polar Electr Inc. USA).
As this was a test of the subject’s everyday walking endurance any orthoses normally worn by the 
subject were worn during the test. Many of the subjects found walking on the treadmill challenging 
to their balance so were allowed light upper limb support if required. The Borg scale 1 was used to 
measure the subject’s perceived exertion every minute of the treadmill walking task (appendix 4). 
Additionally heart rate and pain level, using a 10 point visual rating scale, were recorded every 
minute during the test. When the subject reached Borg level 17 (very hard) the treadmill test was 
stopped. Additionally walking would have been stopped if:
1. Pain exceeded level 7 out of 10 on the rating scale
2. If the heart rate exceeds 85% of their maximal heart rate as calculated by 220-age.
3. Chest pain
4. Signs of poor perfusion (cyanosis, pallor)
5. Technical difficulties that prevent the recording heart rate.
6. Subject asks to stop
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Points 2-5 include absolute and relative indications for terminating exercise tests as given by the 
American College of Cardiology/American Heart Association Task Force on Practice Guidelines 5. 
Following cessation of the test subjects were asked to indicate what made them stop the walking 
test. Four visual analogue scales were completed to indicate the degree of pain, breathlessness, 
proximal muscle fatigue and distal muscle fatigue at the end of the test. Control subjects walked at 
the same speed and cadence on the treadmill for the same duration as the CMT subject they were 
matching for.
6.2.1.3 Myometry
The primary outcome measure for this study was the change in hip flexor strength with prolonged 
walking. MVC measures for the hip flexors and plantarflexors were taken before and immediately 
after the treadmill walking test. The positions of the myometry straps were marked at the initial 
measurement to aid reliable placement. To calculate the moment, the length of the lever was 
measured from the greater trochanter to the centre of the strap. For the hip flexor measurement, 
multi-meters connected to the strain gauges were used to monitor the output voltage of the strain 
gauges so measurements were all taken from the same baseline tension. Tests of MVC were 
performed within 2 minutes of the subject completing the treadmill test. To check for motivational 
influences, a hand held dynamometer was used to measure grip MVC before and after the treadmill 
test. Repeatability testing of this method demonstrated good agreement between trials with an ICC 
of 0.83 (appendix 7).
Strain gauge
Figure 6.2: Fixed myometry set up for Figure 6.3: Fixed myometry setup for
measurement of the hip flexors measurement of the plantarflexors
gauge
Multi-meters
Strain
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6.2.2 Session 2: Hip Flexor Fatigue Test
At a follow up session the effects of selectively fatiguing the hip flexors on walking endurance were 
tested. Infrared marker placement was identical to session 1. Subjects initially walked on the 
treadmill at the same speed and cadence as the first session for three minutes to obtain pre-fatigue 
kinematic data.
6.2.2.1 Hip flexor fatigue protocol
Subjects sat supported with their hips in 50° flexion, pelvis and chest constrained by straps (see 
figure 6.2). Straps were placed over the distal thigh and linked to strain gauges mounted on the 
rigid frame. Bilateral hip flexor MVC recordings were firstly taken. Subjects then performed 
alternating contractions of the hip flexors to 50% of their MVC at a rate of 40 contractions per 
minute. Visual feedback of the applied tension was provided by the multi-meters attached to the 
strain gauge output. MVC measures were taken every two minutes throughout the test. The test 
was terminated once the hip flexors had fatigued by 20%. Subjects were then immediately 
transferred to the treadmill and began a treadmill walking test identical to session 1. Kinematics, 
heart rate, the Borg scale and pain were monitored every minute and the walking test was stopped 
when the subject reached Borg level 17 or the pain scale exceeded 7 out of 10.
On immediate cessation of the treadmill test a repeat measurement of hip flexor MVC was taken as 
were the VAS measures of pain, dyspnoea, proximal and distal lower limb fatigue.
6.2.3 Analysis
In session 1 the initial kinematics were compared to the last trial prior to cessation of the treadmill 
test. In session 2 an initial pre test trial of walking was recorded (pre test) and compared to walking 
within one minute after the hip flexor fatigue test (post test 1) and the last trial prior to cessation of 
the walking test (post test 2). Kinematics often changed within the first minute of walking as subjects 
adapted to the treadmill even in the absence of any fatigue, therefore the first trial was analysed 
after 1 minute of walking.
In each trial the average of 3 strides were calculated (see chapter 2). Changes in preswing and 
swing phase were compared as they represent the period of force generation followed by limb 
progression. Preswing was defined as the time between opposite initial contact and toe off. For the 
isometric strength measurement, MVC was defined as the difference between the peak and 
baseline force.
140
6.2.3.1 Statistical Analysis
Group comparison: clinical measures were compared using 2-tailed unpaired t-tests. Non- 
parametric data was analysed using a Mann-Whitney test. Significance was taken as p<0.05 with 
means reported ± the standard deviation unless indicated.
Response to treadmill walking test: The response of people with CMT and the control group was 
compared using a repeated measures general linear model. A factor of trial with 2 levels in session 
1 (pre and post) and 3 levels in session 2 (pre, post 1 and post 2) was included. A primary analysis 
was performed based on the prediction introduced at the start of this chapter.
The primary analysis observed:
♦ hip flexor and plantarflexor MVC
♦ peak hip flexion velocity during pre-swing and swing phase
♦ peak hip flexion during pre-swing and swing phase
As six comparisons were made as part of the primary analysis a modified Bonferroni test was 
applied to account for multiple comparisons (appendix 1) 16. Changes at other joints were expected 
to occur so a secondary analysis assessed the changes in:
♦ peak sagittal ankle, knee and hip amplitude and velocity during preswing
♦ peak sagittal ankle and knee amplitude and velocity during swing
♦ peak sagittal trunk flexion and peak to peak changes in coronal and horizontal trunk rotation
Again, a modified Bonferroni test was applied to account for the 19 comparisons. The relationships 
between the clinical measures and the walking performance were analysed using the Spearman’s 
rank correlation test.
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6.3 Results
6.3.1 Session 1: Treadmill Endurance Test
This section outlines the response of people with CMT and matched control subjects to the treadmill 
endurance test. Grand average graphs are presented at the end of this section. There are 
discrepancies between peak values and apparent peaks on the grand average graphs. This is due 
to alterations in the grand average trace resulting from variations in the timing of the peaks between 
individual participants.
6.3.1.1 Group differences
Eighteen people with CMT were compared to 14 healthy matched controls. Subjects were matched 
according to age, gender, height and weight with no significant differences found between these 
variables (table 6.2). Four of the subjects with CMT wore ankle foot orthoses (AFOs). One wore 
bilateral rigid AFOs, two wore less rigid bilateral ankle braces (neoprene and silicon) and one 
subject wore an anti-inversion ankle brace on the left leg.
Age (years) Gender Height (m) Weight (kg)
CMT subjects 37 (± 12.9) 10 male; 8 female 1.69 (±0.7) 70.5 (±12.2)
Control subjects 34 (± 9.7) 8 male; 6 female 1.7 (±0.5) 68.4 (±10.3)
Table 6.2: Age, gender, height and weight data for both subject groups
MVC (Nm/kg) CMT subjects Control subjects
Hip flexors 1.13 ±0.42 1.32 ±0.38
Hip extensors 0.65 ±0.33 1.09 ±0.68
Knee extensors 1.53 ±0.68 2.06 ±0.64
Plantarflexors 0.63 ±0.57 * 1.21 ±0.58
Dorsiflexors 0.10 ±0.08* 0.39 ±0.17
Table 6.3: Maximum voluntary contraction of lower limb muscles (Nm/kg) for CMT and control 
subjects. *p<0.05
Strength: People with CMT were weaker distally than the control subjects but demonstrated similar 
strength in the proximal muscles (table 6.3).
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Range of motion: Joint range of movement was similar to that of controls subjects in the proximal 
joints but there was a difference in the range of ankle dorsiflexion. None of the subjects recruited 
had a scoliosis but a high proportion had foot and ankle deformity associated with CMT (table 6.4).
CMT subjects Control subjects
Goniometry (degrees) Hip flexion 122 ±11 128 ±11
Hip extension 5 ±3 7 ±4
Knee flexion 139 ±7 143 ±6
Knee extension 3 ±4 2 ±2
Dorsiflexion -3 ±10 * 14 ±5
Plantarflexion 62 ±12 62 ±12
Percentage of subjects with scoliosis 0 0
Percentage of subjects with pes cavus 56% 0
Percentage of subjects with calcaneal varus 44% 0
Table 6.4: Range of movement and secondary musculoskeletal complications. *p<0.05
Sensation: People with CMT demonstrated a reduction in the ability to perceive light touch stimuli 
over the plantar aspect. In addition they showed significantly higher appearance and disappearance 
threshold for vibration perception compared to control subjects (table 6.5).
Cardiorespiratory Function: There was no significant difference in cardiovascular or respiratory 
measures between the two groups (table 6.5).
Fatigue and health status: People with CMT had a higher fatigue severity rating compared to the 
controls (table 6.5). The SF-36 showed lower scores with physical functioning, role limitation due to 
physical status, energy and fatigue, social functioning, pain and general health (table 6.5). The 
groups showed no difference in emotional well being and role limitation due to emotional status
Baseline gait differences: Over 10m people with CMT walk at a significantly slower speed and at a 
lower cadence than control subjects (table 6.5).
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Clinical Measures CMT subjects Control subjects
Resting heart rate 
Blood pressure: Systolic 
Diastolic
74 bpm (±9) 
123 mmHg (±9) 
78 mmHg (±10)
65 bpm (±13) 
128 mmHg (±16) 
78 mmHg (±9)
Lung function: FEV1 
FVC 
PEF
3.2 I (± 0.7) 
3.9 I (± 0.9) 
394 l/min (±115)
3 .51 (±1.0) 
4 .31 (±1.0) 
464.5 l/min (± 163)
Sensation:
Light pressure
Vibration Malleolus 
Threshold
Great toe
5 out of 10 (±2.9)*
AT: 6.1 microns (± 6.1) * 
DT: 4.9 microns (± 5.2) * 
AT: 8.4 microns (± 8.5) * 
DT: 6.0 microns (± 6.3) *
10 out of 10 (±0)
AT: 0.6 microns (±0.7) 
DT: 1.1 microns (±1.1) 
AT: 0.4 microns (±0.3) 
DT: 0.2 microns (±0.2)
Gait: Speed 
Cadence
1.13 m/sec (±0.1)* 
108 steps/minute (±7.3)*
1.59 m/sec (±0.2) 
120 steps/minute (±10.7)
Fatigue Severity Scale 38.2 (± 14.9) * 16.9 (±6.6)
SF-36: Total 
Physical Function 
Role limitation (physical) 
Role limitation (emotional) 
Energy/fatigue 
Emotional well being 
Social functioning 
Pain
General Health
998.2 (±1034.0)*
59.7 (± 24.3) *
43.8 (± 47.0) *
68.9 (± 46.2) 
51.3 (±21.3)* 
78.7 (±15.3) 
68.0 (±28.1)* 
66.1 (±26.6)* 
61.6 (±21.3)*
3227.9 (±183.3) 
97.5 (±4.0) 
100 (±0)
94.4 (±19.2)
72.5 (±14.7) 
85 (±11.1) 
92.1 (±16.1)
96.7 (±4.9)
83.8 (±11.7)
Table 6.5: Summary of clinical measures for study participants. Mean values are shown with 
standard deviations in brackets. For FSS, higher value indicates increased severity; for SF-36, 
higher value indicates better health status. AT- appearance threshold, DT- disappearance 
threshold. * p<0.05
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6.3.1.2 Effect of prolonged walking: general comparison
People with CMT walked for a mean time of 48 minutes. Control subjects walked for an average of 
44 minutes which although not significantly different, it was slightly less than subjects with CMT. 
This was because there were four less control subjects.
At the start of the treadmill test, people with CMT reported perceived exertion as ‘very light’ of level 
nine of the Borg scale (appendix 4). Control subjects started at level 6.5 or ‘very, very light’. By the 
end of the treadmill test, people with CMT reported a median Borg level of 17, or ‘very hard’. For the 
same speed and time walking, control subjects reported a median score of eight, which was 
significantly less than the CMT subjects (Z= -4.93, P<0.0001). In addition, heart rate, expressed as 
a percentage of the maximum predicted rate, was significantly higher in people with CMT, (t =3.38, 
P=0.002) (table 6.6).
CMT Controls
Mean walk time (minutes) 48.3 ±40.5 44.0 ±40.8
Median Borg scale (start) 9 6.5
Median Borg scale (finish) 17* 8 *
% of maximum heart rate (finish) 60.0 ±10.7 * 57.8 ±11.1*
Table 6.6: Average walk time, change in Borg scale and heart rate expressed as a percentage of 
the maximum predicted value (220 -  age) on cessation of the walk test. * p<0.05
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6.3.1.3 Effect of prolonged walking: primary comparison
At the end of the treadmill walking test both the CMT and control groups demonstrated a significant 
decrease in the MVC of the hip flexors (GLM: trial F =33.76, P<0.0001). People with CMT dropped 
their MVC by 20% of the initial MVC compared to 14% in the control subjects (figure 6.4). No 
changes were seen in grip strength indicating that subjects’ effort was the same before and after 
the treadmill test. No change was seen in plantarflexor MVC.
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Figure 6.4: Hip flexor MVC measures before and after the treadmill walk test. Error bars are 
standard error of the mean. * significant difference.
The reduction in hip flexor MVC in the control subjects was unexpected. To investigate this further, 
five control subjects returned and repeated the treadmill walking test for the same amount of time 
as they walked in the matched condition. On this occasion they walked at their chosen speed and 
cadence. Hip flexor MVC was recorded before and after treadmill walking as before. No significant 
difference was seen in hip flexor MVC before and after walking on the treadmill at a self selected 
speed (t =0.22 , P=0.84). In the original condition walking at a matched speed, the difference was 
significant for these five subjects (t =3.25 ,P=0.03).
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Both groups also showed a significant increase in hip flexor angle at the end of the treadmill test 
(GLM: trial F= 10.59, P=0.003) (figure 6.5a). In addition, people with CMT showed a significant 
reduction in hip flexor velocity during swing whereas control subjects increased the hip velocity 
(GLM: trial x group F =9.31, P=0.005; post hoc t-tests: CMT t = -2.44, P=0.03; control t =2.76, 
P=0.02 ) (figure 6 .5b).
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Figure 6.5: Hip flexor angular kinematics at the start and the end of the treadmill walk test. (A) hip 
flexor angular displacement during swing, (B) hip flexor velocity during swing. Error bars are 
standard error of the mean. Pw CMT: subjects with CMT; Controls: control subjects. * significant 
difference.
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6.3.1.3 Effect o f prolonged walking: secondary comparison
Changes were observed in some of the gait variables analysed for the secondary comparison. At 
the hip, increased extension was seen during preswing in people with CMT compared to controls at 
the beginning of the walking test. At the end of the treadmill test, both groups significantly 
decreased extension at the hip (GLM: trial F =16.94, P=0.0003; post hoc cmt v control pre walking 
test: t =2.85, P=0.008) (figure 6.6a).
Peak knee flexion angle during swing phase also changed by the end of the treadmill walking test. 
Control subjects significantly increased knee flexion whereas subjects with CMT did not change 
(GLM: trial x group: F =7.50, P=0.01; post hoc t-test: control t =-2.8, P=0.014) (figure 6.6b).
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Figure 6.6: Angular kinematics at the start and the end of the treadmill walk test (A) hip extension 
during preswing. Negative values indicate hip extension. (B) knee flexion during swing. Error bars 
are standard error of the mean. Pw CMT: subjects with CMT; Controls: control subjects. * significant 
difference.
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The ankle angle did not change in people with CMT but control subjects showed a trend towards 
increased ankle dorsiflexion during preswing (GLM: trial F =5.34, P=0.03) (figure 6.7a and 6.11). In 
early swing the control subjects also showed a trend towards increased plantarflexion angle (GLM: 
trial F =5.13, P=0.03) (figure 6.7b and 6.11). Both groups of subjects demonstrated increased 
dorsiflexion velocity during preswing (GLM: trial F=26.33, P<0.0001) (figure 6.7c and 6.12).
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Figure 6.7: Ankle angular displacement at the start and the end of the treadmill walk test (A) 
dorsiflexion angle during preswing, (B) plantarflexor angle during swing, (C) dorsiflexion velocity 
during preswing. Error bars are standard error of the mean. Pw CMT: subjects with CMT; Controls: 
control subjects. * significant difference.
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Increased trunk flexion during pre-swing was observed in people with CMT at the end of the 
treadmill test (figure 6.8a). Peak trunk flexion was reached during pre-swing (GLM: trial x group 
F =5.31 P=0.03) though this was non significant post modified Bonferroni correction. In addition, 
greater coronal trunk motion occurred in both groups (GLM: trial F =8.59, P=0.006).
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Figure 6.8: Trunk angular motion at the start and the end of the treadmill walk test. (A) peak trunk 
flexion during preswing, (B) peak to peak coronal rotation for the whole cycle. Error bars are 
standard error of the mean. Pw CMT: subjects with CMT; Controls: control subjects. * significant 
difference.
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6.3.1.4 Reasons for walking cessation
People with CMT were asked what factors caused them to stop walking during the treadmill test. 
Sixty seven percent of subjects reported stopping due to fatigue of the legs and a deterioration of 
their gait pattern. Pain was the reason reported by 22% and 11% stopped because they were 
breathless.
Visual analogue scores taken after the treadmill walking test showed proximal fatigue was most 
highly rated symptom with 50% of subjects scoring over five out of ten, i.e. a moderate to severe 
rating (figure 6.9).
o  40
proximal distal fatiguepain dyspnoea
fatigue
Figure 6.9: Graph of the percentage of subjects with visual analogue scores rated over five out of 
ten. Visual analogue scores were rated for pain, dyspnoea, proximal and distal fatigue.
6.3.1.5 Factors affecting walking endurance
Correlation analysis was performed to ascertain what factors limited walking endurance in people 
with CMT. Relationships with walk time were the main correlations performed and presented but 
similar results were found with total distance and steps taken.
Clinical measures: No significant differences were observed between total walking time on the 
treadmill and strength, range of motion, sensory impairment and cardio-respiratory measures. 
Relationships were observed, however, with fatigue severity and sections of the SF-36 relating to 
physical functioning and fatigue (figure 6.10a and b) (table 6.7).
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Walk time versus: Correlation r value P value
FSS -0.68 0.002
SF-36: Physical functioning 0.71 0.002
SF-36: Role limitation due to 
physical problems
0.65 0.006
SF-36: Energy and fatigue 0.52 0.037
Table 6.7: Significant relationships between walking time and clinical measures.
Primary outcome measures: There were no significant correlations, for the main group of people 
with CMT, between the change in the primary variables and walking time. However, when subjects 
who stopped for reasons other than leg fatigue were excluded (i.e. pain or a negative relationship 
between the change in the hip flexor angle and the walk time was observed (table 6.8, figure 6.10c), 
That is people who increased their hip flexor angle more tended to walk for a shorter time.
Walk time versus: Correlation r value P value
Change in hip flexor MVC -0.50 0.11
Change in hip flexion angle in swing -0.65 0.02
Change in hip flexion velocity in swing -0.17 0.52
Table 6.8: Relationships between walking time and primary outcome measures.
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Figure 6.10: Correlations between treadmill walking time and (A) Fatigue Severity Scale (FSS), (B) 
physical functioning section of the SF-36, (C) change in hip flexion angle post walk - pre walk.
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6.3.2 Session 2: Hip Flexor Fatigue Test
Of the original 18 subjects with CMT, 16 returned for the hip flexor fatigue test. One subject 
dropped out of the study and one was unable to continue due to a newly diagnosed cardiac 
condition.
6.3.2.1 Hip flexor fatigue test
During the hip flexor fatigue test, the left and right sides did not fatigue at the same rate with the left 
side fatiguing more quickly in the majority of subjects. The decision was made to halt the test when 
one side had fatigued by 20% of the MVC. The test was not continued to allow the more fatigue 
resistant side to reach a 20% drop because the already fatigued side would tire further. This was 
deemed potentially detrimental to the CMT subjects. In addition, it could not be fatigued in isolation 
because the contra-lateral side would recover.
MVC pre HF 
fatigue test 
(Nm/kg)
MVC post HF fatigue test 
(Nm/kg)
MVC post treadmill 
test (Nm/kg)
Average of left and 
right
1.11 ±0.31* 0.94 ±0.26* 14.6%
drop
0.86 ±0.28* 19.6%
drop
Left hip flexors 1.13 ±0.32* 0.91 ±0.29* 19.5%
drop
0.85 ±0.29 21.7%
drop
Right hip flexors 1.13 ±0.36* 0.99 ±0.28* 10.1%
drop
0.88 ±0.36 17.2%
drop
Table 6.9: Maximum voluntary contraction of the hip flexors before the fatigue teat, after the fatigue 
test and after the subsequent treadmill walking test. * p<0.05.
The hip flexors reduced their MVC by an average of 14.6% after the hip flexor fatigue test, 
eventually dropping to 19.6% after the treadmill walking test (GLM: trial F =13.16, P=0.0002). In 
view of the differing fatigue rates, each side was analysed individually. The left hip flexors fatigued 
by 19.5% percent of the MVC compared with 10.2% on the right after the fatigue test. After the 
treadmill walking test, there was less of a difference with a drop to 21.7% on the left and 17.2% on 
the right (table 6.9).
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6.3.2.2 General gait comparison
Following the hip flexor fatigue task, people with CMT walked on the treadmill for a mean time of 26 
minutes. This was significantly less than the mean time of 48 minutes in session 1 (t =2.077, 
P=0.047). The median perceived exertion at the start of the walking test was level 11 of the Borg 
scale. At the end of the walking test it was 17.
6.3.2.3 Primary kinematic comparison
Kinematic hip variables varied according to the trial condition. Peak hip flexion significantly 
increased when measured immediately after the fatigue test and subsequently during the walking 
test (GLM: trial F =4.73, P=0.02; post hoc: post testl v post test2: t =2.29, P=0.04) (figure 6.15). In 
view of the asymmetrical fatigue rate, the left and right sides were also analysed separately. The left 
hip did not show a significant change with the trial conditions (GLM: trial F =2.81, P=0.07). The right 
hip, however, showed a significant increase in flexion after both the fatigue and treadmill tests 
(GLM: F =6.02, P=0.006; post hoc: post testl v post test21 =2.32, P=0.03).
Pre HF fatigue test Post HF fatigue test Post treadmill test
Average peak hip flexion 
angle swing (degrees)
• Left hip flexion swing
• Right hip flexion
34.09 ±12.01 
34.03 ±13.29 
34.16 ±11.76
39.94 ±12.43 
38.15 ±14.08 
41.75 ±11.91
44.54 ±14.93 
44.64 ±20.24 
44.43 ±13.53
Average peak hip flexion 
velocity swing (degrees/sec)
• Left hip flexion swing
• Right hip flexion
154.93 ±29.18 
164.15 ±38.96 
145.72 ±27.91
153.20 ±27.93 
147.38 ±30.82* 
159.00 ±44.13
145.55 ±28.31 
141.08 ±32.63 
150.02 ±33.24
Table 6.10: Change in primary kinetic variables. Average of the left and right hip flexors and mean 
values for each side ± standard deviation. * significant difference between pre HF fatigue and post 
HF fatigue test.
The peak hip flexor velocity did not show any change with trial condition (GLM: trials F =1.08, 
P=0.35) (figure 6.16). Again, in view of the asymmetrical fatigue rate of the hip flexors each side 
was analysed individually. The left hip showed a significant reduction in hip flexor velocity during 
swing after the hip flexor fatigue test (GLM: trials F =6.92, P=0.003; post hoc: pre test v post testl t 
=-2.18, P=0.046). No further change was seen after the treadmill test and no change was observed 
with the right hip (GLM: F =0.97, P=0.38).
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6.3.2.4 Secondary comparison
The secondary comparison revealed differences in other kinematic variables following hip flexor 
fatigue or with subsequent walking. Peak knee flexion angle during swing phase increased after the 
hip flexor fatigue test but did not change any further after the treadmill test (GLM: trial F =3.69, 
P=0.04; post hoc: pre test v post testl t =-2.44, P=0.03) (figure 6.15) but the GLM was not 
significant post modified Bonferroni correction.
Pre HF fatigue test Post HF fatigue test Post treadmill test
Peak knee flexion angle 
swing (degrees)
54.07 ±11.51 56.71 ±12.83* 57.09 ±13.26
Peak trunk flexion angle pre­
swing (degrees)
9.08 ±6.45 11.26 ±5.82* 12.50 ±4.43
Peak to peak coronal trunk 
(degrees)
4.94 ±5.17 5.59 ±5.55 6.59 ±6.13T
Peak to peak horizontal trunk 
(degrees)
10.33 ±8.10 10.74 ±8.13 12.55 ±6.90*
Table 6.11: Significant changes in secondary kinetic variables. Average of the left and right hip 
flexors and mean values for each side ± standard deviation. * significant difference between pre HF 
fatigue and post HF fatigue test;f significant difference between pre HF fatigue and post walking 
test.
Increased trunk flexion during pre-swing was observed following the hip flexor fatigue test but did 
not change after the treadmill test (GLM: F =4.96, P=0.01; post hoc: pre v postl t =4.34, P=0.0006) 
(figure 6.15). The GLM was non-significant post Bonferroni correction so this observation was a 
trend despite the change following the hip flexor fatigue test. There were also changes in trunk 
coronal and horizontal motion. Coronal trunk motion significantly increased after the fatigue test 
plus the treadmill test (GLM: F =9.70, P=0.0006; post hoc: postl v post2 t =2.79, P=0.01). A similar 
pattern was seen for the horizontal motion of the trunk (GLM: F =7.55, P=0.002; post hoc: postl v 
post21 =2.45, P=0.03) (figure 6.17).
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6.3.2.5 Reasons for walking cessation
70 
60 •
50 ■
o
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fatigue
Figure 6.14: Graph of the percentage of subjects with visual analogue scores rated over five out of 
ten. Visual analogue scores were rated for pain, dyspnoea, proximal and distal fatigue.
People with CMT were asked what factors caused them to stop walking during the treadmill test. 
Seventy five percent of subjects reported stopping due to fatigue of the legs and a deterioration of 
their gait pattern. Pain was the reason reported by 19% and 6% stopped because they were 
breathless. Visual analogue scores taken after the treadmill walking test showed proximal fatigue 
was most highly rated symptom with 66.67% of subjects scoring over five out of ten (figure 6.14).
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people with CMT. Solid lines are pre walk test and dashes lines are post hip flexor fatigue test,
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6.4 Discussion
6.4.1 Group differences
As expected, people with CMT showed greater weakness and sensory loss distally compared to 
healthy control subjects. Interestingly, despite reports of de-conditioning in CMT in the literature, 
there were no differences in the cardiorespiratory measures. This probably reflects that the 
measures used do not give a valid indication of fitness levels. More thorough exercise testing with 
an analysis of oxygen consumption would be required to make a judgement on differences between 
the two subject groups.
The fatigue severity scale and SF-36 revealed findings consistent with previous literature. Increased 
fatigue reported in this study reflects work by Kalkman et a l7 though a different fatigue outcome 
measure was used on 137 subjects with CMT in their study. Vinci et al 18 reported poor general 
health perception measured by the SF-36. They found a reduction in all domains of the SF-35 
whereas the present study did not show reductions in sections related to emotional status. This 
discrepancy may be due to differences in the sample size.
6.4.2 Primary comparison
When people with CMT walked until they reached a ‘very hard’ level of perceived exertion, they 
demonstrated a reduction of the hip flexor MVC. This change could have been due to fatigue of a 
compensatory hip flexor strategy but it could also be because of reduced motivation and central 
influences. The grip strength measure, however, was unchanged pre and post treadmill walking in 
session one suggesting that motivation was not a confounding factor. Unexpectedly, the control 
subjects also showed a reduction in hip flexor MVC test after walking on the treadmill. The speed 
and cadence of the controls was constrained to equal the CMT subject they were matched for. The 
control subjects subjectively reported that the slower speed felt very unnatural and they perceived 
changes in their gait pattern because of that. Alterations in the gait pattern may have meant that 
they were using their hip flexors more than normal so accounting for the change in MVC. The five 
subjects that were recalled to perform the treadmill task at a self selected pace did not show the 
same drop in hip flexor MVC indicating that the slow pace was a factor. Despite this, even though 
the control subjects did demonstrate decreased hip flexor MVC after the original walking test, they 
only reported level 8 of the Borg scale compared to level 17 for the subjects with CMT. This 
indicated that the drop in hip flexor strength did not increase the perceived walking effort in the 
control subjects and they would have been able to continue beyond the time of the person with 
CMT they were matching for.
After the treadmill test in session 1, the hip flexor MVC dropped by a mean of 20% in people with 
CMT. In session 2 the asymmetrical fatigue rate of the hip flexors initially was deemed a problem, 
but analysis of the left and right sides was actually revealing. The left side demonstrated
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approximately a 20% drop in hip flexor MVC and also demonstrated some of the proximal kinematic 
changes observed in session 1. At the end of the treadmill test in the first session, the velocity of hip 
flexion reduced. This was also seen on the left side after the hip flexor fatigue test in session 2 and 
did not reduce further with the subsequent treadmill test. These findings implicate fatigue of the hip 
flexors as the cause of reduced hip velocity. Interestingly, the right side that only fatigued by 10% 
did not show these changes indicating a possible threshold of hip flexor strength required to 
maintain hip kinematics over time.
The hip flexor muscles are thought to work synergistically with gastrocnemius to accelerate the limb 
from pre-swing into swing phase 13,20. The control subjects do not show this drop in hip velocity 
perhaps because the intact gastrocnemius assisted the acceleration of the limb and modelling 
studies have indeed shown that the plantarflexor muscles may compensate for proximal 
impairments 6. Therefore, it is likely that, in healthy subjects, distal compensation prevented a 
reduction in velocity of hip flexion (see section 6.4.3). If the plantarflexors are weak, as in CMT, the 
hip flexors may not have the synergistic assistance from gastrocnemius and fatigue prematurely.
During session 1, people with CMT showed an increase in the hip flexion angle during swing phase 
that was also observed in control subjects. The increase in hip flexion may have been a 
compensation for foot drop (see chapter 3) that became exaggerated as the person fatigued and 
tripping was a higher risk. The ankle amplitude graph (figure 6.11) suggests a trend towards a 
reduction in dorsiflexion in mid to late swing phase that may support this, though the difference was 
not significant on testing. This increase in flexion, however, seems counterintuitive as a reduction 
would be expected in view of the reduction in hip velocity. The correlation analysis may offer an 
explanation. Figure 6.9c shows that although the majority of subjects increased hip flexion others 
decreased it as indicated by the negative values. The subjects who decreased hip flexion amplitude 
tended to be those who walked for much longer, i.e. over one hour. The positive correlation 
between fatigue severity and walking time suggests that subjects that walk for the shortest time are 
limited by central factors and may still have the capacity to increase hip flexion (e.g. to aid with foot 
clearance). In contrast the subjects who walk for the greatest time were more likely to be limited by 
physical factors and show a reduction in hip flexion amplitude. Results from session 2 support this 
showing that after both the fatigue and treadmill tests, the less fatigued right hip showed a 
significant increase in hip flexion. The more fatigued left hip showed no change.
6.4.3 Secondary comparison
Distal differences were seen with the treadmill walking test but these changes were primarily in the 
control group. Changes in ankle motion and velocity could represent distal compensatory strategies 
employed by the control subjects as the hip flexor muscles fatigued. No change was observed in 
people with CMT which could be an indication that they are unable to compensate distally due to
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weakness of the ankle muscles. Consideration must also be given to possible restrictions in range 
as four subjects with CMT wore AFOs. While we cannot assume that a lack of change in ankle 
motion is due to entirely to ankle weakness, the majority of subjects did not wear AFOs and 
changes were not observed.
Changes at the knee were seen in control subjects. They tended to increase the peak knee flexion 
angle during swing phase whereas people with CMT did not change significantly. The degree of 
knee flexion in swing phase is related to the peak knee velocity during preswing. This in turn is 
determined by momentum from rapid hip flexion and ankle plantarflexion and the activity of the 
biceps femoris 12. As was discussed in the previous section, hip flexor velocity increases in control 
subjects so the increase in knee flexion is probably due to increased momentum from hip flexion. 
Although not significantly different, there is a trend towards reduced knee angle in people with CMT 
(figure 6.6b) which could be due to reduced hip velocity and thus reduced momentum. In session 2, 
however, an increase in knee flexion is seen after the hip flexor fatigue test. It may be that with 
prolonged walking in session 1 there is not only fatigue in the hip flexors but also in other muscle 
groups such as the hamstrings. In session 2 only the hip flexors are fatigued so the hamstrings may 
still able to increase knee flexion. It is possible that the increase in knee flexion during swing phase 
is to compensate for altered hip motion to assist foot clearance.
In addition to increased hip flexion during swing, people with CMT and control subjects also show a 
decrease in hip extension during pre-swing. At the start of the test people with CMT show greater 
hip extension than control subjects. This may be because the dorsiflexion angle at pre-swing is 
increased in people with CMT due to decreased eccentric plantarflexor control (chapter 3) resulting 
in a collapse forward of the extended limb at the ankle. This would result in increased hip extension. 
The change that occurs after the walking test could be due to differences at the trunk rather than 
the leg as the hip angle is defined by the trunk and thigh segments. An increase in trunk flexion is 
observed, particularly in people with CMT, which would also be reflected in the hip angle as there 
was no significant change in the angle of the thigh with respect to vertical.
A trend towards increased trunk flexion is seen in people with CMT following the treadmill test 
(session 1). In session 2 a similar increase in trunk flexion after the hip flexor fatigue test was 
observed that did not increase further with the subsequent treadmill test. Although not significant 
following modified Bonferroni correction the grand average graphs indicate an increase in trunk 
flexion throughout the gait cycle so supporting this as a real finding and not a false positive result 
(figures 6.11 and 6.15). Thus an increase in trunk flexion seems to occur when the hip flexors are 
fatigued. It is possible that this is another level of compensatory strategy employed when the hip 
strategy fails through fatigue. It could be argued that increased trunk flexion is due to a stooped 
posture adopted due to general fatigue as the subject reaches Borg 17. Results from session 2
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refute this, as the increase in trunk flexion was seen immediately following the hip fatigue test when 
the Borg was 11.
If we assume that the hip flexor strategy primarily assists limb progression, as discussed earlier, 
then it is possible that trunk flexion is a secondary strategy that assists limb progression when the 
hip flexor strategy starts to fail. Studies of trunk motion during walking have suggested that a ‘trunk 
leading’ strategy is a way of using the heavy trunk segment to direct movement of the lower body by 
pulling the leg into swing phase 10. Due the increased motion of the heavy trunk segment the 
strategy may be more costly and less efficient than the hip flexor strategy hence the walking time 
was almost halved in session 2.
An increase in coronal trunk motion was observed after treadmill walking in both sessions, but did 
not occur after the hip flexor fatigue test in session 2. The analysis in chapter 3 did not definitively 
reveal why people with CMT have increased trunk motion in the coronal plane though the 
relationship with plantarflexor stiffness may indicate that it is related to foot clearance. Coronal 
motion did not increase after specific hip flexor fatigue so it may be a consequence of fatigue of 
other muscle groups e.g. the dorsiflexors. Horizontal trunk motion also increased in session 2 at the 
end of the treadmill test. In chapter 3 horizontal trunk motion was related to plantarflexor strength so 
it is possible that it occurs in session 2 due to distal fatigue, though plantarflexor MVC was not 
measured in this session to verify this. In view of the synergistic action of the plantarflexors and hip 
flexors this situation, where the hip flexors are fatigued, may have increased the demand on the 
weak plantarflexors to maintain limb progression. This may have resulted in increased fatigue by 
the end of the walking test that was compensated for by an increase in horizontal trunk motion.
6.4.3 Reasons for walking cessation
The changes in hip kinetics may indicate that fatigue of a hip flexor strategy limits walking and 
indeed the majority of people with CMT reported moderate to severe proximal leg fatigue and 
stopped because of leg weakness. The correlation analysis, however, indicated that factors other 
than physical impacted on walking time. No correlation was seen between the drop in hip flexor 
MVC and the time spent walking on the treadmill. Subjects’ perception of fatigue and physical 
limitation did appear to have a significant influence on walking endurance in people with CMT. Both 
the FSS and SF-36 are multi-dimensional scales that reflect more than local muscle fatigue. 
Chronic fatigue that occurs independent of local muscle fatigue has been reported in other long 
term conditions such as multiple sclerosis and chronic demyelinating polyneuropathy. Increased 
central activation failure has been reported in a cohort of people with CMT measured by 
superimposed electrical stimulation during MVC contractions 15. The central activation failure 
correlated positively with reported fatigue severity so supporting the assumption that fatigue 
reported by people with CMT is due to central factors rather than peripheral muscle fatigue.
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It is likely that the limitations to walking endurance are due to a number of factors that vary with 
individuals. There are indications that people who report high fatigue severity are limited by central 
factors whereas people with low fatigue severity walk further and are limited by local muscle fatigue. 
These factors should be considered when physiotherapy intervention is aimed at improving walking 
endurance.
6.4.4 Clinical Implications
A deterioration is seen in hip kinematics and strength with prolonged walking in people with CMT. In 
order to prolong functional walking distances training the proximal muscles, perhaps specifically the 
hip flexors, may enable people with CMT to compensate for distal weakness for longer periods of 
walking.
In view of the link between walking endurance and fatigue severity, approaches that have been 
shown to influence fatigue in other chronic conditions could be successfully employed, for example 
general aerobic exercise and drug therapy.
6.4.5 Future work
This study implicates fatigue of the hip flexors as a limiting factor of prolonged walking. Fatigue of 
muscles will occur simultaneously and could be more influential on walking endurance, e.g. 
quadriceps or hamstrings, but the present study did not investigate this. The number of muscles 
that could be measured pre and post walking was limited due to recovery on cessation of walking. 
In view of the results from chapter 3, which suggest increased activity of the knee musculature, a 
repeat study focusing on the knee extensors and flexors would be useful.
If, as the present study suggests, hip flexor fatigue is a factor affecting walking endurance, then a 
training study would be useful. Training regimes could be compared for efficacy e.g. a regime to 
improve peak strength of the hip flexors versus endurance training. Some caution must be given 
with resistance training as concerns have been expressed about overwork weakness in CMT 17 
though the evidence for this is limited. Previous studies of moderate resistance exercise in CMT 
have not shown a deterioration in strength measures 2'9
The subjects who had the most limited walking endurance were the most fatigued, as measured by 
fatigue severity scales. The impact of a general exercise approach would be of clinical interest. 
Aerobic training has been found to reduce fatigue in some studies of people with multiple sclerosis 
11,14 . If aerobic training reduces fatigue in people with CMT who report severe levels of fatigue this 
may have a greater impact on walking endurance than strengthening proximal muscles. A study 
investigating the impact on fatigue, general health perception and walking endurance would useful 
with a post hoc analysis to see if indeed the most fatigued people respond best to this approach.
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6.5 Summary
♦ When walking on a treadmill people with CMT took a mean of 48 minutes to reach Borg level
17. Control subjects performing the exact same walking task only reported a Borg level of 8.
♦ After the walking test, the maximum voluntary contraction of the hip flexors reduced in both 
groups. People with CMT also demonstrated a reduction in hip velocity and an increase in trunk 
motion within the coronal and sagittal planes. Both groups showed an increase in hip extension 
during pre-swing and hip flexion during swing.
♦ When the hip flexors were specifically fatigued people with CMT were only able to walk for a 
mean of 26 minutes. The left and right sides did not fatigue symmetrically. The hip flexion 
velocity decreased for the more fatigued left side and increased sagittal plane trunk motion 
occurred. An increase in hip flexion occurred in the less fatigued right hip but did not change in 
the more fatigued left hip.
♦ Fatigue severity, physical functioning sections of the SF-36 and the change in hip flexion angle 
correlated significantly with the total treadmill walking time.
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7 Overview
This chapter gives an overview of the main findings of the four studies presented in chapters 3 to 6. 
The conclusions of each experiment are examined side by side and compared to the original 
hypothesis of the thesis stated at the end of chapter 1.
7.1 Aims of the thesis
This thesis aimed to test the theory that during preswing, hip flexor action increases to compensate 
for weakened plantarflexor activity to continue forward progression of the trunk and lower limb. Until 
recently, there were no in depth studies of gait in people with CMT and this theory originated from 
studies of people with stroke and peripheral neuropathy. The hypothesis for this study assumed that 
such theories could be extrapolated to people with CMT due to the presentation of common 
impairments such as distal weakness and sensory disturbance.
Four approaches have been utilised to explore the existence and impact of these theorised 
strategies in people with CMT. Firstly, the kinematics and kinetics of the gait pattern were examined 
and compared with physically matched controls (chapter 3). Relationships between presenting 
impairments and gait deviations in people with CMT were considered and an attempt was made to 
look for potential differences in the two main disease types. The next study attempted to replicate, 
in healthy subjects, one of the key distal impairments that present in people with CMT and to 
explore the compensatory strategies employed (chapter 4). In people with CMT, distal gait 
deviations were altered using external, below knee orthotic devices to see if this caused any 
change to proximal gait variables (chapter 5). Finally, the impact of the theorised hip flexor strategy 
on walking endurance was considered with a study of prolonged walking on a treadmill (chapter 6) 
and the effects of isolated hip flexor fatigue on walking endurance assessed.
The main methods used were biomechanical analysis of gait. The kinematics and kinetics (in 
chapters 3-5) were analysed to make inferences about muscle contributions to gait variables. This 
did not include EMG analysis due to difficulty recording from the ilio-psoas muscle group and it was 
felt that rectus femoris recordings would not represent the action of the hip flexors as it is known to 
have a different function 31 ’33. In addition to the traditional gait analysis methods, motion of the trunk 
was also monitored. This has not been considered in other detailed studies of walking in people 
with CMT but trunk deviations have been described in descriptive studies 41 and some suggest that 
it is utilised to progress the centre of mass 4311.
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7.2 Summary and interpretation of findings
7.2.1 Temporal and spatial differences
People with CMT demonstrate reduced gait speed, step length, cadence and increased double 
support time compared to age, gender, height and weight matched controls walking at a self 
selected pace. These variables correlated with distal muscle strength, particularly the plantarflexors, 
and compliment the results of other studies of neurological conditions29'37’40 50.
The experimental designs of chapters 4 and 6 did not allow a comparison of these parameters in 
healthy subjects with plantarflexor fatigue or people with CMT after prolonged walking. In both 
studies subjects subjectively reported increased effort to maintain the temporal and spatial 
constraints after fatigue which was quantitatively expressed in the walking endurance study.
In chapter 4, despite increased effort, healthy subjects were still able to maintain the target 
parameters. Although this may not have been their maximal speed, if unconstrained, it may have 
been faster than what they would have adopted as their self selected pace38.
It was interesting that there was no improvement in these variables with the application of AFOs 
despite the improvement in dorsiflexion angle. Some authors suggest that reduced gait speed is a 
compensatory strategy in itself261 20. If this is the case in people with CMT it will be a strategy 
developed insidiously with the slow deterioration of distal muscle strength over time. As a result, the 
changes brought about by the AFOs may not have impacted on these compensations immediately 
but may alter over time. An alternative explanation for the lack of effect of the AFOs is that their 
main effect is to improve dorsiflexion angle. Dorsiflexion strength is correlated with gait speed, 
cadence and dorsiflexion angle in swing phase. The correlation with gait speed and cadence, 
however, could be an incidental correlation rather than causative due to the strong correlation 
between plantarflexion and dorsiflexion strength. If this is so, changes in dorsiflexion angle by the 
AFOs would not be expected to alter these variables.
The Mult'rfit AFO, however, did increase double support time. Logically this could be explained by 
the reduction in ankle power production when this splint was worn supported by the relationship 
between plantarflexor strength with ankle power production and plantarflexor strength with double 
support time.
7.2.2 Distal differences related to propulsion
People with CMT presented with increased distal weakness, sensory loss and a high incidence of 
pes cavus and calcaneal varus. Compared to matched controls they demonstrated reduced peak 
and delayed ankle power generation that correlated with distal muscle strength. In the weaker 
group of people with axonal degenerative CMT there was an additional reduction in heel rise. This 
same reduction in plantarflexor power generation was not observed in control subjects whose
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plantarflexor muscles were fatigued by 25% of their MVC, though the ankle did move through less 
plantarflexion range. This was thought to be because there was still sufficient reserve in the 
plantarflexors to produce enough power to maintain cadence and step length. In addition, no 
change in ankle kinematics at preswing were observed when people with CMT walked to fatigue on 
the treadmill plus no change in plantarflexor MVC when tested after walking. This indicates that 
plantarflexor fatigue was not key in maintaining walking or limiting walking in these subjects.
When AFOs were applied there was a significant increase in stiffness of the ankle. Increased 
stiffness did not increase the plantarflexor moment in preswing as suggested by previous authors28, 
401 42. In fact one of the stiffer devices had a detrimental effect with a reduction in ankle power 
generation. This was probably because of the energy storage and release properties of the material 
it was constructed from.
7.2.3 Proximal differences related to propulsion and progression
The ankle plantar flexors work synergistically with proximal muscles during preswing to progress the 
trunk and leg. Soleus is the primary muscle involved in forward progression of the trunk but rectus 
femoris also works eccentrically to transfer energy to the trunk as it decelerates the leg 33151. The 
gastrocnemius muscle works with the uni-articular hip flexors to initiate swing and accelerate the 
leg, progressing it from preswing to swing 32,33,51. An increase in hip kinetics has been reported in 
people with plantarflexor weakness to ensure sufficient trunk and limb progression 13,28,29135.
People with CMT do not demonstrate a clear increase in preswing hip kinetics as described in other 
patient populations 28,36. Despite no change in hip kinetics in chapter 3, the results from chapter 6 
do indicate that the hip flexors are prematurely fatigued by prolonged walking in people with CMT. A 
reduction in hip velocity is observed and a drop of 20% of the MVC is seen in this group after 
walking on the treadmill until perceived exertion is “very hard”. So why would they fatigue 
prematurely when there is no increase in hip kinetics? As seen in chapter 3, there is a delay in the 
onset of ankle power generation which results in generation of hip power before the onset of ankle 
power generation. In the control group the reverse was true in every subject. Thus in people with 
CMT, the hip flexors are active in initiating swing phase and progressing the lower limb without the 
synergistic assistance of the plantarflexors, particularly gastrocnemius32 The drop in knee extensor 
moment indicated a reduction in the decelerating action of rectus femoris on the limb. As a result, 
less force would be required to accelerate the limb. Normally gastrocnemius assists with initiating 
and propagating swing but in this situation delayed onset of ankle power generation means that the 
hip flexors initiate swing alone and have reduced assistance in accelerating the leg. Although less 
force is required to accelerate the limb, there is less assistance from gastrocnemius so this may be 
why there is no net change in hip kinetics. Meinders et al 25 supports this relationship between the 
three muscles by suggesting that the work done by eccentric knee extensor action is the difference 
between the net work of the leg and the positive work of the plantarflexors and hip flexors .
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The other key finding of chapter 3, that has not been described before in people with CMT, was the 
increased motion of the trunk in the horizontal plane. Increased trunk rotation was inversely related 
to plantarflexor strength so it may be a compensation for reduced contribution of the ankle 
plantarflexors to propulsion of the body. Along with the unopposed, but unassisted, action of the 
hip flexors this may be sufficient for limb progression albeit slower than controls as indicated by 
reduced speed and step length. In support of this finding, horizontal rotation of the trunk has also 
been linked to maintenance of step length in studies of healthy subjects 43. In the treadmill walking 
study, horizontal trunk motion did not change after specific fatigue of the hip flexors but it did 
increase after subsequent walking. If the strategy assisted limb progression it would be expected 
that there would be an increase when the hip flexors were less effective through fatigue. This could 
support the alternative possibility that this is a strategy to assist the role of the plantarflexors in 
progressing the trunk forwards, though there is no additional data to support this theory.
Flexion of the trunk was observed in healthy subjects with plantarflexor fatigue and in people with 
CMT with fatigue of the hip flexor muscles. It was not, however, observed in people with CMT while 
walking for a short duration at a self selected speed. It is possible that this was employed as a 
strategy when subjects had to walk at a faster pace than they would select themselves due to 
constrained gait speed/cadence/step length. Davies and Ounpuu 11 describe a single case of a 
healthy subject being asked to walk with a flexed trunk. They noted was a forward shift of the centre 
of gravity and movement of the hip into flexion due to increased anterior tilt of the pelvis. It is 
possible that when muscles that assist trunk and limb progression are fatigued, this strategy is 
employed in an effort to keep the trunk anterior of the centre of gravity shifting the onus on other 
muscle groups to control the ‘forward fair.
In addition to increased hip kinetics, healthy subjects with plantarflexor fatigue also seemed to use 
hip and knee extension in early stance to assist with trunk progression. The vasti and gluteus 
maximus have been implicated in facilitating trunk progression in early stance 13 51 and appear to be 
the main strategy in this case. The same strategy was not seen in people with CMT in this study 
though the study by Don et a l12 observed some similarities with increased knee extensor angular 
impulse later in stance in subjects with plantarfiexion failure, defined by an inability to raise the 
heels off the ground more than 2 cm.
So why are the compensatory strategies for plantarflexor weakness in people with CMT and 
neurologically intact individuals different? In the study on healthy subjects, there was a rapid onset 
of plantarflexor weakness with the fatiguing task. As discussed, subjects appeared to use hip and 
knee extensor strategies in stance and a hip flexor strategy in preswing to maintain trunk and limb 
progression. When requested, the subjects were able to maintain the same temporal and spatial 
parameters but not the same kinematics post fatigue. All of these findings are remarkably similar to
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a modelling study by Goldberg et al 13. The subjects, however, were not tested over a prolonged 
period. The strategies may have changed with further walking as they may be inefficient, effortful or 
quick to fatigue.
In contrast, people with CMT experience a very slow reduction in plantarflexor strength. They show 
an increase in trunk horizontal rotation and reduced braking by the knee extensors during preswing 
as implied from a reduction in knee extensor moment. This strategy allows them to maintain the 
ability to walk but they cannot maintain the same speed, step length and cadence as matched 
controls indicating that they were unable to progress the trunk as effectively. Although people with 
CMT cannot walk for as long as intact control subjects, the strategies used may be more efficient 
and fatigue resistant than the adaptations used by healthy subjects with acute plantarflexor fatigue 
in chapter 4.
This could be explored with further investigation of healthy subjects. The fatiguing paradigm would 
not be a useful tool in a study of prolonged walking due to recovery. Plantarflexor action in preswing 
could be blocked, however, using an external device. We have seen in chapter 5 that certain AFOs 
have the potential to reduce ankle power generation at preswing so such a device could be used. 
Alternatively a tibial nerve block could be introduced that would ensure plantarflexor weakness for 
up to five hours. The other muscles supplied by the tibial nerve would also be affected, i.e. flexor 
hallucis longus, flexor digitorum longus, and tibialis posterior, and reduced sensation would occur 
on the plantar aspect. In severe CMT, these muscles are also weak and sensory loss is also 
present. As the purpose of this experiment would be to replicate CMT, not look at the action of the 
muscles in isolation, this may be a useful side effect. Another issue with this method is overflow of 
anaesthetic into the anterior compartment muscles causing foot drop. Again this could be a useful 
effect to see how long healthy subjects can use their compensatory strategies for the range of 
impairments found in people with CMT 46. Healthy subjects could then walk on a treadmill for a 
prolonged period with monitoring of perceived exertion and either 2D kinematic analysis, as in 
chapter 6, or a before and after 3D kinetic and kinematic analysis. It would be interesting to see if 
there is a change in their compensatory strategies over time, how long they can walk for and how 
their perceived exertion compares to matched people with CMT.
7.2.4 Proximal differences related to foot clearance
Don et a l12 attributed their observation of increased hip impulse at preswing as a compensation for 
foot drop during swing leading to an increased hip flexor angle. They split their group of people with 
CMT in to a group with just foot drop and a group with foot drop and plantarflexor failure and found 
an increase in angular impulse in the former group. Data from chapter 3 of this thesis showed 
increased hip flexion in people with CMT that indeed correlated with reduced dorsiflexor angle but 
there was no accompanying increase in hip kinetics. Control subjects in chapter 4 did show a 
change in hip kinetics at preswing but this was when the plantarflexors were weakened. The
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dorsiflexor muscles were not weakened by the fatigue protocol so would not have contributed to 
the proximal changes at the hip. This finding disputes the suggestion of Don et al 12 and is 
supported by modelling studies 13 which also surmise that increased hip kinetics at preswing are 
due to plantarflexor weakness at preswing push off and not dorsiflexor weakness.
So if people with CMT raise the thigh through hip flexion to clear a dropped foot, but no increase in 
hip kinetics is seen, what strategy is employed to do this? Data from chapter 3 demonstrated a 
burst of knee power generation at preswing that was not present in control subjects. Studies of 
healthy subjects walking over obstacles also demonstrate this kinetic feature M' 39. The authors 
attribute this power burst to knee flexor activity causing flexion of the hip and knee through the 
action of inter-segmental forces. Indeed Don et a l12 reported a burst of biceps femoris EMG activity 
in people with CMT at around this time which was greater in the group with foot drop and could 
represent this compensation, though the absence of joint power data does not allow a direct 
comparison.
Coronal motion of the trunk may be a strategy employed to assist foot clearance in people with 
CMT. It relates to plantarflexor stiffness which could suggest a link with reduced dorsiflexion range 
in swing. Prolonged walking on the treadmill revealed an increase in coronal motion when the hip 
flexion velocity was reduced suggesting that it compensates for a reduction in the hip flexor strategy 
as a secondary adaptation. With specific fatigue of the hip flexors, coronal trunk motion did not 
increase when one hip was fatigued to 20% but emerged when they both were.
An interesting finding from the AFO study, chapter 4, was that reducing foot drop did not change the 
hip flexor angle or any other proximal variables. In a similar argument for the lack of temporal and 
spatial changes, it was probably because measurement was taken within a few minutes of applying 
the AFO. People with CMT will have slowly developed their gait pattern as the disease progressed 
so changing established strategies may require a longer period wearing the AFO. In addition, the 
clinical measures showed that there was a significant reduction in proprioceptive perception in 
people with CMT so there may have been reduced awareness of the change in joint angle.
7.2.5 Distal differences related to support
Other distal differences between healthy subjects and people with CMT seemed to relate to support 
of the lower limb in stance phase. The most prominent distal finding was an increase in the 
dorsiflexion angle at the end of stance, prior to preswing. This was primarily attributed to decreased 
eccentric control of the shank by the plantarflexor muscles. Several studies have investigated the 
role of the plantarflexor muscles in the control of the ankle rocker which support this supposition 2’ 
13, is. 16 App|yjng splints to stiffen the ankle did not significantly alter that variable but this was 
probably because the AFOs studied were not rigid enough as it has been described in other studies 
that investigated rigid AFOs. No increase in forward motion of the shank was observed in healthy
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subjects with plantarflexor fatigue despite changes in proximal kinetics during stance. This may be 
because post fatigue they were not as weak as the people with CMT and were able to control the 
ankle position sufficiently.
On loading and through stance the ankle was supinated in people with CMT. A modelling study has 
examined the effect of tibial torsion on the function of the soleus muscle and found a reduction in 
body centre of mass support and propulsion 44 In addition to plantarflexor weakness, tibial torsion 
and knee valgus occurs in people with CMT due to excessive foot supination. Calcaneal deformity 
may also change the axis of the subtalar joint and foot deformity will also change the length and 
weight of the shank and foot segments 46. It is possible that these problems with alignment were 
also contributing to reduced control of the shank by soleus because of what Schwartz and Lakin 44 
term lever arm dysfunction.
7.2.6 Proximal differences related to support
On loading there was an increase in knee flexion in healthy subjects with plantarflexor fatigue. A 
corresponding increase in hip extensor moment was seen that was likely to be a strategy to control 
this. The finding is in keeping with the findings of Goldberg et a l13. In people with CMT there was 
only a trend to this increase in knee flexion and there were no other proximal changes associated 
with it. This discrepancy could be due to differences in gait speed. As has already been mentioned, 
slower gait speed could be a primary compensatory strategy in people with CMT that would reduce 
the destabilisation of the segments as the centre of mass moves over the foot25 . Conversely, the 
observation of an increase in knee flexion during loading in healthy subjects with plantarflexor 
fatigue could be exaggerated due to the goal of maintaining step length and cadence.
7.3 Clinical application and further study
The results of these experiments indicate that in people with CMT, proximal compensatory 
strategies are used to allow walking to continue when distal impairments are present. The gait 
adaptations, however, make walking effortful and lead to a reduction in walking distance when 
fatigue of these strategies occurs. Based on this information, clinicians may choose to intervene in 
two ways:
1. Improve the ability of the person to utilise their compensatory strategies for longer
2. Reduce the impact of distal impairments so reducing proximal compensations
The results of these studies confirm the link between distal impairments and proximal 
compensations so adding information to the clinical reasoning process. Chapter 5 also explored the 
effect of AFOs as an intervention but this was not a randomised control trial. Therefore these results 
do not provide direct recommendations about what interventions to apply. The following sections
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will outline the two approaches to CMT listed above and recommend investigations that will help 
provide this information.
7.3.1 Utilisation of compensatory strategies
Emphasising the use of compensatory strategies has been recommended in people with diabetic 
neuropathy 28 by encouraging hip flexion rather than push off from the ankle, even in people who 
did not primarily do this. This, however, was to reduce the formation of plantar ulcers rather than 
prolong function and was met with a certain amount of criticism in the literature 9' 24 as others 
question the encouragement of a strategy without trying other management approaches to reduce 
ulceration.
The suggestion from the present studies does not encourage the use of a specific strategy as such 
but recommends increasing how long an established strategy can be used. The results from 
chapter 6 show that the hip flexors starts to fatigue with prolonged walking with the emergence of 
other proximal adaptations. Strengthening the muscles that control this, e.g. the hip flexors, may be 
a way of prolonging walking.
Further investigation is required to see if this approach is effective in increasing walking endurance 
but also so see what type of strengthening protocol is most effective. Because endurance is the aim 
of the intervention one assumes that subjects would need to be strengthened with an endurance 
protocol, i.e. low resistance and high repetition, but increasing their maximum strength may also be 
useful. A study by Lindeman et al 20 showed that people with CMT fatigued their quadriceps 
muscles at the same rate as healthy control subjects but started at a lower MVC, that is they had a 
similar degree of fatigability. If people with CMT have a higher maximal strength this may prolong 
the time taken to reach the threshold due to the inverse relationship between the percentage 
maximal force generated and the time to fatigue i.e. around 20% of the MVC when hip flexion starts 
to fail23
It is worth noting, though, that the intention of this approach is not to change the strategies used so 
no alteration in kinematics is expected during short walks. In addition the subjective impact of 
fatigue may impact on the results as the correlation between subjective reports of fatigue with 
walking time was a key finding in chapter 6. This must be a recognised covariate in any study 
looking at improving walking endurance and should be considered in the design and analysis of any 
investigation.
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7.3.2 Reducing the impact of distal impairments
The most obvious area to try to improve is the strength of the ankle muscles as distal weakness 
causes the majority of gait deviations seen in people with CMT. Strengthening studies in CMT have 
to date concentrated mainly on larger muscle groups 1i 10,17,19,21 or upper limb muscles 1’10,17. One 
study of resistance training in neuromuscular disease found that increases in strength were only 
found when the baseline values were greater than 15% of normal control data 27. In chapter 3 the 
subjects with CMT had a mean strength of the ankle plantarflexors that was 32% of the controls and 
dorsiflexion strength that was 15%. There may be some potential, therefore, to strengthen the 
plantarflexor muscles aiming to improve the ankle plantarflexor moments and power generation at 
preswing. In contrast the more affected dorsiflexor muscles may be too weak to be strengthened. 
The study of resistance training, however, was performed on subjects with a mixture of 
neuromuscular pathologies, the majority having muscular dystrophy. Because CMT is a neuropathic 
condition and not a muscle disease, people could respond differently to strengthening so this 
finding may not apply.
The other consideration when strengthening the weaker distal muscles is over work weakness. The 
evidence for this is not conclusive and the pathological process is not fully understood 47 . It is 
possible that the mechanism of overwork weakness in people with CMT, particularly type 1, is 
similar to that proposed in people with post polio syndrome where motor units enlarged due to 
partial denervation are vulnerable to increased oxidative stress 48. Kilmer et al found that high 
resistance strength training at a 12 repetition maximum in people with progressive neuromuscular 
disease resulted in a reduction of the eccentric peak torque of the elbow flexor muscles 17. This 
difference, however, was also seen in the contra-lateral elbow that was not trained indicating that 
this may be a neural adaptation rather then damage to the local muscle tissue, though the authors 
were unable to explain why there was a negative cross over effect. In addition, there were no 
detrimental effects seen in the knee extensors with high resistance training or with both muscle 
groups when a moderate resistance training programme was applied 1. The main problem with 
these two studies was that they included people with not only CMT but also muscular dystrophy. 
Generalising the results to just CMT is therefore difficult.
A study by Vinci et al 49 observed that people with CMT tended to be stronger in the non-dominant 
hand and suggested this was evidence of overwork weakness because the dominant hand is used 
more. This study used manual muscle testing as the main outcome measure which has been 
criticised in studies of muscle strength in CMT7 In addition, the timescale of deterioration suggested 
in this paper is over a person’s lifetime. Extrapolating this to a study of strengthening larger muscle 
groups over a 12 week period is difficult although the long term effects of any strengthening 
program and the presumed increased use of a muscle after strengthening must be considered.
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In view of the concerns about overwork weakness an investigation of this in people with CMT would 
be very useful. Strength changes and motor unit number estimation 4 would ascertain if there has 
been any detriment through strengthening. Stratifying the subject group into weaker and stronger 
people would also indicate if weaker muscles can be strengthened safely. Functional and 
biomechanical analysis of gait would also show if any strengthening effect is enough to improve 
functional gait and the kinetic and kinematic gait deviations identified in this and other studies.
Another way of intervening distally is through external support. Chapter 5 demonstrated that some 
distal deviations can be altered with an AFO such as foot drop. As discussed previously longitudinal 
studies would be required to ascertain if reducing foot drop reduces associated proximal 
compensations over time. Although chapter 5 was not a randomised control trial and so does not 
give a definitive recommendation as to the best device to use, the potentially detrimental effects of 
one type of AFO should be considered when clinically reasoning the prescription of such a device. 
Only a limited range of devices were tested in this study and the results were not stratified 
according to subject presentation. More rigid devices may limit ankle power production in some, but 
people who are severely weakened may benefit from the extra bracing to support the lower limb 
during the ankle rocker. Also, the potential for carbon fibre AFOs should be investigated because a 
spring assistance of ankle power would be beneficial to this group. Studies of AFOs should include 
a stratified subject group and a combination of functional measures and biomechanical measures 
allowing investigators to see not only whether they work but also how they work and who they work 
best with. This will allow clinicians to understand the principles of the devices as they reason their 
use and not just administer AFOs in a prescriptive manner.
Orthoses can assist other distal impairments seen in this group. Pes cavus can be a problematic 
presentation for a few reasons. Pain is a common complaint due to altered musculoskeletal 
alignment and altered weight bearing 5. Also the function of the ankle muscles can be worsened by 
poor alignment due to lever dysfunction as described by Schwartz and Lakin 44. A randomised 
control trial of the use of foot orthoses in people with pes cavus showed improvement in pain, 
plantar pressure and reported physical functioning 6. To date there has not been a study using 3D 
motion analysis as an outcome measure in this type of intervention study. This would be useful to 
see if foot orthoses alter alignment problems such as tibial torsion and EMG study of soleus would 
indicate if there is any improvement in activation as has been suggested44.
7.4 Limitations of methods
The limitations of the design of each study has been discussed in the relevant chapters. This 
section, however, discusses some of the problems associated with the main measurement tool 
used, 3D gait analysis. Concern has been raised about error due to skin and marker movement and 
also the error associated with the linked segment model used for calculations of the hip joint 14. 
Maynard et a l22 looked at the reliability of the CODAmotion system and found reduced intra-rater
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reliability of hip joint angles that they supposed was due to variability in marker placement. Another 
source of error could be the estimated location of the hip joint centre. The CODAmotion system 
uses a method described by Bell et al 3 which involves calculating the hip joint centre from 
anatomical landmarks and reports estimations within 2.6 cm from the centre of the hip joint when 
compared with radiographs. The accuracy of this method has been questioned and newer methods 
have been described that estimate the position of the functional hip joint. This method relies on the 
subject rotating the hip in two planes during a pre-walking calibration test. As the leg moves, 
markers on the knee joint trace a trajectory that is then assumed to be the arc of sphere, the centre 
of which is the functional hip joint centre 18.
More recently another method has been proposed using arrangements of marker clusters to 
represent two segments, e.g. the pelvis and thigh. The assumption is that as these two segments 
move relative to each other and the segments intersect at a common point on the axis of rotation 
which represents the joint centre 45 New software packages can accommodate these methods 
while using data from existing motion analysis systems such as CODA. One example is Visual 3D 
which uses alternative marker arrangements 8 Marker clusters on rigid plates are used to define a 
local co-ordinate system for each segment. The position and orientation (PORE) of the segment is 
calculated and the PORE itself is tracked frame by frame rather than each individual marker as with 
traditional methods. It also allows the calculation of the joint centres through identifying where the 
segments inter-connect, as described 45 and is reported to be less vulnerable to error through skin 
movement. In addition, when marker clusters have to be removed and reapplied e.g. in chapter 4, 
the position of the marker clusters relative to each other and anatomical bony landmarks and the 
joint centres can be recalculated after the gait trial so eliminating the concerns that were raised in 
that chapter about the accuracy of the replacement of markers post intervention. The future use of 
this type of system would help to clarify the accuracy of particularly kinematic and kinetic data which 
was crucial to this thesis.
7.5 Overall conclusion
People with CMT demonstrated proximal changes in gait kinematics and kinetics that compensated 
for distal impairments. The compensatory strategies found in people with CMT differed from those 
found in healthy subjects with weakened plantarflexor muscles and studies of people with other 
conditions such as stroke. This difference may be due to the slow adaptation that a person with 
CMT develops in response to the insidious disease progression.
A role of the hip flexor muscles is hypothesised based on the reduction in strength with prolonged 
walking and alterations in walking time and kinematics subsequent to selective fatigue. In addition 
other compensatory strategies were noted. An increase in knee power generation at the end of 
swing phase may help to elevate the limb whilst an increase in trunk motion may aid limb 
progression and increase stride length.
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With prolonged walking different compensatory strategies may emerge as “first choice” strategies 
that later fail due to muscle fatigue. Understanding the role and interaction of different 
compensatory techniques would allow therapists to develop training that specifically aims to 
optimize and prolong these strategies thus improving walking endurance. Such research should be 
conducted in parallel with work investigating whether it is possible to reduce the underlying primary 
impairment and target additional influences on walking and function such as the possible presence 
central fatigue and the use of ankle-foot orthoses
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Appendix 1: Modified Bonferroni Correction
The modified Bonferroni correction is based on the ordered P-values of individual tests. TX,...,T  is a 
set of n statistics with corresponding p-values Pl9...P„for testing hypothesis The p-
values were ordered as PiX),...P{n) to test the hypothesis H 0 = { i / (1),... / /(w)} . The null hypothesis
H 0 was rejected if P(J) < j a / n  for any j  = 1 Below the procedure is demonstrated with the 
data from the primary analysis for chapter 3:
Test
rank Variables P-value
Modified Bonferroni 
threshold
Modified Bonferroni 
outcome
1 Ankle power preswing 0.001 0.005 REJECT H0
2 Hip flexion swing 0.009 0.010 REJECT H0
3 PF moment preswing 0.010 0.015 REJECT H0
4 Hip ankle timing 0.020 0.020 REJECT H0
5 HF velocity preswing 0.037 0.025 ACCEPT H0
6 PF angle preswing 0.109 0.030 ACCEPT H0
7 DF angle foot clearance 0.128 0.035 ACCEPT H0
8 HF angle preswing 0.160 0.040 ACCEPT H0
9 HF moment preswing 0.215 0.045 ACCEPT H0
10 Hip power preswing 0.930 0.050 ACCEPT H0
Table A1.1: Data from the primary comparison in Chapter 3 demonstrating application of the 
modified Bonferroni test.
Reference
Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986; 
73:751-754.
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Appendix 2: investigating the reliability of the position of the 
CODA pelvic frame with walking and with repeat application
Introduction
CODA cx1 is a 3D motion analysis system developed by Charnwood Dynamics Limited. The 
system includes a segmental analysis set up which consists of recommended marker placement to 
allow the CODA system to calculate gait analysis data. Data is presented in a report relatively 
quickly which has obvious benefits to the clinical setting.
The gait set up includes a pelvic frame for the placement of the pelvic markers. This was developed 
to extend some of the markers away from the pelvis due to the tendency for arm swing to obscure 
markers. The frame consists of two lateral bars and a sacral wand which slot together and attach to 
the outside of a Velcro belt. The markers correspond to the anterior superior iliac spines (ASIS), the 
posterior superior iliac spines (PSIS) and the end of the sacral wand.
The frame’s location is significant as the CODA software automatically calculates the internal hip 
joint centre from the marker positions and additional anthropometric data. The location of the hip 
joint centre needs to be accurate as it is a component of the calculation of hip moments and 
powers. Several methods of calculating the hip joint centre are described and CODA uses a 
technique by Bell et a l1. Charnwood recommend the pelvic frame be tilted so that the plane defined 
by the PSIS and ASIS markers includes the actual PSIS and ASIS landmarks. The marker set is 
used to define the local co-ordinate frame of the pelvic segment, the orientation of which is known 
as the Embedded Vector Basis (EVB). A line linking the PSIS and ASIS is used to define the local X 
axis as a unit vector. Derivation of the local Y and Z unit vectors is achieved using the Gram- 
Schmidt algorithm to orthogonalise the axes. The EVB is involved in the calculation of segment 
rotations using Euler angles. The rotation calculation requires definition of a proximal segment for a 
distal segment to move relative to. In this situation, the pelvis is the distal segment and the lab co­
ordinates represent the proximal segment with unit vectors [1,0,0][0,1,0j[0,0,1].
The reliability of the frame placement with repeated applications and during functional tasks, such 
as walking, is therefore important . The frame sits on the pelvis secured by a Velcro strap rather 
than the more common method of fixation with adhesive tape. This may make it vulnerable to 
slippage with movement e.g. walking. Some experimental designs require comparison of gait 
kinetics and kinematics on different occasions requiring removal of the frame. Any inconsistency in 
application or slippage of the frame during walking may affect the reliability of measures requiring 
the hip joint centre e.g. moments. Piazza 5 warns us that there are a number of motion analysis 
studies suggesting that kinetic and kinematic variables are highly sensitive to errors in hip joint 
centre location.
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Maynard et at4 report on inter and intra-rater reliability of gait measurement using the CODA mpx30 
system. The CODA bilateral gait marker set up was applied to healthy subjects who walked over 
force plates embedded in a walkway. Kinetic, kinematic and spatio-temporal data was collected 
twice in one day and again one week later. Results demonstrated generally poor correlation 
between the three sessions for the intra-rater analysis of 10 subjects. Inter-rater analysis showed 
good agreement for knee variables and spatio-temporal parameters but hip angle agreement was 
particularly poor. The authors accounted for the poor agreements by the variability of marker 
placement. Normal variation of the gait cycle is implicated as another source of inconsistency
suggesting that analysis of one gait cycle would be particularly vulnerable to this. Three to ten
cycles are recommended for reliable analysis 3.
Methodology
Seven healthy subjects were recruited from staff and clinical students at the National Hospital for 
Neurology and Neurosurgery and the Institute of Neurology. Two CODA CX1 scanners were used 
(Charnwood Dynamics Ltd). The bilateral gait marker set up was applied to the subject:
• 6 pelvic markers on the pelvic frame (PSIS, ASIS, sacral wand; left and right)
• 2 hip markers on the greater trochanter
• 2 anterior and 2 posterior femoral markers mounted on thigh wands
• 2 knee markers on the lateral joint line
• 2 anterior and 2 posterior tibial markers on shank wands
• 2 markers on the lateral malleoli
• 2 lateral heel markers
•  2 toe markers on the base of the 5th metatarsal
Tape markers were applied to the ASIS and PSIS to help to visualise the anatomical landmarks 
when positioning the pelvic frame.
Prior to data collection, subjects were asked to walk on a motorised treadmill for two minutes to find 
a preferred walking speed. Two marks were made on the treadmill belt, 40 cm apart. Subjects were 
asked to stand barefoot with the lateral edge of the foot (base of 5th metatarsal) level with the mark 
(figure A2.1).
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40 cm
Figure A2.1: Position of the feet and toe markers
Subjects were instructed to stand still for 30 seconds with their arms by their sides. Data was 
sampled at 200 Hz. Baseline data was obtained by comparing two trials collected consecutively with 
no alteration in task or set up in between. The effects of walking on the frame position was 
investigated by comparing trials before and after a 2 minute walk on the treadmill at the subject’s 
preferred speed. For the application repeatability, a standing trial was recorded then the pelvic 
frame was completely removed and reapplied. A second standing trial followed.
The pelvic segment rotation was calculated via CODAmotion software and exported as text files for 
subsequent analysis using MATLAB programmes written in-house (MATLAB, Mathworks Inc). The 
segment rotations obtained from the CODAmotion software were expressed in three directions: 
oblique (medio-lateral rotation), tilt (antero-posterior rotation) and rotation (rotation around 
vertical).
Data analysis
Two types of analysis were carried out on the data to test for the repeatability. Interclass correlation 
(ICC) and the Bland Altman methods were used. For the ICC, model 3 was used for one rater (3,1) 
as the same rater would be collecting data in the main study. ICCs over 0.75 were considered as 
demonstrating good agreement. All calculations were done using SPSS.
Although the ICC will give a measure of agreement it does not give us actual measures, indicate 
bias or clinical importance of any disagreement. In addition, the Bland Altman method was applied 2 
in order to obtain the 95% “limits of agreement” to indicate a range of error. The mean difference 
between the trials should be zero as the same measure is used. The confidence intervals for the 
limits of agreement were not considered as the sample size was too small. A sample set of at least 
50 is required 6
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Results
The two baseline trials showed good agreement for segmental rotation in all directions measures 
with high ICCs. The limits of agreement for the tilt direction show a wide interval of 11.16 degrees 
with a higher coefficient of repeatability (table 1).
Tilt Oblique Rotation
Mean difference (deg) 0.66 0.19 -0.32
Standard deviation of difference (deg) 2.80 0.37 1.08
Standard error of difference (deg) 1.06 0.14 0.41
Upper limits of agreement (deg) 6.25 0.93 1.84
Lower limits of agreement (deg) -4.93 -0.56 -2.48
Coefficient of repeatability 5.59 0.74 2.16
ICC (3,1) 0.9416 0.9970 0.9817
Upper confidence interval 0.9900 0.9996 0.9968
Lower confidence interval 0.6599 0.9865 0.8933
Table A2.1: Results of Bland Altman and Interclass Correlation Coefficient tests for baseline trials.
The trials comparing the effect of walking on the frame position demonstrated excellent agreement 
as demonstrated by the high ICCs, low coefficients of repeatability and narrow limits of agreement 
for all directions of movement (table 2). In contrast, the frame repeatability trials did not show such 
good agreement and had wider limits (table 3).
Tilt Oblique Rotation
Mean difference 0.35 0.13 0.19
Standard deviation of difference 1.54 0.37 2.01
Standard error of difference 0.58 0.14 0.76
Upper limits agreement 3.44 0.86 4.21
Lower limits agreement -2.74 -0.61 -3.83
Coefficient of repeatability 3.09 0.74 4.02
ICC (3,1) 0.9850 0.9974 0.9499
Upper confidence interval 0.9974 0.9996 0.9914
Lower confidence interval 0.9130 0.9849 0.7084
Table A2.2: Results of Bland Altman and Interclass Correlation Coefficient tests for effect of 
walking trials.
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Tilt Oblique Rotation
Mean difference 1.90 1.67 2.60
Standard deviation of difference 6.66 3.16 4.99
Standard error of difference 2.52 1.19 1.89
Upper limits agreement 15.23 7.99 12.57
Lower limits agreement -11.43 -4.65 -7.38
Coefficient of repeatability 13.33 6.32 9.98
ICC (3,1) 0.6345 0.4524 0.5641
Upper confidence interval 0.9371 0.9059 0.9251
Lower confidence interval -1.1271 -2.1868 -1.5367
Table A2.3: Results of Bland Altman and Interclass Correlation Coefficient tests for frame 
repeatability trials.
Discussion
The baseline results show good agreement according to the ICC but the wide limits of agreement 
for the tilt direction is of concern. The error is large enough to risk obscuring changes due to an 
intervention in a study. An explanation could be that while a person stands, there is natural variation 
in the in antero-posterior pelvic tilt. This is more likely to occur in the tilt direction because the 
constrained foot position would help to standardise the oblique and rotation components. To 
standardise the antero-posterior tilt in an experimental situation would be difficult without 
constraining lumber movement which would restrict more dynamic tasks such as walking.
It is encouraging that walking did not dramatically alter the position of the frame. However, the 
agreement is better than the baseline trials. This could be because the walking trials were 
performed after the subject had been relatively active. The second baseline trial was performed 
straight after the first. A more prolonged stand may have resulted in postural “fatigue” where 
subjects gradually move to a position of least effort or activity.
The frame repeatability comparison demonstrated that the application of the pelvic frame is not as 
reliable, even with tape markers on the anatomical landmarks. This has implications for comparative 
studies using this equipment. If a research design necessitates removal of the apparatus, within a 
session or comparison on a different day, the measures of segmental rotation may be too variable 
to detect change due to interventions that may be applied. The segmental rotation measure relies 
on the accurate position of the pelvic markers. This is also true for the calculation of the hip joint 
centre when deriving hip moments. This finding implies that the inaccuracy in repositioning the 
pelvic markers (via the frame) could increase variability and also may explain why particularly poor
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agreement in hip angles was found by Maynard et al 4. As the tilt of the frame is important for 
uniform calculations of the EVB, repeatability may be improved by marking the position of the arms 
of the frame with long pieces of straight tape rather than just tape markers on the bony landmarks.
Conclusion
Good repeatability is demonstrated in variables derived from the pelvic markers in baseline trials, 
and before and after walking. Some variability is seen with the baseline in the antero-posterior 
pelvic tilt that could be a result of a prolonged stand. The repeatability is diminished when the frame 
is removed and reapplied.
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Appendix 3: Clinical tests
Scoliosis screen: Adam’s Forward Bend Test
Patients are asked to bend over at the waist as if they were touching their toes.
Instruct the patients to place their feet shoulder-width apart, extend their arms with the hands 
placed together, and bend forward slowly. The examiner gets their eyes level with the back and 
looks for one side being higher than the other, or any asymmetry of the back. If this position reveals 
trunk asymmetry, record forward bend test as positive.
Block Test:
Note the position of the heel when standing on a 2cm block. Then get the patient to stand with the 
forefoot over the medial edge. If a varus remains then the subtalar joint is fixed. If it corrects to 
valgus then the joint is mobile.
Plantar areas tested for pressure perception:
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Appendix 4: Borg perceived exertion scale
6
7 Very, Very Light
8
9 Very Light
10
11 Fairly Light
12
13 Somewhat Hard
14
15 Hard
16
17 Very Hard
18
19 Very, Very Hard
20
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Appendix 5: Fatigue Severity Scale Questionnaire
Please read each statement and circle a number from 1 to 7, depending on how appropriate you 
feel the statement applies to you over the last week. A low value indicates that the statement is not 
very appropriate whereas a high value indicates agreement.
During the past week, 1 have found that...
Never Hardly
any
time
Some 
of the 
time
About 
half of 
the 
time
A lot of 
the 
time
Nearly 
all of 
the 
time
All of 
the 
time
1. My Motivation is lower 
when I am fatigued
1 2 3 4 5 6 7
2. Exercise brings on my 
fatigue
1 2 3 4 5 6 7
3 .1 am easily fatigued 1 2 3 4 5 6 7
4. Fatigue interferes with my 
physical functioning
1 2 3 4 5 6 7
5. Fatigue causes frequent 
problems for me
1 2 3 4 5 6 7
6. My fatigue prevents 
sustained physical 
functioning
1 2 3 4 5 6 7
7. Fatigue interferes with 
carrying out certain duties 
and responsibilities
1 2 3 4 5 6 7
8. Fatigue is among my 
three most disabling 
symptoms
1 2 3 4 5 6 7
9. Fatigue interferes with my 
work, family or social life
1 2 3 4 5 6 7
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Appendix 6: RAND 36-Item Health Survey 1.0 Questionnaire Items
1. In general, would you 
say
your health is:
Excellent 1
Very good 2
Good 3
Fair 4
Poor 5
2. Compared to one year ago,
how would your rate your health in general
now?
Much better now than one year ago 1
Somewhat better now than one year ago 2
About the same 3
Somewhat worse now than one year ago 4
Much worse now than one year ago 5
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The following items are about activities you might do during a typical day. Does your health now 
limit you in these activities? If so, how much?
(Circle One Number on Each Line)
Yes,
Limited a Yes, Limited No, Not 
Lot a Little limited at All
3. Vigorous activities, such as running, lifting [1] [2] (3]
heavy objects, participating in strenuous sports
4. Moderate activities, such as moving a table, [1] [2] [3]
pushing a vacuum cleaner, bowling, or playing
golf
5. Lifting or carrying groceries [1] [2j [3]
6. Climbing several flights of stairs [1] [2] [3]
7. Climbing one flight of stairs [1] [2] [3]
8. Bending, kneeling, or stooping [1] [2] [3]
9. Walking more than a mile [1] [2j [3]
10. Walking several blocks [1] [2] [3]
11. Walking one block [1] [2] [3]
12. Bathing or dressing yourself [1} [2] [3]
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During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of your physical health?
(Circle One Number on Each Line)
Yes No
13. Cut down the amount of time you spent on work or other activities 1 2
14. Accomplished less than you would like 1 2
15. Were limited in the kind of work or other activities 1 2
16. Had difficulty performing the work or other activities (for example, it took extra 1 2
effort)
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (such as feeling depressed or 
anxious)?
(Circle One Number on Each Line)
Yes No
17. Cut down the amount of time you spent on work or other activities 1 2
18. Accomplished less than you would like 1 2
19. Didn't do work or other activities as carefully as usual 1 2
20. During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered with your normal social activities with family, friends, neighbors, or groups?
(Circle One Number)
Not at all 1 Quite a bit 4
Slightly 2 Extremely 5
Moderately 3
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21. How much bodily pain have you had during the past 4 weeks?
(Circle One Number)
None 1 
Very mild 2 
Mild 3 
Moderate 4 
Severe 5 
Very severe 6
22. During the past 4 weeks, how much did pain interfere with your normal work (including both 
work outside the home and housework)?
(Circle One Number)
Not at all 1 
A little bit 2 
Moderately 3 
Quite a bit 4 
Extremely 5
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These questions are about how you feel and how things have been with you during the past 4 
weeks. For each question, please give the one answer that comes closest to the way you have 
been feeling.
How much of the time during the past 4 weeks . . .
(Circle One Number on Each Line)
All of Most of A Good Some of A Little None of 
the the Bit of the the of the the
Time Time Time Time Time Time
23. Did you feel full of 
pep?
24. Have you been a very 
nervous person?
25. Have you felt so down 
in the dumps that nothing 
could cheer you up?
26. Have you felt calm 
and peaceful?
27. Did you have a lot of 
energy?
28. Have you felt 
downhearted and blue?
29. Did you feel worn out?
30. Have you been a 
happy person?
31. Did you feel tired?
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32. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting with friends, relatives, etc.)?
(Circle One Number)
All of the time 1 
Most of the time 2 
Some of the time 3 
A little of the time 4 
None of the time 5
How TRUE or FALSE is each of the following statements for you. 
(Circle One Number on Each Line)
3 3 .1 seem to get sick a little 
easier than other people
34 .1 am as healthy as 
anybody I know
35.1 expect my health to get 
worse
36. My health is excellent
Definitely Mostly Don't Mostly
True True Know False
Definitely
False
5
5
5
5
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Appendix 7: Reliability of hip flexor myometry method
Introduction
Hip flexor myometry was one of the primary outcome measures in chapter 6. The repeatability of 
the method used was unknown and a repeatability study was undertaken.
Method
The hip flexor measurement was taken from a strain gauges attached to a rigid metal frame. The 
subject was seated with the hips at 50° and the trunk and pelvis restrained. The strain gauge was 
attached to the subject via a canvas strap that they were asked to pull against during the MVC test. 
A multi-meter was connected to the strain gauge to monitor the output voltage so measurements 
were all taken from the same baseline tension. To calculate the moment, the length of the lever was 
measured from the greater trochanter to the centre of the strap. In chapter 6, bilateral recordings 
were taken.
Figure A7.1: Fixed
Repeatability of the hip flexor myometry set up described in chapter 6 was tested on the left hip on 
different days. Two trials were compared. Intraclass correlation coefficient (ICC), confidence 
intervals and limits of agreement 1 were calculated to examine repeatability between the two trials. 
An ICC over 0.75 was considered as demonstrating good agreement. ICC and confidence intervals 
were calculated using SPSS and the limits of agreement with the formulae suggested by Bland and 
Altman using Excel to perform the calculations.
Results
Table A7.1 shows the hip flexor moment recorded at the two trials and the difference between 
them.
Strain gauge
Multi-meter 
myometry set up for the hip flexors
2 0 8
Trial 1 Trial 2 Difference
1 49.64696 76.17342 26.52646
2 100.3834 88.29947 -12.0839
3 45.8934 47.2605 1.3671
4 64.4056 87.36063 22.95503
5 106.9905 114.705 7.714462
6 50.78497 63.36817 12.5832
7 132.7748 95.00688 -37.7679
8 72.9904 70.8665 -2.12391
9 64.03345 57.59289 -6.44056
10 107.3572 110.815 3.457803
11 70.31108 70.10504 -0.20604
12 47.75677 40.20438 -7.55239
13 49.907 44.2557 -5.6513
14 116.7427 107.8757 -8.86701
Table A7.1: Hip flexor moment recorded at trials 1 and 2 plus the difference between them.
Table A7.2 show the results and figure A7.1 shows a Bland Altman plot demonstrating the 
distribution of the data and the limits of agreement. The results show good agreement in the 
moment measures between the two trials.
Mean difference (deg) -0.43
Standard deviation of difference (deg) 15.80
Standard error of difference (deg) 4.22
Upper limits of agreement (deg) 31.17
Lower limits of agreement (deg) 32.04
ICC 0.83
Upper confidence interval 0.94
Lower confidence interval 0.56
Table A7.2: Descriptive statistics, limits of agreement1, ICC and confidence intervals for the data.
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Figure A7.2: Bland and Altman plot demonstrating the agreement of the data and the position 
within the upper and lower limits of agreement (red lines).
Conclusion
The statistics performed demonstrate good agreement between the trials indicating sufficient 
repeatability with the method used in chapter 6.
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